{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 193616, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:20:26Z", "timestamp": 1574162426374}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 2, 1]], "date-time": "1992-02-01T00:00:00Z", "timestamp": 696902400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Letters"], "published-print": {"date-parts": [[1992, 2]]}, "DOI": "10.1016/0304-3940(92)90444-c", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T06:26:26Z", "timestamp": 1051251986000}, "page": "235-238", "source": "Crossref", "is-referenced-by-count": 497, "title": ["Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid"], "prefix": "10.1016", "volume": "135", "author": [{"given": "Thomas", "family": "Wisniewski", "sequence": "first", "affiliation": []}, {"given": "Blas", "family": "Frangione", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:030439409290444C?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:030439409290444C?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T23:58:59Z", "timestamp": 1553212739000}, "score": 61.683132, "issued": {"date-parts": [[1992, 2]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[1992, 2]]}, "issue": "2"}, "alternative-id": ["030439409290444C"], "URL": "http://dx.doi.org/10.1016/0304-3940(92)90444-c", "ISSN": ["0304-3940"], "issn-type": [{"value": "0304-3940", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T16:05:30Z", "timestamp": 1574265930142}, "reference-count": 53, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "license": [{"URL": "http://creativecommons.org/licenses/by/2.0", "start": {"date-parts": [[2008, 12, 1]], "date-time": "2008-12-01T00:00:00Z", "timestamp": 1228089600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMC Neurosci"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1186/1471-2202-9-s2-s5", "type": "journal-article", "created": {"date-parts": [[2008, 12, 4]], "date-time": "2008-12-04T19:17:19Z", "timestamp": 1228418239000}, "source": "Crossref", "is-referenced-by-count": 30, "title": ["Preventing \u03b2-amyloid fibrillization and deposition: \u03b2-sheet breakers and pathological chaperone inhibitors"], "prefix": "10.1186", "volume": "9", "author": [{"given": "Thomas", "family": "Wisniewski", "sequence": "first", "affiliation": []}, {"given": "Martin", "family": "Sadowski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 12, 3]]}, "reference": [{"key": "986_CR1", "doi-asserted-by": "publisher", "first-page": "1075", "DOI": "10.1016/0022-2836(92)90106-T", "volume": "225", "author": "CJ Barrow", "year": "1992", "unstructured": "Barrow CJ, Yasuda A, Kenny PT, Zagorski MG: Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol. 1992, 225: 1075-1093. 10.1016/0022-2836(92)90106-T.", "journal-title": "J Mol Biol"}, {"key": "986_CR2", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1006/nbdi.1997.0147", "volume": "4", "author": "T Wisniewski", "year": "1997", "unstructured": "Wisniewski T, Ghiso J, Frangione B: Biology of A\u03b2 amyloid in Alzheimer's disease. Neurobiol Dis. 1997, 4: 313-328. 10.1006/nbdi.1997.0147.", "journal-title": "Neurobiol Dis"}, {"key": "986_CR3", "doi-asserted-by": "publisher", "first-page": "12243", "DOI": "10.1073/pnas.91.25.12243", "volume": "91", "author": "A Lorenzo", "year": "1994", "unstructured": "Lorenzo A, Yankner BA: Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA. 1994, 91: 12243-12247. 10.1073/pnas.91.25.12243.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR4", "doi-asserted-by": "publisher", "first-page": "2959", "DOI": "10.1073/pnas.92.7.2959", "volume": "92", "author": "G Merlini", "year": "1995", "unstructured": "Merlini G, Ascari E, Amboldi N, Bellotti V, Arbustini E, Perfetti V, Ferrari M, Zorzoli I, Marinone MG, Garini P: Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA. 1995, 92: 2959-2963. 10.1073/pnas.92.7.2959.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR5", "doi-asserted-by": "publisher", "first-page": "6839", "DOI": "10.1074/jbc.271.12.6839", "volume": "271", "author": "T Tomiyama", "year": "1996", "unstructured": "Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, Endo N: Inhibition of amyloid \u03b2 protein aggregation and neurotoxicity by rifampicin \u2013 Its possible function as a hydroxyl radical scavenger. J Biol Chem. 1996, 271: 6839-6844. 10.1074/jbc.271.12.6839.", "journal-title": "J Biol Chem"}, {"key": "986_CR6", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1038/nm0295-143", "volume": "1", "author": "R Kisilevsky", "year": "1995", "unstructured": "Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, Szarek WA: Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med. 1995, 1: 143-148. 10.1038/nm0295-143.", "journal-title": "Nat Med"}, {"key": "986_CR7", "doi-asserted-by": "publisher", "first-page": "7185", "DOI": "10.1074/jbc.273.13.7185", "volume": "273", "author": "M Pappolla", "year": "1998", "unstructured": "Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J: Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem. 1998, 273: 7185-7188. 10.1074/jbc.273.13.7185.", "journal-title": "J Biol Chem"}, {"key": "986_CR8", "doi-asserted-by": "publisher", "first-page": "1172", "DOI": "10.1111/j.1471-4159.2006.04426.x", "volume": "101", "author": "DM Walsh", "year": "2007", "unstructured": "Walsh DM, Selkoe DJ: Abeta oligomers \u2013 a decade of discovery. J Neurochem. 2007, 101: 1172-1184. 10.1111/j.1471-4159.2006.04426.x.", "journal-title": "J Neurochem"}, {"key": "986_CR9", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0022-2836(92)90835-8", "volume": "228", "author": "C Hilbich", "year": "1992", "unstructured": "Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K: Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease \u03b2A4 peptides. J Mol Biol. 1992, 228: 1-14. 10.1016/0022-2836(92)90835-8.", "journal-title": "J Mol Biol"}, {"key": "986_CR10", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.1006/bbrc.1996.1413", "volume": "226", "author": "C Soto", "year": "1996", "unstructured": "Soto C, Kindy MS, Baumann M, Frangione B: Inhibition of Alzheimer's amyloidosis by peptides that prevent \u03b2-sheet conformation. Biochem Biophys Res Commun. 1996, 226: 672-680. 10.1006/bbrc.1996.1413.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "986_CR11", "doi-asserted-by": "publisher", "first-page": "822", "DOI": "10.1038/nm0798-822", "volume": "4", "author": "C Soto", "year": "1998", "unstructured": "Soto C, Sigurdsson EM, Morelli L, Kumar A, Casta\u00f1o EM, Frangione B: \u03b2-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med. 1998, 4: 822-826. 10.1038/nm0798-822.", "journal-title": "Nat Med"}, {"key": "986_CR12", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1093/jnen/59.1.11", "volume": "59", "author": "EM Sigurdsson", "year": "2000", "unstructured": "Sigurdsson EM, Permanne B, Soto C, Wisniewski T, Frangione B: In vivo reversal of amyloid \u03b2 lesions in rat brain. J Neuropath Exp Neurol. 2000, 59: 11-17.", "journal-title": "J Neuropath Exp Neurol"}, {"key": "986_CR13", "doi-asserted-by": "crossref", "first-page": "860", "DOI": "10.1096/fj.01-0841fje", "volume": "16", "author": "B Permanne", "year": "2002", "unstructured": "Permanne B, Adessi C, Saborio GP, Fraga S, Frossard MJ, Van Dorpe J, Dewachter I, Banks WA, Van Leuven F, Soto C: Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a \u03b2-sheet breaker peptide. FASEB J. 2002, 16: 860-862.", "journal-title": "FASEB J"}, {"key": "986_CR14", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1016/S0140-6736(99)11419-3", "volume": "355", "author": "C Soto", "year": "2000", "unstructured": "Soto C, Kascsak RJ, Saborio GP, Aucouturier P, Wisniewski T, Prelli F, Kascsak R, Mendez E, Harris DA, Ironside J, Tagliavini F, Carp RI, Frangione B: Reversion of prion protein conformational changes by synthetic \u03b2-sheet breaker peptides. Lancet. 2000, 355: 192-197. 10.1016/S0140-6736(99)11419-3.", "journal-title": "Lancet"}, {"key": "986_CR15", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0304-3940(92)90444-C", "volume": "135", "author": "T Wisniewski", "year": "1992", "unstructured": "Wisniewski T, Frangione B: Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992, 135: 235-238. 10.1016/0304-3940(92)90444-C.", "journal-title": "Neurosci Lett"}, {"key": "986_CR16", "first-page": "1030", "volume": "145", "author": "T Wisniewski", "year": "1994", "unstructured": "Wisniewski T, Casta\u00f1o EM, Golabek AA, Vogel T, Frangione B: Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994, 145: 1030-1035.", "journal-title": "Am J Pathol"}, {"key": "986_CR17", "doi-asserted-by": "publisher", "first-page": "1943", "DOI": "10.2174/138161207781039788", "volume": "13", "author": "M Sadowski", "year": "2007", "unstructured": "Sadowski M, Wisniewski T: Disease modifying approaches for Alzheimer's pathology. Curr Pharmaceutic Design. 2007, 13: 1943-1954. 10.2174/138161207781039788.", "journal-title": "Curr Pharmaceutic Design"}, {"key": "986_CR18", "doi-asserted-by": "publisher", "first-page": "860", "DOI": "10.1172/JCI117407", "volume": "94", "author": "DA Sanan", "year": "1994", "unstructured": "Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ: Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest. 1994, 94: 860-869. 10.1172/JCI117407.", "journal-title": "J Clin Invest"}, {"key": "986_CR19", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1038/372092a0", "volume": "372", "author": "J Ma", "year": "1994", "unstructured": "Ma J, Yee A, Brewer HB, Das S, Potter H: Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994, 372: 92-94. 10.1038/372092a0.", "journal-title": "Nature"}, {"key": "986_CR20", "doi-asserted-by": "publisher", "first-page": "11830", "DOI": "10.1073/pnas.192203399", "volume": "99", "author": "LV Johnson", "year": "2002", "unstructured": "Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH: The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 2002, 99: 11830-11835. 10.1073/pnas.192203399.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR21", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1023/A:1021600212829", "volume": "28", "author": "KW Boyett", "year": "2003", "unstructured": "Boyett KW, DiCarlo G, Jantzen PT, Jackson J, O'Leary C, Wilcock D, Morgan D, Gordon MN: Increased fibrillar beta-amyloid in response to human C1q injections into hippocampus and cortex of APP+PS1 transgenic mice. Neurochem Res. 2003, 28: 83-93. 10.1023/A:1021600212829.", "journal-title": "Neurochem Res"}, {"key": "986_CR22", "doi-asserted-by": "publisher", "first-page": "956", "DOI": "10.1016/S0140-6736(95)90701-7", "volume": "345", "author": "T Wisniewski", "year": "1995", "unstructured": "Wisniewski T, Lalowski M, Golabek AA, Vogel T, Frangione B: Is Alzheimer's disease an apolipoprotein E amyloidosis?. Lancet. 1995, 345: 956-958. 10.1016/S0140-6736(95)90701-7.", "journal-title": "Lancet"}, {"key": "986_CR23", "doi-asserted-by": "publisher", "first-page": "10602", "DOI": "10.1074/jbc.271.18.10602", "volume": "271", "author": "AA Golabek", "year": "1996", "unstructured": "Golabek AA, Soto C, Vogel T, Wisniewski T: The interaction between apolipoprotein E and Alzheimer's amyloid \u03b2-peptide is dependent on \u03b2-peptide conformation. J Biol Chem. 1996, 271: 10602-10606. 10.1074/jbc.271.52.33623.", "journal-title": "J Biol Chem"}, {"key": "986_CR24", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1006/bbrc.1997.7727", "volume": "240", "author": "B Permanne", "year": "1997", "unstructured": "Permanne B, Perez C, Soto C, Frangione B, Wisniewski T: Detection of apolipoprotein E dimeric soluble amyloid \u03b2 complexes in Alzheimer's disease brain supernatants. Biochem Biophys Res Commun. 1997, 240: 715-720. 10.1006/bbrc.1997.7727.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "986_CR25", "doi-asserted-by": "publisher", "first-page": "674", "DOI": "10.1097/00005072-199807000-00004", "volume": "57", "author": "HM Wisniewski", "year": "1998", "unstructured": "Wisniewski HM, Sadowski M, Jakubowska-Sadowska K, Tarnawski M, Wegiel J: Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease. J Neuropathol Exp Neurol. 1998, 57: 674-683. 10.1097/00005072-199807000-00004.", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "986_CR26", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/0304-3940(94)91030-8", "volume": "167", "author": "E Kida", "year": "1994", "unstructured": "Kida E, Golabek AA, Wisniewski T, Wisniewski KE: Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci Lett. 1994, 167: 73-76. 10.1016/0304-3940(94)91030-8.", "journal-title": "Neurosci Lett"}, {"key": "986_CR27", "first-page": "526", "volume": "145", "author": "G Gallo", "year": "1994", "unstructured": "Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B: Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol. 1994, 145: 526-530.", "journal-title": "Am J Pathol"}, {"key": "986_CR28", "doi-asserted-by": "publisher", "first-page": "9649", "DOI": "10.1073/pnas.90.20.9649", "volume": "90", "author": "DE Schmechel", "year": "1993", "unstructured": "Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 9649-9653. 10.1073/pnas.90.20.9649.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR29", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1016/0896-6273(93)90070-8", "volume": "11", "author": "GW Rebeck", "year": "1993", "unstructured": "Rebeck GW, Reiter JS, Strickland DK, Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993, 11: 575-580. 10.1016/0896-6273(93)90070-8.", "journal-title": "Neuron"}, {"key": "986_CR30", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1038/ng1197-263", "volume": "17", "author": "KR Bales", "year": "1997", "unstructured": "Bales KR, Verina T, Dodel RC, Du YS, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM: Lack of apolipoprotein E dramatically reduces amyloid \u03b2-peptide deposition. Nat Genet. 1997, 17: 263-264. 10.1038/ng1197-263.", "journal-title": "Nat Genet"}, {"key": "986_CR31", "doi-asserted-by": "publisher", "first-page": "15233", "DOI": "10.1073/pnas.96.26.15233", "volume": "96", "author": "KR Bales", "year": "1999", "unstructured": "Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM: Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 1999, 96: 15233-15238. 10.1073/pnas.96.26.15233.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR32", "doi-asserted-by": "publisher", "first-page": "R15", "DOI": "10.1172/JCI6179", "volume": "103", "author": "DM Holtzman", "year": "1999", "unstructured": "Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM: Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest. 1999, 103: R15-R21. 10.1172/JCI6179.", "journal-title": "J Clin Invest"}, {"key": "986_CR33", "doi-asserted-by": "publisher", "first-page": "2892", "DOI": "10.1073/pnas.050004797", "volume": "97", "author": "DM Holtzman", "year": "2000", "unstructured": "Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM: Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2000, 97: 2892-2897. 10.1073/pnas.050004797.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR34", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1073/pnas.90.5.1977", "volume": "90", "author": "WJ Strittmatter", "year": "1993", "unstructured": "Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 1977-1981. 10.1073/pnas.90.5.1977.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR35", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1006/bbrc.1993.1423", "volume": "192", "author": "T Wisniewski", "year": "1993", "unstructured": "Wisniewski T, Golabek AA, Matsubara E, Ghiso J, Frangione B: Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun. 1993, 192: 359-365. 10.1006/bbrc.1993.1423.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "986_CR36", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/0896-6273(95)90079-9", "volume": "15", "author": "J Naslund", "year": "1995", "unstructured": "Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N, Gandy SE, Lannfelt L, Terenius L, Nordstedt C: Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron. 1995, 15: 219-228. 10.1016/0896-6273(95)90079-9.", "journal-title": "Neuron"}, {"key": "986_CR37", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1016/0197-4580(96)00112-1", "volume": "17", "author": "J Ma", "year": "1996", "unstructured": "Ma J, Brewer BH, Potter H, Brewer HB: Alzheimer A\u03b2 neurotoxicity: promotion by antichymotrypsin, apoE4; inhibition by A\u03b2-related peptides. Neurobiol Aging. 1996, 17: 773-780. 10.1016/0197-4580(96)00112-1.", "journal-title": "Neurobiol Aging"}, {"key": "986_CR38", "doi-asserted-by": "publisher", "first-page": "937", "DOI": "10.1016/S0002-9440(10)63355-X", "volume": "165", "author": "M Sadowski", "year": "2004", "unstructured": "Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, Mathews P, Fryer JD, Holtzman DM, Sigurdsson EM, Wisniewski T: Blocking the apolipoprotein E/\u03b2-amyloid interaction reduces \u03b2-amyloid toxicity and decreases \u03b2-amyloid load in transgenic mice. Am J Pathol. 2004, 165: 937-948.", "journal-title": "Am J Pathol"}, {"key": "986_CR39", "doi-asserted-by": "publisher", "first-page": "18787", "DOI": "10.1073/pnas.0604011103", "volume": "103", "author": "M Sadowski", "year": "2006", "unstructured": "Sadowski M, Pankiewicz J, Scholtzova H, Mehta P, Prelli F, Quartermain D, Wisniewski T: Blocking the apolipoproteinE/Amyloid \u03b2 interaction reduces the parenchymal and vascular amyloid-\u03b2 deposition and prevents memory deficit in AD transgenic mice. Proc Natl Acad Sci USA. 2006, 103: 18787-18792. 10.1073/pnas.0604011103.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "986_CR40", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1002/jnr.10328", "volume": "69", "author": "MD Kirkitadze", "year": "2002", "unstructured": "Kirkitadze MD, Bitan G, Teplow DB: Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res. 2002, 69: 567-577. 10.1002/jnr.10328.", "journal-title": "J Neurosci Res"}, {"key": "986_CR41", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1038/417254a", "volume": "417", "author": "MB Pepys", "year": "2002", "unstructured": "Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN: Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 2002, 417: 254-259. 10.1038/417254a.", "journal-title": "Nature"}, {"key": "986_CR42", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1046/j.1365-2141.1997.303194.x", "volume": "99", "author": "JD Gillmore", "year": "1997", "unstructured": "Gillmore JD, Hawkins PN, Pepys MB: Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol. 1997, 99: 245-256. 10.1046/j.1365-2141.1997.303194.x.", "journal-title": "Br J Haematol"}, {"key": "986_CR43", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1016/S0197-4580(04)80065-4", "volume": "25", "author": "PS Aisen", "year": "2004", "unstructured": "Aisen PS, Mehran M, Poole R, Lavoie E, Gervais F, Laurin J, Braind R, Garceau L: Clinical data on Alzhemed after 12 months of treatment in patients with mild to moderate Alzheimer's disease. Neurobiol Aging. 2004, 25: 20-10.1016/S0197-4580(04)80065-4.", "journal-title": "Neurobiol Aging"}, {"key": "986_CR44", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1038/nm1423", "volume": "12", "author": "J McLaurin", "year": "2006", "unstructured": "McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL, Darabie AA, Cousins JE, French JE, Lan MF, Chen F, Wong SS, Mount HT, Fraser PE, Westaway D, St George-Hyslop P: Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med. 2006, 12: 801-808. 10.1038/nm1423.", "journal-title": "Nat Med"}, {"issue": "Suppl 4", "key": "986_CR45", "doi-asserted-by": "publisher", "first-page": "S99", "DOI": "10.1097/00002093-200307004-00004", "volume": "17", "author": "S DeKosky", "year": "2003", "unstructured": "DeKosky S: Early intervention is key to successful management of Alzheimer disease. Alzheimer Dis Assoc Disord. 2003, 17 (Suppl 4): S99-104. 10.1097/00002093-200307004-00004.", "journal-title": "Alzheimer Dis Assoc Disord"}, {"key": "986_CR46", "doi-asserted-by": "publisher", "first-page": "2530", "DOI": "10.1111/j.1460-9568.2006.05149.x", "volume": "24", "author": "A Asuni", "year": "2006", "unstructured": "Asuni A, Boutajangout A, Scholtzova H, Knudsen E, Li Y, Quartermain D, Frangione B, Wisniewski T, Sigurdsson EM: A\u03b2 derivative vaccination in alum adjuvant prevents amyloid deposition and does not cause brain microhemorrhages in Alzheimer's model mice. Eur J Neurosci. 2006, 24: 2530-2542. 10.1111/j.1460-9568.2006.05149.x.", "journal-title": "Eur J Neurosci"}, {"key": "986_CR47", "doi-asserted-by": "publisher", "first-page": "2908", "DOI": "10.1093/brain/awl266", "volume": "129", "author": "CR Mondadori", "year": "2006", "unstructured": "Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K: Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain. 2006, 129: 2908-2922. 10.1093/brain/awl266.", "journal-title": "Brain"}, {"key": "986_CR48", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.1212/WNL.55.3.370", "volume": "55", "author": "FA Schmitt", "year": "2000", "unstructured": "Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR: \"Preclinical\" AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000, 55: 370-376.", "journal-title": "Neurology"}, {"key": "986_CR49", "doi-asserted-by": "publisher", "first-page": "1553", "DOI": "10.1212/01.WNL.0000159740.16984.3C", "volume": "64", "author": "S Gilman", "year": "2005", "unstructured": "Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Boada Rovira M, Forette F, Orgogozo JM: Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interupted trial. Neurology. 2005, 64: 1553-1562. 10.1212/01.WNL.0000159740.16984.3C.", "journal-title": "Neurology"}, {"key": "986_CR50", "doi-asserted-by": "publisher", "first-page": "547", "DOI": "10.1016/S0896-6273(03)00294-0", "volume": "38", "author": "C Hock", "year": "2003", "unstructured": "Hock C, Konietzko U, Straffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Axel Wollmar M, Umbricht D, de Quervain DJF, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM: Antibodies against \u03b2-amyloid slow cognitive decline in Alzheimer's disease. Neuron. 2003, 38: 547-554. 10.1016/S0896-6273(03)00294-0.", "journal-title": "Neuron"}, {"key": "986_CR51", "doi-asserted-by": "publisher", "first-page": "3784", "DOI": "10.1111/j.1742-4658.2007.05919.x", "volume": "274", "author": "T Wisniewski", "year": "2007", "unstructured": "Wisniewski T, Sigurdsson EM: Therapeutic approaches for prion and Alzheimer's diseases. FEBS J. 2007, 274: 3784-3798. 10.1111/j.1742-4658.2007.05919.x.", "journal-title": "FEBS J"}, {"key": "986_CR52", "doi-asserted-by": "publisher", "first-page": "6174", "DOI": "10.1523/JNEUROSCI.0730-07.2007", "volume": "27", "author": "WE Klunk", "year": "2007", "unstructured": "Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST: Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007, 27: 6174-6184. 10.1523/JNEUROSCI.0730-07.2007.", "journal-title": "J Neurosci"}, {"key": "986_CR53", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1016/j.neurobiolaging.2006.12.018", "volume": "29", "author": "E Sigurdsson", "year": "2008", "unstructured": "Sigurdsson E, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, Tsui WH, Sadowski M, Turnbull D, de Leon M, Wisniewski T: A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging. 2008, 29: 836-847. 10.1016/j.neurobiolaging.2006.12.018.", "journal-title": "Neurobiol Aging"}], "container-title": ["BMC Neuroscience"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1471-2202-9-S2-S5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1471-2202-9-S2-S5/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1471-2202-9-S2-S5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T18:59:56Z", "timestamp": 1548183596000}, "score": 37.920483, "issued": {"date-parts": [[2008, 12]]}, "references-count": 53, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "S2"}, "alternative-id": ["986"], "URL": "http://dx.doi.org/10.1186/1471-2202-9-s2-s5", "relation": {"cites": []}, "ISSN": ["1471-2202"], "issn-type": [{"value": "1471-2202", "type": "electronic"}], "article-number": "S5"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:18:46Z", "timestamp": 1574104726649}, "reference-count": 15, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 3, 1]], "date-time": "1995-03-01T00:00:00Z", "timestamp": 794016000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the Neurological Sciences"], "published-print": {"date-parts": [[1995, 3]]}, "DOI": "10.1016/0022-510x(94)00274-r", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:33:30Z", "timestamp": 1027636410000}, "page": "74-75", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein"], "prefix": "10.1016", "volume": "129", "author": [{"given": "J.", "family": "Ghiso", "sequence": "first", "affiliation": []}, {"given": "G.T.", "family": "Plant", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "R\u00e9v\u00e9sz", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Wisniewski", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Frangione", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the Neurological Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0022510X9400274R?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0022510X9400274R?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T03:23:58Z", "timestamp": 1555644238000}, "score": 30.506454, "issued": {"date-parts": [[1995, 3]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[1995, 3]]}, "issue": "1"}, "alternative-id": ["0022510X9400274R"], "URL": "http://dx.doi.org/10.1016/0022-510x(94)00274-r", "ISSN": ["0022-510X"], "issn-type": [{"value": "0022-510X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T12:12:52Z", "timestamp": 1574424772693}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Neurol"], "published-print": {"date-parts": [[1996, 2, 1]]}, "DOI": "10.1001/archneur.1996.00550020105022", "type": "journal-article", "created": {"date-parts": [[2011, 11, 29]], "date-time": "2011-11-29T04:13:50Z", "timestamp": 1322540030000}, "page": "189", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Cerebrospinal Fluid Concentrations of Soluble Amyloid \u03b2-Protein and Apolipoprotein E in Patients With Alzheimer's Disease"], "prefix": "10.1001", "volume": "53", "author": [{"given": "T.", "family": "Pirttil\u00e4", "sequence": "first", "affiliation": []}], "member": "10", "container-title": ["Archives of Neurology"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamaneurology/fullarticle/593864", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T06:29:08Z", "timestamp": 1481956148000}, "score": 30.07005, "subtitle": ["Correlations With Amyloid Load in the Brain"], "issued": {"date-parts": [[1996, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1001/archneur.1996.00550020105022", "ISSN": ["0003-9942"], "issn-type": [{"value": "0003-9942", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T02:15:43Z", "timestamp": 1575166543822}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 1, 1]], "date-time": "1996-01-01T00:00:00Z", "timestamp": 820454400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurobiology of Aging"], "published-print": {"date-parts": [[1996, 1]]}, "DOI": "10.1016/s0197-4580(96)80702-0", "type": "journal-article", "created": {"date-parts": [[2005, 8, 5]], "date-time": "2005-08-05T11:14:36Z", "timestamp": 1123240476000}, "page": "S174", "source": "Crossref", "is-referenced-by-count": 0, "title": ["700 Binding between apolipoprotein E and amyloid \u03b2 is dependent on secondary structure"], "prefix": "10.1016", "volume": "17", "author": [{"given": "A.A.", "family": "Golabek", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Soto", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neurobiology of Aging"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0197458096807020?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0197458096807020?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 23]], "date-time": "2019-01-23T23:59:19Z", "timestamp": 1548287959000}, "score": 27.918945, "issued": {"date-parts": [[1996, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 1]]}, "issue": "4"}, "alternative-id": ["S0197458096807020"], "URL": "http://dx.doi.org/10.1016/s0197-4580(96)80702-0", "ISSN": ["0197-4580"], "issn-type": [{"value": "0197-4580", "type": "print"}], "subject": ["Developmental Biology", "Ageing", "General Neuroscience", "Geriatrics and Gerontology", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:21:08Z", "timestamp": 1574367668308}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Neuropathology and Experimental Neurology"], "published-print": {"date-parts": [[1995, 5]]}, "DOI": "10.1097/00005072-199505000-00021", "type": "journal-article", "created": {"date-parts": [[2008, 5, 4]], "date-time": "2008-05-04T16:03:01Z", "timestamp": 1209916981000}, "page": "411", "source": "Crossref", "is-referenced-by-count": 0, "title": ["APOLIPOPROTEIN E AMYLOID IN ALZHEIMER\u02bcS PLAQUE"], "prefix": "10.1093", "volume": "54", "author": [{"given": "T.", "family": "Wisniewski", "sequence": "first", "affiliation": []}, {"given": "A. Golabek. M.", "family": "Lalowski", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Vogelo", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Frangione", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Journal of Neuropathology and Experimental Neurology"], "language": "en", "deposited": {"date-parts": [[2015, 11, 26]], "date-time": "2015-11-26T20:26:46Z", "timestamp": 1448569606000}, "score": 27.214537, "subtitle": ["2"], "issued": {"date-parts": [[1995, 5]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00005072-199505000-00021", "ISSN": ["0022-3069"], "issn-type": [{"value": "0022-3069", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:50:38Z", "timestamp": 1574488238408}, "reference-count": 91, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/3.0/", "start": {"date-parts": [[2012, 1, 1]], "date-time": "2012-01-01T00:00:00Z", "timestamp": 1325376000000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["NS073502", "AG020245", "AG025711", "AG037942"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Alzheimer's Disease"], "published-print": {"date-parts": [[2012]]}, "abstract": "<jats:p>The amyloid cascade hypothesis remains a robust model of AD neurodegeneration. However, amyloid deposits contain proteins besides A<jats:italic>\u03b2</jats:italic>, such as apolipoprotein E (apoE). Inheritance of the apoE4 allele is the strongest genetic risk factor for late-onset AD. However, there is no consensus on how different apoE isotypes contribute to AD pathogenesis. It has been hypothesized that apoE and apoE4 in particular is an amyloid catalyst or \u201cpathological chaperone\u201d. Alternatively it has been posited that apoE regulates A<jats:italic>\u03b2</jats:italic>clearance, with apoE4 been worse at this function compared to apoE3. These views seem fundamentally opposed. The former would indicate that removing apoE will reduce AD pathology, while the latter suggests increasing brain ApoE levels may be beneficial. Here we consider the scientific basis of these different models of apoE function and suggest that these seemingly opposing views can be reconciled. The optimal therapeutic target may be to inhibit the interaction of apoE with A<jats:italic>\u03b2</jats:italic>rather than altering apoE levels. Such an approach will not have detrimental effects on the many beneficial roles apoE plays in neurobiology. Furthermore, other A<jats:italic>\u03b2</jats:italic>binding proteins, including ACT and apo J can inhibit or promote A<jats:italic>\u03b2</jats:italic>oligomerization/polymerization depending on conditions and might be manipulated to effect AD treatment.</jats:p>", "DOI": "10.1155/2012/489428", "type": "journal-article", "created": {"date-parts": [[2012, 7, 15]], "date-time": "2012-07-15T21:04:17Z", "timestamp": 1342386257000}, "page": "1-9", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade"], "prefix": "10.1155", "volume": "2012", "author": [{"given": "Huntington", "family": "Potter", "sequence": "first", "affiliation": [{"name": "Department of Molecular Medicine, Suncoast Gerontology Center, Johnnie B. Byrd Sr. Alzheimer\u2019s Institute, University of South Florida, Tampa, FL 33620, USA"}, {"name": "Department of Neurology and Linda Crnic Institute for Downs Syndrome, School of Medicine, University of Colorado Aurora, CO 80045, USA"}]}, {"given": "Thomas", "family": "Wisniewski", "sequence": "additional", "affiliation": [{"name": "Departments of Neurology, Pathology, and Psychiatry, New York University School of Medicine, New York, NY 10016, USA"}]}], "member": "98", "reference": [{"key": "1", "volume": "9", "issue": "3", "first-page": "151", "year": "2006", "journal-title": "Journal of Alzheimer's Disease"}, {"key": "2", "volume": "10", "first-page": "698", "year": "2011", "journal-title": "Nature Reviews Drug Discovery", "DOI": "10.1038/nrd3505", "doi-asserted-by": "crossref"}, {"key": "3", "DOI": "10.1074/jbc.272.35.22364", "doi-asserted-by": "publisher"}, {"key": "4", "volume": "95", "issue": "11", "first-page": "6448", "year": "1998", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America", "DOI": "10.1073/pnas.95.11.6448", "doi-asserted-by": "crossref"}, {"key": "5", "DOI": "10.1021/bi972029u", "doi-asserted-by": "publisher"}, {"key": "6", "DOI": "10.1038/nature04533", "doi-asserted-by": "publisher"}, {"key": "7", "DOI": "10.1016/S0006-8993(01)03058-X", "doi-asserted-by": "publisher"}, {"key": "8", "DOI": "10.1038/416535a", "doi-asserted-by": "publisher"}, {"key": "9", "volume": "52", "issue": "4", "first-page": "487", "year": "1988", "journal-title": "Cell", "DOI": "10.1016/0092-8674(88)90462-X", "doi-asserted-by": "crossref"}, {"key": "10", "DOI": "10.1016/0006-8993(91)91092-F", "doi-asserted-by": "publisher"}, {"key": "11", "DOI": "10.1016/0304-3940(92)90444-C", "doi-asserted-by": "publisher"}, {"key": "12", "volume": "345", "issue": "8955", "first-page": "956", "year": "1995", "journal-title": "The Lancet", "DOI": "10.1016/S0140-6736(95)90701-7", "doi-asserted-by": "crossref"}, {"key": "13", "volume": "3", "first-page": "d436", "year": "1998", "journal-title": "Frontiers in Bioscience", "DOI": "10.2741/A290", "doi-asserted-by": "crossref"}, {"key": "14", "DOI": "10.1016/S0197-4580(01)00308-6", "doi-asserted-by": "publisher"}, {"key": "15", "DOI": "10.2174/1568007054038229", "doi-asserted-by": "publisher"}, {"key": "16", "volume": "64", "first-page": "146", "year": "1907", "journal-title": "Allgemeine Zeitschrift fur Psychiatrie und Psychisch-gerichtliche Medizin"}, {"key": "17", "volume": "9", "issue": "4", "first-page": "339", "year": "1988", "journal-title": "Neurobiology of Aging"}, {"key": "18", "volume": "86", "issue": "19", "first-page": "7611", "year": "1989", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America", "DOI": "10.1073/pnas.86.19.7611", "doi-asserted-by": "crossref"}, {"key": "19", "volume": "90", "issue": "5", "first-page": "1977", "year": "1993", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America", "DOI": "10.1073/pnas.90.5.1977", "doi-asserted-by": "crossref"}, {"key": "20", "volume": "261", "issue": "5123", "first-page": "921", "year": "1993", "journal-title": "Science", "DOI": "10.1126/science.8346443", "doi-asserted-by": "crossref"}, {"key": "21", "volume": "92", "first-page": "4725", "year": "1995", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America", "DOI": "10.1073/pnas.92.11.4725", "doi-asserted-by": "crossref"}, {"key": "22", "volume": "88", "first-page": "344", "year": "1999", "journal-title": "American Journal of Medical Genetics", "DOI": "10.1002/(SICI)1096-8628(19990820)88:4<344::AID-AJMG10>3.0.CO;2-1", "doi-asserted-by": "crossref"}, {"key": "23", "DOI": "10.2174/156720507783018334", "doi-asserted-by": "publisher"}, {"key": "24", "DOI": "10.1016/j.neuron.2009.06.026", "doi-asserted-by": "publisher"}, {"key": "25", "DOI": "10.1016/S1474-4422(10)70325-2", "doi-asserted-by": "publisher"}, {"key": "26", "DOI": "10.1016/j.plipres.2010.09.001", "doi-asserted-by": "publisher"}, {"key": "27", "DOI": "10.1038/372092a0", "doi-asserted-by": "publisher"}, {"key": "28", "volume": "145", "issue": "5", "first-page": "1030", "year": "1994", "journal-title": "American Journal of Pathology"}, {"key": "29", "volume": "94", "issue": "2", "first-page": "860", "year": "1994", "journal-title": "Journal of Clinical Investigation", "DOI": "10.1172/JCI117407", "doi-asserted-by": "crossref"}, {"key": "30", "DOI": "10.1016/0197-4580(96)00112-1", "doi-asserted-by": "publisher"}, {"key": "31", "volume": "17", "issue": "3", "first-page": "263", "year": "1997", "journal-title": "Nature genetics", "DOI": "10.1038/ng1197-263", "doi-asserted-by": "crossref"}, {"key": "32", "DOI": "10.1073/pnas.96.26.15233", "doi-asserted-by": "publisher"}, {"key": "33", "volume": "47", "issue": "6", "first-page": "739", "year": "2000", "journal-title": "Annals of Neurology", "DOI": "10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8", "doi-asserted-by": "crossref"}, {"key": "34", "DOI": "10.1073/pnas.050004797", "doi-asserted-by": "publisher"}, {"key": "35", "volume": "157", "issue": "6", "first-page": "2003", "year": "2000", "journal-title": "American Journal of Pathology", "DOI": "10.1016/S0002-9440(10)64839-0", "doi-asserted-by": "crossref"}, {"key": "36", "volume": "21", "issue": "5", "first-page": "1444", "year": "2001", "journal-title": "Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.21-05-01444.2001", "doi-asserted-by": "crossref"}, {"key": "37", "year": "2001", "volume-title": "Beyond beta protein\u2014the essential role of inflammation in Alzheimer Amyloid formation"}, {"key": "38"}, {"key": "39", "DOI": "10.1016/j.neurobiolaging.2006.05.024", "doi-asserted-by": "publisher"}, {"key": "40", "DOI": "10.1371/journal.pone.0014586", "doi-asserted-by": "publisher"}, {"key": "41", "volume": "135", "first-page": "2155", "year": "2012", "journal-title": "Brain", "DOI": "10.1093/brain/aws127", "doi-asserted-by": "crossref"}, {"key": "42", "volume": "345", "issue": "8955", "first-page": "956", "year": "1995", "journal-title": "The Lancet", "DOI": "10.1016/S0140-6736(95)90701-7", "doi-asserted-by": "crossref"}, {"key": "43", "volume": "15", "issue": "1", "first-page": "219", "year": "1995", "journal-title": "Neuron", "DOI": "10.1016/0896-6273(95)90079-9", "doi-asserted-by": "crossref"}, {"key": "44", "volume": "271", "issue": "18", "first-page": "10602", "year": "1996", "journal-title": "Journal of Biological Chemistry", "DOI": "10.1074/jbc.271.18.10602", "doi-asserted-by": "crossref"}, {"key": "45", "first-page": "161", "year": "2007", "volume-title": "Apolipoprotein E, amyloid beta-peptide and Alzheimer's disease"}, {"key": "46", "DOI": "10.1126/scitranslmed.3002156", "doi-asserted-by": "publisher"}, {"key": "47", "volume": "103", "issue": "6", "first-page": "R15", "year": "1999", "journal-title": "Journal of Clinical Investigation", "DOI": "10.1172/JCI6179", "doi-asserted-by": "crossref"}, {"key": "48", "DOI": "10.1006/nbdi.2002.0483", "doi-asserted-by": "publisher"}, {"key": "49", "DOI": "10.1073/pnas.0409072102", "doi-asserted-by": "publisher"}, {"key": "50", "DOI": "10.1172/JCI36663", "doi-asserted-by": "publisher"}, {"key": "51", "DOI": "10.1073/pnas.151261398", "doi-asserted-by": "publisher"}, {"key": "52", "DOI": "10.1038/nn842", "doi-asserted-by": "publisher"}, {"key": "53", "DOI": "10.1126/science.1067568", "doi-asserted-by": "publisher"}, {"key": "54", "volume": "23", "issue": "1", "first-page": "29", "year": "2003", "journal-title": "Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.23-01-00029.2003", "doi-asserted-by": "crossref"}, {"key": "55", "DOI": "10.1016/j.neuron.2008.04.010", "doi-asserted-by": "publisher"}, {"key": "56", "DOI": "10.1074/jbc.M110.108100", "doi-asserted-by": "publisher"}, {"key": "57", "volume": "335", "issue": "6075", "first-page": "1503", "year": "2012", "journal-title": "Science", "DOI": "10.1126/science.1217697", "doi-asserted-by": "crossref"}, {"key": "58", "DOI": "10.1172/JCI33622", "doi-asserted-by": "publisher"}, {"key": "59", "volume": "31", "first-page": "18007", "year": "2011", "journal-title": "The Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.3773-11.2011", "doi-asserted-by": "crossref"}, {"key": "60", "volume": "32", "issue": "14", "first-page": "4803", "year": "2012", "journal-title": "The Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.0033-12.2012", "doi-asserted-by": "crossref"}, {"key": "61", "volume": "269", "issue": "38", "first-page": "23403", "year": "1994", "journal-title": "Journal of Biological Chemistry"}, {"key": "62", "DOI": "10.1021/bi9626362", "doi-asserted-by": "publisher"}, {"key": "63", "DOI": "10.1042/0264-6021:3480359", "doi-asserted-by": "publisher"}, {"key": "64", "DOI": "10.1016/j.neuron.2004.07.017", "doi-asserted-by": "publisher"}, {"key": "65", "year": "1991"}, {"key": "66", "year": "1999"}, {"key": "67", "DOI": "10.1016/j.expneurol.2004.07.007", "doi-asserted-by": "publisher"}, {"key": "68", "DOI": "10.1007/s11481-007-9069-z", "doi-asserted-by": "publisher"}, {"key": "69", "DOI": "10.3233/JAD-2010-091471", "doi-asserted-by": "publisher"}, {"key": "70", "DOI": "10.1046/j.0953-816X.2001.01666.x", "doi-asserted-by": "publisher"}, {"key": "71", "DOI": "10.1523/JNEUROSCI.5715-08.2009", "doi-asserted-by": "publisher"}, {"key": "72", "DOI": "10.1016/j.npep.2010.03.001", "doi-asserted-by": "publisher"}, {"key": "73", "volume": "7", "first-page": "1693", "year": "2011", "journal-title": "Molecular BioSystems", "DOI": "10.1039/c1mb05019b", "doi-asserted-by": "crossref"}, {"key": "74", "volume": "165", "issue": "3", "first-page": "937", "year": "2004", "journal-title": "American Journal of Pathology", "DOI": "10.1016/S0002-9440(10)63355-X", "doi-asserted-by": "crossref"}, {"key": "75", "DOI": "10.1073/pnas.0604011103", "doi-asserted-by": "publisher"}, {"key": "76", "DOI": "10.3233/JAD-2011-101401", "doi-asserted-by": "publisher"}, {"key": "77", "volume": "14", "issue": "2", "first-page": "447", "year": "1995", "journal-title": "Neuron", "DOI": "10.1016/0896-6273(95)90300-3", "doi-asserted-by": "crossref"}, {"key": "78", "DOI": "10.1038/sj.npp.1300668", "doi-asserted-by": "publisher"}, {"key": "79", "volume": "293", "issue": "1", "first-page": "27", "year": "1993", "journal-title": "Biochemical Journal", "DOI": "10.1042/bj2930027", "doi-asserted-by": "crossref"}, {"key": "80", "DOI": "10.1021/bi002186k", "doi-asserted-by": "publisher"}, {"key": "81", "DOI": "10.1016/j.biocel.2008.12.003", "doi-asserted-by": "publisher"}, {"key": "82", "DOI": "10.1038/sj.jcbfm.9600419", "doi-asserted-by": "publisher"}, {"key": "83", "DOI": "10.1111/j.1471-4159.2007.04938.x", "doi-asserted-by": "publisher"}, {"key": "84", "DOI": "10.1073/pnas.162228299", "doi-asserted-by": "publisher"}, {"key": "85", "DOI": "10.1038/nrneurol.2009.219", "doi-asserted-by": "publisher"}, {"key": "86", "volume": "22", "issue": "18", "first-page": "7873", "year": "2002", "journal-title": "Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.22-18-07873.2002", "doi-asserted-by": "crossref"}, {"key": "87", "DOI": "10.4161/cc.10.9.15478", "doi-asserted-by": "publisher"}, {"key": "88", "volume": "16", "issue": "1", "first-page": "31", "year": "1996", "journal-title": "Journal of Neuroscience", "DOI": "10.1523/JNEUROSCI.16-01-00031.1996", "doi-asserted-by": "crossref"}, {"key": "89", "DOI": "10.1016/S0891-0618(98)00012-X", "doi-asserted-by": "publisher"}, {"key": "90", "DOI": "10.1371/journal.pone.0008556", "doi-asserted-by": "publisher"}, {"key": "91", "DOI": "10.1073/pnas.0914984107", "doi-asserted-by": "publisher"}], "container-title": ["International Journal of Alzheimer's Disease"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/ijad/2012/489428.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/ijad/2012/489428.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/ijad/2012/489428.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 30]], "date-time": "2019-06-30T23:44:10Z", "timestamp": 1561938250000}, "score": 26.587402, "issued": {"date-parts": [[2012]]}, "references-count": 91, "alternative-id": ["489428", "489428"], "URL": "http://dx.doi.org/10.1155/2012/489428", "relation": {"cites": []}, "ISSN": ["2090-8024", "2090-0252"], "issn-type": [{"value": "2090-8024", "type": "print"}, {"value": "2090-0252", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T18:07:52Z", "timestamp": 1575050872975}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 4, 1]], "date-time": "1993-04-01T00:00:00Z", "timestamp": 733622400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical and Biophysical Research Communications"], "published-print": {"date-parts": [[1993, 4]]}, "DOI": "10.1006/bbrc.1993.1423", "type": "journal-article", "created": {"date-parts": [[2002, 10, 6]], "date-time": "2002-10-06T17:58:31Z", "timestamp": 1033927111000}, "page": "359-365", "source": "Crossref", "is-referenced-by-count": 183, "title": ["Apolipoprotein E: Binding to Soluble Alzheimer\u2032s \u03b2-Amyloid"], "prefix": "10.1006", "volume": "192", "author": [{"given": "T.", "family": "Wisniewski", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Golabek", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Matsubara", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Ghiso", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Frangione", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical and Biophysical Research Communications"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006291X83714233?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006291X83714233?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 6]], "date-time": "2019-05-06T21:23:37Z", "timestamp": 1557177817000}, "score": 26.009884, "issued": {"date-parts": [[1993, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 4]]}, "issue": "2"}, "alternative-id": ["S0006291X83714233"], "URL": "http://dx.doi.org/10.1006/bbrc.1993.1423", "ISSN": ["0006-291X"], "issn-type": [{"value": "0006-291X", "type": "print"}], "subject": ["Biophysics", "Cell Biology", "Biochemistry", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:49:36Z", "timestamp": 1576781376574}, "reference-count": 0, "publisher": "IOS Press", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAD"], "published-print": {"date-parts": [[2011, 4, 11]]}, "DOI": "10.3233/jad-2011-101401", "type": "journal-article", "created": {"date-parts": [[2018, 5, 16]], "date-time": "2018-05-16T08:19:54Z", "timestamp": 1526458794000}, "page": "269-285", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Blocking the Apolipoprotein E/Amyloid-\u03b2 Interaction Reduces Fibrillar Vascular Amyloid Deposition and Cerebral Microhemorrhages in TgSwDI Mice"], "prefix": "10.3233", "volume": "24", "author": [{"given": "Jing", "family": "Yang", "sequence": "first", "affiliation": [{"name": "Department of Neurology, New York University School of Medicine, New York, NY, USA"}]}, {"given": "Yong", "family": "Ji", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, New York University School of Medicine, New York, NY, USA"}]}, {"given": "Pankaj", "family": "Mehta", "sequence": "additional", "affiliation": [{"name": "New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, NY, USA"}]}, {"given": "Kristyn A.", "family": "Bates", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, New York University School of Medicine, New York, NY, USA"}, {"name": "School of Exercise, Biomedical and Health Science, Edith Cowan University, Western Australia"}]}, {"given": "Yanjie", "family": "Sun", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, New York University School of Medicine, New York, NY, USA"}]}, {"given": "Thomas", "family": "Wisniewski", "sequence": "additional", "affiliation": [{"name": "Department of Neurology, New York University School of Medicine, New York, NY, USA"}, {"name": "Department of Pathology, New York University School of Medicine, New York, NY, USA"}, {"name": "Department of Psychiatry, New York University School of Medicine, New York, NY, USA"}]}], "member": "7437", "container-title": ["Journal of Alzheimer's Disease"], "link": [{"URL": "https://content.iospress.com/download?id=10.3233/JAD-2011-101401", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T06:36:40Z", "timestamp": 1575355000000}, "score": 25.66301, "issued": {"date-parts": [[2011, 4, 11]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.3233/jad-2011-101401", "ISSN": ["1875-8908", "1387-2877"], "issn-type": [{"value": "1387-2877", "type": "print"}, {"value": "1875-8908", "type": "electronic"}], "subject": ["Clinical Psychology", "Geriatrics and Gerontology", "Psychiatry and Mental health", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:49:24Z", "timestamp": 1574520564558}, "publisher-location": "Dordrecht", "reference-count": 430, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789400754157", "type": "print"}, {"value": "9789400754164", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-94-007-5416-4_16", "type": "book-chapter", "created": {"date-parts": [[2012, 12, 5]], "date-time": "2012-12-05T23:36:12Z", "timestamp": 1354750572000}, "page": "389-455", "source": "Crossref", "is-referenced-by-count": 60, "title": ["Parkinson\u2019s Disease"], "prefix": "10.1007", "author": [{"given": "Timothy R.", "family": "Mhyre", "sequence": "first", "affiliation": []}, {"given": "James T.", "family": "Boyd", "sequence": "additional", "affiliation": []}, {"given": "Robert W.", "family": "Hamill", "sequence": "additional", "affiliation": []}, {"given": "Kathleen A.", "family": "Maguire-Zeiss", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 12, 6]]}, "reference": [{"key": "16_CR1", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1001/archneur.60.3.387", "volume": "60", "author": "D Aarsland", "year": "2003", "unstructured": "Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387\u2013392", "journal-title": "Arch Neurol"}, {"key": "16_CR2", "doi-asserted-by": "publisher", "first-page": "1255", "DOI": "10.1002/mds.20527", "volume": "20", "author": "D Aarsland", "year": "2005", "unstructured": "Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20:1255\u20131263", "journal-title": "Mov Disord"}, {"key": "16_CR3", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/S1474-4422(09)70146-2", "volume": "8", "author": "D Aarsland", "year": "2009a", "unstructured": "Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E (2009a) Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 8:613\u2013618", "journal-title": "Lancet Neurol"}, {"key": "16_CR4", "doi-asserted-by": "publisher", "first-page": "2175", "DOI": "10.1002/mds.22589", "volume": "24", "author": "D Aarsland", "year": "2009b", "unstructured": "Aarsland D, Marsh L, Schrag A (2009b) Neuropsychiatric symptoms in Parkinson\u2019s disease. Mov Disord 24:2175\u20132186", "journal-title": "Mov Disord"}, {"key": "16_CR5", "doi-asserted-by": "publisher", "first-page": "1062", "DOI": "10.1212/WNL.0b013e3181f39d0e", "volume": "75", "author": "D Aarsland", "year": "2010", "unstructured": "Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062\u20131069", "journal-title": "Neurology"}, {"key": "16_CR6", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1038/nrneurol.2011.189", "volume": "8", "author": "D Aarsland", "year": "2012", "unstructured": "Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease[mdash]epidemiology, mechanisms and management. Nat Rev Neurol 8:35\u201347", "journal-title": "Nat Rev Neurol"}, {"key": "16_CR7", "doi-asserted-by": "publisher", "first-page": "456", "DOI": "10.1212/WNL.57.3.456", "volume": "5", "author": "RD Abbott", "year": "2001", "unstructured": "Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology 5:456\u2013462", "journal-title": "Neurology"}, {"key": "16_CR8", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1016/0166-2236(89)90074-X", "volume": "12", "author": "RL Albin", "year": "1989", "unstructured": "Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366\u2013375", "journal-title": "Trends Neurosci"}, {"key": "16_CR9", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1111/j.1365-2990.2007.00888.x", "volume": "34", "author": "J Alegre-Abarrategui", "year": "2008", "unstructured": "Alegre-Abarrategui J, Ansorge O, Esiri M, Wade-Martins R (2008) LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 34:272\u2013283", "journal-title": "Neuropathol Appl Neurobiol"}, {"key": "16_CR10", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1146/annurev.ne.09.030186.002041", "volume": "9", "author": "GE Alexander", "year": "1986", "unstructured": "Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9:357\u2013381", "journal-title": "Ann Rev Neurosci"}, {"key": "16_CR11", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1016/S0079-6123(08)62678-3", "volume": "85", "author": "GE Alexander", "year": "1990", "unstructured": "Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions. Prog Brain Res 85:119\u2013146", "journal-title": "Prog Brain Res"}, {"key": "16_CR12", "doi-asserted-by": "publisher", "first-page": "1287", "DOI": "10.1136/bmj.320.7245.1287", "volume": "320", "author": "H Allain", "year": "2000", "unstructured": "Allain H, Schuck S, Mauduit N (2000) Depression in Parkinson\u2019s disease. BMJ 320:1287\u20131288", "journal-title": "BMJ"}, {"key": "16_CR13", "doi-asserted-by": "publisher", "first-page": "1436", "DOI": "10.1212/01.wnl.0000183359.50822.f2", "volume": "65", "author": "G Alves", "year": "2005", "unstructured": "Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2005) Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65:1436\u20131441", "journal-title": "Neurology"}, {"key": "16_CR14", "doi-asserted-by": "publisher", "first-page": "14807", "DOI": "10.1073/pnas.0703219104", "volume": "104", "author": "E Andres-Mateos", "year": "2007", "unstructured": "Andres-Mateos E Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, Dawson VL (2007) DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA 104:14807\u201314812", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "50", "key": "16_CR15", "doi-asserted-by": "publisher", "first-page": "15846", "DOI": "10.1523/JNEUROSCI.4357-09.2009", "volume": "29", "author": "E Andres-Mateos", "year": "2009", "unstructured": "Andres-Mateos E, Mejias R, Sasaki M, Li X, Lin BM, Biskup S, Zhang L, Banerjee R, Thomas B, Yang L, Liu G, Beal MF, Huso DL, Dawson TM, Dawson VL (2009) Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). J Neurosci 29(50):15846\u201315850", "journal-title": "J Neurosci"}, {"key": "16_CR16", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1016/S1474-4422(10)70213-1", "volume": "9", "author": "E Angot", "year": "2010", "unstructured": "Angot E, Steiner JA, Hansen C, Li JY, Brundin P (2010) Are synucleinopathies prion-like disorders? Lancet Neurol 9:1128\u20131138", "journal-title": "Lancet Neurol"}, {"key": "16_CR17", "doi-asserted-by": "publisher", "first-page": "493", "DOI": "10.1016/0021-9681(75)90058-2", "volume": "28", "author": "KA Ansari", "year": "1975", "unstructured": "Ansari KA, Johnson A (1975) Olfactory function in patients with Parkinson\u2019s disease. J Chronic Dis 28:493\u2013497", "journal-title": "J Chronic Dis"}, {"key": "16_CR18", "doi-asserted-by": "publisher", "first-page": "464", "DOI": "10.1002/mds.23501", "volume": "26", "author": "A Antonini", "year": "2011", "unstructured": "Antonini A, Siri C, Santangelo G, Cilia R, Poletti M, Canesi M, Caporali A, Mancini F, Pezzoli G, Ceravolo R, Bonuccelli U, Barone P (2011) Impulsivity and compulsivity in drug-naive patients with Parkinson\u2019s disease. Mov Disord 26:464\u2013468", "journal-title": "Mov Disord"}, {"key": "16_CR19", "doi-asserted-by": "publisher", "first-page": "887", "DOI": "10.1212/WNL.51.3.887", "volume": "51", "author": "S Arawaka", "year": "1998", "unstructured": "Arawaka S, Saito Y, Murayama S, Mori H (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 51:887\u2013889", "journal-title": "Neurology"}, {"key": "16_CR20", "doi-asserted-by": "publisher", "first-page": "1460", "DOI": "10.1001/archneurol.2009.247", "volume": "66", "author": "A Ascherio", "year": "2009", "unstructured": "Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460\u20131468", "journal-title": "Arch Neurol"}, {"key": "16_CR21", "doi-asserted-by": "crossref", "first-page": "958", "DOI": "10.1016/S0140-6736(05)61511-5", "volume": "352", "author": "F Assal", "year": "1998", "unstructured": "Assal F, Spahr L, Hadengue A, Rubbia-Brandt L, Burkhard PR (1998) Tolcapone and fulminant hepatitis. Lancet 352:958", "journal-title": "Lancet"}, {"key": "16_CR22", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1067/mcp.2001.113989", "volume": "69", "author": "AJ Atkinson", "year": "2001", "unstructured": "Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89\u201395", "journal-title": "Clin Pharmacol Ther"}, {"issue": "Pt 2", "key": "16_CR23", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1093/brain/awh054", "volume": "127", "author": "R Bandopadhyay", "year": "2004", "unstructured": "Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, Lees AJ (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127(Pt 2):420\u2013430", "journal-title": "Brain"}, {"key": "16_CR24", "doi-asserted-by": "publisher", "first-page": "1852", "DOI": "10.1002/mds.21552", "volume": "22", "author": "AL Bartels", "year": "2007", "unstructured": "Bartels AL, Leenders KL (2007) Neuroinflammation in the pathophysiology of Parkinson\u2019s disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord 22:1852\u20131856", "journal-title": "Mov Disord"}, {"issue": "Pt 2", "key": "16_CR25", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1093/brain/awp322", "volume": "133", "author": "KD Beck", "year": "2010", "unstructured": "Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ (2010) Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 133(Pt 2):433\u2013447", "journal-title": "Brain"}, {"key": "16_CR26", "doi-asserted-by": "publisher", "first-page": "1438", "DOI": "10.1212/01.wnl.0000303818.38960.44", "volume": "70", "author": "C Becker", "year": "2008", "unstructured": "Becker C, Jick SS, Meier CR (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70:1438\u20131444", "journal-title": "Neurology"}, {"key": "16_CR27", "first-page": "344", "volume": "50", "author": "AL Benabid", "year": "1987", "unstructured": "Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50:344\u2013346", "journal-title": "Appl Neurophysiol"}, {"key": "16_CR28", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/0140-6736(91)91175-T", "volume": "337", "author": "AL Benabid", "year": "1991", "unstructured": "Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, Perret JE, de Rougemont J (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337:403\u2013406", "journal-title": "Lancet"}, {"key": "16_CR29", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1016/S0197-0186(01)00045-6", "volume": "39", "author": "EN Benveniste", "year": "2001", "unstructured": "Benveniste EN, Nguyen VT, O\u2019Keefe GM (2001) Immunological aspects of microglia: relevance to Alzheimer\u2019s disease. Neurochem Int 39:381\u2013391", "journal-title": "Neurochem Int"}, {"key": "16_CR30", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.3389/fnins.2011.00080", "volume": "5", "author": "D Beraud", "year": "2011", "unstructured": "Beraud D, Twomey M, Bloom B, Mittereder A, Ton V, Neitzke K, Chasovskikh S, Mhyre TR, Maguire-Zeiss KA (2011) Alpha-synuclein alters toll-like receptor expression. Front Neurosci 5:80", "journal-title": "Front Neurosci"}, {"issue": "Pt 12", "key": "16_CR31", "doi-asserted-by": "crossref", "first-page": "3000", "DOI": "10.1093/brain/awh666", "volume": "128", "author": "D Berg", "year": "2005", "unstructured": "Berg D, Schweitzer KJ, Leitner P, Zimprich A, Lichtner P, Belcredi P, Brussel T, Schulte C, Maass S, Nagele T, Wszolek ZK, Gasser T (2005) Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson\u2019s disease*. Brain 128(Pt 12):3000\u20133011", "journal-title": "Brain"}, {"issue": "Suppl 3", "key": "16_CR32", "doi-asserted-by": "publisher", "first-page": "S28", "DOI": "10.1002/mds.10140", "volume": "17", "author": "H Bergman", "year": "2002", "unstructured": "Bergman H, Deuschl G (2002) Pathophysiology of Parkinson\u2019s disease: from clinical neurology to basic neuroscience and back. Mov Disord 17(Suppl 3):S28\u2013S40", "journal-title": "Mov Disord"}, {"key": "16_CR33", "doi-asserted-by": "publisher", "first-page": "382", "DOI": "10.1007/BF02158964", "volume": "15", "author": "A Bertler", "year": "1959", "unstructured": "Bertler A, Rosengren E (1959) On the distribution in brain of monoamines and of enzymes responsible for their formation. Experientia 15:382\u2013384", "journal-title": "Experientia"}, {"issue": "2", "key": "16_CR34", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1016/j.nbd.2005.12.003", "volume": "22", "author": "R Betarbet", "year": "2006", "unstructured": "Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Yagi A, Klinefelter G, Cookson MR, Greenamyre JT (2006) Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 22(2):404\u2013420", "journal-title": "Neurobiol Dis"}, {"key": "16_CR35", "first-page": "787", "volume": "73", "author": "W Birkmayer", "year": "1961", "unstructured": "Birkmayer W, Hornykiewicz O (1961) The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73:787\u2013788", "journal-title": "Wien Klin Wochenschr"}, {"key": "16_CR36", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1016/j.neulet.2008.12.053", "volume": "452", "author": "J Blackinton", "year": "2009", "unstructured": "Blackinton J, Kumaran R, van der Brug MP, Ahmad R, Olson L, Galter D, Lees A, Bandopadhyay R, Cookson MR (2009) Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci Lett 452:8\u201311", "journal-title": "Neurosci Lett"}, {"key": "16_CR37", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1038/nrn2038", "volume": "8", "author": "ML Block", "year": "2007", "unstructured": "Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369", "journal-title": "Nat Rev Neurosci"}, {"key": "16_CR38", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1155/2011/143857", "volume": "24", "author": "LX Blonder", "year": "2011", "unstructured": "Blonder LX, Slevin JT (2011) Emotional dysfunction in Parkinson\u2019s disease. Behav Neurol 24:201\u2013217", "journal-title": "Behav Neurol"}, {"key": "16_CR39", "doi-asserted-by": "publisher", "first-page": "4246", "DOI": "10.1073/pnas.0511256103", "volume": "103", "author": "RA Bodner", "year": "2006", "unstructured": "Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, Hyman BT, McLean PJ, Young AB, Housman DE, Kazantsev AG (2006) Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington\u2019s and Parkinson\u2019s diseases. Proc Natl Acad Sci USA 103:4246\u20134251", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR40", "doi-asserted-by": "publisher", "first-page": "1984", "DOI": "10.1002/mds.22155", "volume": "23", "author": "S Boesveldt", "year": "2008", "unstructured": "Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson\u2019s disease. Mov Disord 23:1984\u20131990", "journal-title": "Mov Disord"}, {"key": "16_CR41", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1126/science.1077209", "volume": "299", "author": "V Bonifati", "year": "2003", "unstructured": "Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259", "journal-title": "Science"}, {"key": "16_CR42", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1186/1750-1326-3-21", "volume": "3", "author": "MK Borland", "year": "2008", "unstructured": "Borland MK, Trimmer PA, Rubinstein JD, Keeney PM, Mohanakumar K, Liu L, Bennett JP Jr (2008) Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson\u2019s disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol Neurodegener 3:21", "journal-title": "Mol Neurodegener"}, {"key": "16_CR43", "first-page": "a007500", "volume": "3", "author": "DA Bosco", "year": "2011", "unstructured": "Bosco DA, LaVoie MJ, Petsko GA, Ringe D (2011) Proteostasis and movement disorders: Parkinson\u2019s disease and amyotrophic lateral sclerosis. Cold Spring Harb. Perspect Biol 3:a007500", "journal-title": "Perspect Biol"}, {"issue": "Suppl 2", "key": "16_CR44", "doi-asserted-by": "publisher", "first-page": "II3", "DOI": "10.1007/PL00007758", "volume": "247", "author": "H Braak", "year": "2000", "unstructured": "Braak H, Braak E (2000) Pathoanatomy of Parkinson\u2019s disease. J Neurol 247(Suppl 2):II3\u201310", "journal-title": "J Neurol"}, {"issue": "Suppl 3", "key": "16_CR45", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/s00415-002-1301-4", "volume": "249", "author": "H Braak", "year": "2002", "unstructured": "Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1\u20135", "journal-title": "J Neurol"}, {"key": "16_CR46", "first-page": "197", "volume": "24", "author": "H Braak", "year": "2003a", "unstructured": "Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003a) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24:197\u2013211", "journal-title": "Neurobiol"}, {"key": "16_CR47", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1007/s00702-002-0808-2", "volume": "110", "author": "H Braak", "year": "2003b", "unstructured": "Braak H, Rub U, Gai WP, Del Tredici K (2003b) Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517\u2013536", "journal-title": "J Neural Transm"}, {"key": "16_CR48", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1007/s00441-004-0956-9", "volume": "318", "author": "H Braak", "year": "2004", "unstructured": "Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134", "journal-title": "Cell Tissue Res"}, {"key": "16_CR49", "doi-asserted-by": "publisher", "first-page": "2042", "DOI": "10.1002/mds.21065", "volume": "21", "author": "H Braak", "year": "2006a", "unstructured": "Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006a) Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051", "journal-title": "Mov Disord"}, {"key": "16_CR50", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1016/j.neulet.2005.11.012", "volume": "396", "author": "H Braak", "year": "2006b", "unstructured": "Braak H, de Vos RA, Bohl J, Del Tredici K (2006b) Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396:67\u201372", "journal-title": "Neurosci Lett"}, {"key": "16_CR51", "doi-asserted-by": "publisher", "first-page": "1916", "DOI": "10.1212/01.wnl.0000312279.49272.9f", "volume": "70", "author": "H Braak", "year": "2008", "unstructured": "Braak H, Del Tredici K (2008) Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925", "journal-title": "Neurology"}, {"key": "16_CR52", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1016/j.neulet.2008.06.040", "volume": "441", "author": "B Brodacki", "year": "2008", "unstructured": "Brodacki B, Staszewski J, Toczylowska B, Kozlowska E, Drela N, Chalimoniuk M, Stepien A (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441:158\u2013162", "journal-title": "Neurosci Lett"}, {"key": "16_CR53", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0006-8993(98)01192-5", "volume": "823", "author": "AI Brooks", "year": "1999", "unstructured": "Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res 823:1\u201310", "journal-title": "Brain Res"}, {"key": "16_CR54", "doi-asserted-by": "publisher", "first-page": "1262", "DOI": "10.1016/S0140-6736(84)92807-1", "volume": "2", "author": "RG Brown", "year": "1984", "unstructured": "Brown RG, Marsden CD (1984) How common is dementia in Parkinson\u2019s disease? Lancet 2:1262\u20131265", "journal-title": "Lancet"}, {"key": "16_CR55", "doi-asserted-by": "publisher", "first-page": "485", "DOI": "10.1002/ana.21541", "volume": "64", "author": "RE Burke", "year": "2008", "unstructured": "Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64:485\u2013491", "journal-title": "Ann Neurol"}, {"key": "16_CR56", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1289/ehp.845537", "volume": "55", "author": "JS Bus", "year": "1984", "unstructured": "Bus JS, Gibson JE (1984) Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55:37\u201346", "journal-title": "Environ Health Perspect"}, {"key": "16_CR57", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1111/j.1600-0404.2006.00694.x", "volume": "185", "author": "A Cagnin", "year": "2006", "unstructured": "Cagnin A, Kassiou M, Meikle SR, Banati RB (2006) In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol Scand Suppl 185:107\u2013114", "journal-title": "Acta Neurol Scand Suppl"}, {"key": "16_CR58", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1196/annals.1332.008", "volume": "1035", "author": "A Campbell", "year": "2004", "unstructured": "Campbell A (2004) Inflammation, neurodegenerative diseases, and environmental exposures. Ann NY Acad Sci 1035:117\u2013132", "journal-title": "Ann NY Acad Sci"}, {"key": "16_CR59", "doi-asserted-by": "crossref", "first-page": "1200", "DOI": "10.1038/1801200a0", "volume": "180", "author": "A Carlsson", "year": "1957", "unstructured": "Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200", "journal-title": "Nature"}, {"key": "16_CR60", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.2174/156652307780363125", "volume": "7", "author": "T Carlsson", "year": "2007", "unstructured": "Carlsson T, Bjorklund T, Kirik D (2007) Restoration of the striatal dopamine synthesis for Parkinson\u2019s disease: viral vector-mediated enzyme replacement strategy. Curr Gene Ther 7:109\u2013120", "journal-title": "Curr Gene Ther"}, {"key": "16_CR61", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.2165/00129785-200404050-00005", "volume": "4", "author": "MJ Carson", "year": "2004", "unstructured": "Carson MJ, Thrash JC, Lo D (2004) Analysis of microglial gene expression: identifying targets for CNS neurodegenerative and autoimmune disease. Am J Pharmacogenomics 4:321\u2013330", "journal-title": "Am J Pharmacogenomics"}, {"key": "16_CR62", "unstructured": "Carta AR, Pisanu A, Carboni E (2011) Do PPAR-Gamma agonists have a future in Parkinson\u2019s disease therapy? Parkinsons Dis 2011:689181", "DOI": "10.4061/2011/689181", "doi-asserted-by": "crossref"}, {"key": "16_CR63", "doi-asserted-by": "publisher", "first-page": "1177", "DOI": "10.1016/S0960-9822(00)80020-2", "volume": "9", "author": "C Cenciarelli", "year": "1999", "unstructured": "Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M, Pagano M (1999) Identification of a family of human F-box proteins. Curr Biol 9:1177\u20131179", "journal-title": "Curr Biol"}, {"key": "16_CR64", "doi-asserted-by": "publisher", "first-page": "1081", "DOI": "10.1038/nature05865", "volume": "447", "author": "CS Chan", "year": "2007", "unstructured": "Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 447:1081\u20131086", "journal-title": "Nature"}, {"issue": "Suppl 1", "key": "16_CR65", "doi-asserted-by": "publisher", "first-page": "S63", "DOI": "10.1002/mds.22801", "volume": "25", "author": "CS Chan", "year": "2010", "unstructured": "Chan CS, Gertler TS, Surmeier DJ (2010) A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S63\u2013S70", "journal-title": "Mov Disord"}, {"key": "16_CR66", "doi-asserted-by": "publisher", "first-page": "1726", "DOI": "10.1093/hmg/ddr048", "volume": "20", "author": "NC Chan", "year": "2011", "unstructured": "Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC (2011) Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20:1726\u20131737", "journal-title": "Hum Mol Genet"}, {"key": "16_CR67", "doi-asserted-by": "publisher", "first-page": "1022", "DOI": "10.1016/j.bbrc.2006.02.061", "volume": "342", "author": "YF Chang", "year": "2006", "unstructured": "Chang YF, Cheng CM, Chang LK, Jong YJ, Yuo CY (2006) The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination. Biochem. Biophys Res Commun 342:1022\u20131026", "journal-title": "Biophys Res Commun"}, {"key": "16_CR68", "doi-asserted-by": "publisher", "first-page": "1167", "DOI": "10.1016/S0140-6736(04)17103-1", "volume": "364", "author": "MC Chartier-Harlin", "year": "2004", "unstructured": "Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169", "journal-title": "Lancet"}, {"key": "16_CR69", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1097/00019052-200108000-00012", "volume": "14", "author": "KR Chaudhuri", "year": "2001", "unstructured": "Chaudhuri KR (2001) Autonomic dysfunction in movement disorders. Curr Opin Neurol 14:505\u2013511", "journal-title": "Curr Opin Neurol"}, {"key": "16_CR70", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/S1474-4422(06)70373-8", "volume": "5", "author": "KR Chaudhuri", "year": "2006", "unstructured": "Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245", "journal-title": "Lancet Neurol"}, {"key": "16_CR71", "doi-asserted-by": "publisher", "first-page": "704", "DOI": "10.1002/mds.22868", "volume": "25", "author": "KR Chaudhuri", "year": "2010", "unstructured": "Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P (2010) The nondeclaration of nonmotor symptoms of Parkinson\u2019s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:704\u2013709", "journal-title": "Mov Disord"}, {"key": "16_CR72", "doi-asserted-by": "publisher", "first-page": "21418", "DOI": "10.1074/jbc.M413955200", "volume": "280", "author": "L Chen", "year": "2005", "unstructured": "Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X (2005) Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem 280:21418\u201321426", "journal-title": "J Biol Chem"}, {"key": "16_CR73", "doi-asserted-by": "publisher", "first-page": "1825", "DOI": "10.1016/j.clinthera.2007.09.021", "volume": "29", "author": "JJ Chen", "year": "2007", "unstructured": "Chen JJ, Swope DM, Dashtipour K (2007) Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson\u2019s disease. Clin Ther 29:1825\u20131849", "journal-title": "Clin Ther"}, {"key": "16_CR74", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1093/aje/kwm260", "volume": "167", "author": "H Chen", "year": "2008a", "unstructured": "Chen H, O\u2019Reilly EJ, Schwarzschild MA, Ascherio A (2008a) Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol 167:90\u201395", "journal-title": "Am J Epidemiol"}, {"key": "16_CR75", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1111/j.1471-4159.2007.05108.x", "volume": "105", "author": "MK Chen", "year": "2008b", "unstructured": "Chen MK, Kuwabara H, Zhou Y, Adams RJ, Brasic JR, McGlothan JL, Verina T, Burton NC, Alexander M, Kumar A, Wong DF, Guilarte TR (2008b) VMAT2 and dopamine neuron loss in a primate model of Parkinson\u2019s disease. J Neurochem 105:78\u201390", "journal-title": "J Neurochem"}, {"key": "16_CR76", "doi-asserted-by": "publisher", "first-page": "15136", "DOI": "10.1073/pnas.0807581105", "volume": "105", "author": "WS Choi", "year": "2008", "unstructured": "Choi WS, Kruse SE, Palmiter RD, Xia Z (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci USA 105:15136\u201315141", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR77", "doi-asserted-by": "publisher", "first-page": "494", "DOI": "10.1212/WNL.0b013e3181ec7fac", "volume": "75", "author": "DO Claassen", "year": "2010", "unstructured": "Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494\u2013499", "journal-title": "Neurology"}, {"key": "16_CR78", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1186/1471-2377-5-11", "volume": "5", "author": "J Clarimon", "year": "2005", "unstructured": "Clarimon J, Xiromerisiou G, Eerola J, Gourbali V, Hellstrom O, Dardiotis E, Peuralinna T, Papadimitriou A, Hadjigeorgiou GM, Tienari PJ, Singleton AB (2005) Lack of evidence for a genetic association between FGF20 and Parkinson\u2019s disease in Finnish and Greek patients. BMC Neurol 5:11", "journal-title": "BMC Neurol"}, {"key": "16_CR79", "doi-asserted-by": "publisher", "first-page": "1162", "DOI": "10.1038/nature04779", "volume": "441", "author": "IE Clark", "year": "2006", "unstructured": "Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162\u20131166", "journal-title": "Nature"}, {"key": "16_CR80", "doi-asserted-by": "publisher", "first-page": "1270", "DOI": "10.1212/01.wnl.0000276989.17578.02", "volume": "69", "author": "LN Clark", "year": "2007", "unstructured": "Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K (2007) Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69:1270\u20131277", "journal-title": "Neurology"}, {"key": "16_CR81", "doi-asserted-by": "publisher", "first-page": "578", "DOI": "10.1001/archneurol.2009.54", "volume": "66", "author": "LN Clark", "year": "2009", "unstructured": "Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K (2009) Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol 66:578\u2013583", "journal-title": "Arch Neurol"}, {"key": "16_CR82", "doi-asserted-by": "publisher", "first-page": "15091", "DOI": "10.1073/pnas.0607260103", "volume": "103", "author": "CM Clements", "year": "2006", "unstructured": "Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP (2006) DJ-1, a cancer- and Parkinson\u2019s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci. USA 103:15091\u201315096", "journal-title": "USA"}, {"key": "16_CR83", "doi-asserted-by": "publisher", "first-page": "292", "DOI": "10.1111/j.1749-6632.2000.tb06195.x", "volume": "899", "author": "CA Colton", "year": "2000", "unstructured": "Colton CA, Chernyshev ON, Gilbert DL, Vitek MP (2000) Microglial contribution to oxidative stress in Alzheimer\u2019s disease. Ann NY Acad Sci 899:292\u2013307", "journal-title": "Ann NY Acad Sci"}, {"key": "16_CR84", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1007/s11481-009-9164-4", "volume": "4", "author": "CA Colton", "year": "2009", "unstructured": "Colton CA (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4:399\u2013418", "journal-title": "J Neuroimmune Pharmacol"}, {"key": "16_CR85", "first-page": "321", "volume": "59", "author": "CA Colton", "year": "1993", "unstructured": "Colton CA, Gilbert DL (1993) Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol 59:321\u2013326", "journal-title": "Adv Neurol"}, {"key": "16_CR86", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.2174/187152710791012053", "volume": "9", "author": "CA Colton", "year": "2010", "unstructured": "Colton CA, Wilcock DM (2010) Assessing activation states in microglia. CNS Neurol Disord Drug Targets 9:174\u2013191", "journal-title": "CNS Neurol Disord Drug Targets"}, {"issue": "Pt 5", "key": "16_CR87", "doi-asserted-by": "publisher", "first-page": "1493", "DOI": "10.1093/brain/awr031", "volume": "134", "author": "Y Compta", "year": "2011", "unstructured": "Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134(Pt 5):1493\u20131505", "journal-title": "Brain"}, {"key": "16_CR88", "unstructured": "Consortium IPDG, 2, WTCCC A two-stage meta-analysis identifies several new loci for Parkinson\u2019s disease. under review"}, {"key": "16_CR89", "doi-asserted-by": "publisher", "first-page": "641", "DOI": "10.1016/S0140-6736(10)62345-8", "volume": "377", "author": "IPDG Consortium", "year": "2011", "unstructured": "Consortium IPDG, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW (2011) Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet 377:641\u2013649", "journal-title": "Lancet"}, {"key": "16_CR90", "doi-asserted-by": "publisher", "first-page": "1318", "DOI": "10.1038/3311", "volume": "4", "author": "KA Conway", "year": "1998", "unstructured": "Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318\u20131320", "journal-title": "Nat Med"}, {"key": "16_CR91", "doi-asserted-by": "publisher", "first-page": "2552", "DOI": "10.1021/bi991447r", "volume": "39", "author": "KA Conway", "year": "2000", "unstructured": "Conway KA, Harper JD, Lansbury PT Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry 39:2552\u20132563", "journal-title": "Biochemistry"}, {"key": "16_CR92", "doi-asserted-by": "publisher", "first-page": "1346", "DOI": "10.1126/science.1063522", "volume": "294", "author": "KA Conway", "year": "2001", "unstructured": "Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha -synuclein protofibril by a Dopamine- alpha -Synuclein adduct. Science 294:1346\u20131349", "journal-title": "Science"}, {"key": "16_CR93", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1056/NEJM196902132800701", "volume": "280", "author": "GC Cotzias", "year": "1969", "unstructured": "Cotzias GC, Papavasiliou PS, Gellene R (1969) Modification of parkinsonism\u2014chronic treatment with L-dopa. New Engl J Med 280:337\u2013345", "journal-title": "New Engl J Med"}, {"key": "16_CR94", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1007/s00401-006-0119-z", "volume": "112", "author": "E Croisier", "year": "2006", "unstructured": "Croisier E, Graeber MB (2006) Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol 112:517\u2013530", "journal-title": "Acta Neuropathol"}, {"key": "16_CR95", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1186/1742-2094-2-14", "volume": "2", "author": "E Croisier", "year": "2005", "unstructured": "Croisier E, Moran LB, Dexter DT, Pearce RK, Graeber MB (2005) Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J Neuroinflammation 2:14", "journal-title": "J Neuroinflammation"}, {"key": "16_CR96", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1176/ajp.149.4.443", "volume": "149", "author": "JL Cummings", "year": "1992", "unstructured": "Cummings JL (1992) Depression and Parkinson\u2019s disease: a review. Am J Psychiatry 149:443\u2013454", "journal-title": "Am J Psychiatry"}, {"key": "16_CR97", "doi-asserted-by": "publisher", "first-page": "542", "DOI": "10.1001/archneurol.2010.79", "volume": "67", "author": "JC Dachsel", "year": "2010", "unstructured": "Dachsel JC, Farrer MJ (2010) LRRK2 and Parkinson disease. Arch Neurol 67:542\u2013547", "journal-title": "Arch Neurol"}, {"key": "16_CR98", "doi-asserted-by": "publisher", "first-page": "889", "DOI": "10.1016/S0896-6273(03)00568-3", "volume": "39", "author": "W Dauer", "year": "2003", "unstructured": "Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909", "journal-title": "Neuron"}, {"key": "16_CR99", "doi-asserted-by": "publisher", "first-page": "14524", "DOI": "10.1073/pnas.172514599", "volume": "99", "author": "W Dauer", "year": "2002", "unstructured": "Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99:14524\u201314529", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR100", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1016/0165-1781(79)90006-4", "volume": "1", "author": "GC Davis", "year": "1979", "unstructured": "Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249\u2013254", "journal-title": "Psychiatry Res"}, {"key": "16_CR101", "doi-asserted-by": "publisher", "first-page": "480", "DOI": "10.1093/oxfordjournals.aje.a008954", "volume": "144", "author": "JW Davis", "year": "1996", "unstructured": "Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM (1996) Observations on serum uric acid levels and the risk of idiopathic Parkinson\u2019s disease. Am J Epidemiol 144:480\u2013484", "journal-title": "Am J Epidemiol"}, {"key": "16_CR102", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1186/1475-2859-10-44", "volume": "10", "author": "A Marco", "year": "2011", "unstructured": "de Marco A (2011) Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact 10:44", "journal-title": "Microb Cell Fact"}, {"issue": "7", "key": "16_CR103", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1016/0166-2236(90)90110-V", "volume": "13", "author": "MR DeLong", "year": "1990", "unstructured": "DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13(7):281\u2013285", "journal-title": "Trends Neurosci"}, {"key": "16_CR104", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1136/jnnp.23.4.283", "volume": "23", "author": "HJW den", "year": "1960", "unstructured": "den HJW, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283\u2013290", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "16_CR105", "doi-asserted-by": "publisher", "first-page": "1761", "DOI": "10.1212/WNL.0b013e318236ef60", "volume": "77", "author": "P Derkinderen", "year": "2011", "unstructured": "Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R (2011) Parkinson disease: the enteric nervous system spills its guts. Neurology 77:1761\u20131767", "journal-title": "Neurology"}, {"key": "16_CR106", "doi-asserted-by": "publisher", "first-page": "13010", "DOI": "10.1073/pnas.0903691106", "volume": "106", "author": "P Desplats", "year": "2009", "unstructured": "Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010\u201313015", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR107", "doi-asserted-by": "publisher", "first-page": "2160", "DOI": "10.1002/mds.23948", "volume": "26", "author": "MJ Devine", "year": "2011", "unstructured": "Devine MJ, Gwinn K, Singleton A, Hardy J (2011) Parkinson\u2019s disease and \u03b1-synuclein expression. Movement Disorders 26:2160\u20132168", "journal-title": "Movement Disorders"}, {"key": "16_CR108", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.2174/092986707780597961", "volume": "14", "author": "ST Dheen", "year": "2007", "unstructured": "Dheen ST, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14:1189\u20131197", "journal-title": "Curr Med Chem"}, {"issue": "3", "key": "16_CR109", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1212/01.wnl.0000338144.10967.2b", "volume": "72", "author": "A Di Fonzo", "year": "2009", "unstructured": "Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, Correia Guedes L, Szczerbinska A, Zhao T, Dubbel-Hulsman LO, Wouters CH, de Graaff E, Oyen WJ, Simons EJ, Breedveld GJ, Oostra BA, Horstink MW, Bonifati V (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72(3):240\u2013245", "journal-title": "Neurology"}, {"issue": "Suppl 3", "key": "16_CR110", "doi-asserted-by": "publisher", "first-page": "S1", "DOI": "10.1016/S1353-8020(09)70769-2", "volume": "15", "author": "DW Dickson", "year": "2009", "unstructured": "Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1\u2013S5", "journal-title": "Parkinsonism Relat Disord"}, {"issue": "Suppl 1", "key": "16_CR111", "doi-asserted-by": "publisher", "first-page": "S78", "DOI": "10.1002/mds.22637", "volume": "25", "author": "DW Dickson", "year": "2010", "unstructured": "Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78\u2013S82", "journal-title": "Mov Disord"}, {"key": "16_CR112", "doi-asserted-by": "publisher", "first-page": "2283", "DOI": "10.1002/mds.23934", "volume": "26", "author": "H Ding", "year": "2011", "unstructured": "Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, Unni VK, Hung AY, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Sudarsky LR, Growdon JH, Ivinson AJ, Hyman BT, Scherzer CR (2011) Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Mov Disord 26:2283\u20132286", "journal-title": "Mov Disord"}, {"key": "16_CR113", "doi-asserted-by": "publisher", "first-page": "956", "DOI": "10.1056/NEJMoa000827", "volume": "345", "author": "Disease Study Group", "year": "2001", "unstructured": "Disease Study Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson\u2019s disease. New Engl J Med 345:956\u2013963", "journal-title": "New Engl J Med"}, {"key": "16_CR114", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.2217/bmm.10.97", "volume": "4", "author": "Disease Study Group", "year": "2010", "unstructured": "Disease Study Group (2010) News & Views in\u2026 Biomarkers in Medicine. Biomarkers Med 4:747\u2013750", "journal-title": "Biomarkers Med"}, {"key": "16_CR115", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/neu.10094", "volume": "53", "author": "Z Dong", "year": "2002", "unstructured": "Dong Z, Ferger B, Feldon J, Bueler H (2002) Overexpression of Parkinson\u2019s disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J Neurobiol 53:1\u201310", "journal-title": "J Neurobiol"}, {"issue": "6", "key": "16_CR116", "doi-asserted-by": "publisher", "first-page": "823", "DOI": "10.1586/14737175.6.6.823", "volume": "6", "author": "ER Dorsey", "year": "2006", "unstructured": "Dorsey ER, Holloway RG, Ravina BM (2006) Biomarkers in Parkinson\u2019s disease. Expert Rev Neurother 6(6):823\u2013831", "journal-title": "Expert Rev Neurother"}, {"key": "16_CR117", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1212/01.wnl.0000247740.47667.03", "volume": "68", "author": "ER Dorsey", "year": "2007", "unstructured": "Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386", "journal-title": "Neurology"}, {"key": "16_CR118", "author": "ER Dorsey", "first-page": "277", "year": "2008", "unstructured": "Dorsey ER, Holloway RG, Ravina BM (2008) Status of biological markers. In: Factor SA, Weiner WJ (eds) Parkinson\u2019s disease\u2014diagnosis and clinical management. Demos, New York, pp\u00a0277\u2013284", "volume-title": "Parkinson\u2019s disease\u2014diagnosis and clinical management"}, {"issue": "Suppl 3", "key": "16_CR119", "doi-asserted-by": "publisher", "first-page": "S225", "DOI": "10.1016/S1353-8020(08)70006-3", "volume": "13", "author": "RL Doty", "year": "2007", "unstructured": "Doty RL (2007) Olfaction in Parkinson\u2019s disease. Parkinsonism Relat Disord 13(Suppl 3):S225\u2013S228", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR120", "doi-asserted-by": "publisher", "first-page": "1478", "DOI": "10.1093/hmg/ddr026", "volume": "20", "author": "A Dmitriu", "year": "2011", "unstructured": "Dumitriu A, Pacheco CD, Wilk JB, Strathearn KE, Latourelle JC, Goldwurm S, Pezzoli G, Rochet JC, Lindquist S, Myers RH (2011) Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson\u2019s disease: results from the GenePD Study. Hum Mol Genet 20:1478\u20131487", "journal-title": "Hum Mol Genet"}, {"key": "16_CR121", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1002/mds.21185", "volume": "22", "author": "T Eckert", "year": "2007", "unstructured": "Eckert T, Feigin A, Lewis DE, Dhawan V, Frucht S, Eidelberg D (2007) Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging. Mov Disord 22:167\u2013173", "journal-title": "Mov Disord"}, {"key": "16_CR122", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1111/j.1469-1809.2009.00560.x", "volume": "74", "author": "TL Edwards", "year": "2010", "unstructured": "Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Zuchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74:97\u2013109", "journal-title": "Ann Hum Genet"}, {"key": "16_CR123", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1016/S1353-8020(98)00012-1", "volume": "4", "author": "H Ehringer", "year": "1998", "unstructured": "Ehringer H, Hornykiewicz O (1998) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Parkinsonism Relat Disord 4:53\u201357", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR124", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1016/j.tins.2009.06.003", "volume": "32", "author": "D Eidelberg", "year": "2009", "unstructured": "Eidelberg D (2009) Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 32:548\u2013557", "journal-title": "Trends Neurosci"}, {"key": "16_CR125", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1038/jcbfm.1994.99", "volume": "14", "author": "D Eidelberg", "year": "1994", "unstructured": "Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783\u2013801", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "16_CR126", "doi-asserted-by": "publisher", "first-page": "917", "DOI": "10.1016/S1474-4422(06)70579-8", "volume": "5", "author": "A Elbaz", "year": "2006", "unstructured": "Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Kruger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA (2006) Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson\u2019s disease: a large-scale international study. Lancet Neurol 5:917\u2013923", "journal-title": "Lancet Neurol"}, {"key": "16_CR127", "doi-asserted-by": "publisher", "first-page": "2871", "DOI": "10.1021/bi036281f", "volume": "43", "author": "S Emadi", "year": "2004", "unstructured": "Emadi S, Liu R, Yuan B, Schulz P, McAllister C, Lyubchenko Y, Messer A, Sierks MR (2004) Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry 43:2871\u20132878", "journal-title": "Biochemistry"}, {"key": "16_CR128", "doi-asserted-by": "publisher", "first-page": "1132", "DOI": "10.1016/j.jmb.2007.02.089", "volume": "368", "author": "S Emadi", "year": "2007", "unstructured": "Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR (2007) Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. J Mol Biol 368:1132\u20131144", "journal-title": "J Mol Biol"}, {"key": "16_CR129", "doi-asserted-by": "publisher", "first-page": "2509", "DOI": "10.1056/NEJMoa041470", "volume": "351", "author": "M Emre", "year": "2004", "unstructured": "Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R (2004) Rivastigmine for dementia associated with Parkinson\u2019s disease. New Engl J Med 351:2509\u20132518", "journal-title": "New Engl J Med"}, {"key": "16_CR130", "doi-asserted-by": "publisher", "first-page": "1689", "DOI": "10.1002/mds.21507", "volume": "22", "author": "M Emre", "year": "2007", "unstructured": "Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707; quiz 1837", "journal-title": "Mov Disord"}, {"key": "16_CR131", "doi-asserted-by": "publisher", "first-page": "969", "DOI": "10.1016/S1474-4422(10)70194-0", "volume": "9", "author": "M Emre", "year": "2010", "unstructured": "Emre M, Tsolaki M, Bonuccelli U, Destee A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladstrom A, Jones R (2010) Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:969\u2013977", "journal-title": "Lancet Neurol"}, {"key": "16_CR132", "first-page": "220", "volume": "153B", "author": "E Evangelou", "year": "2010", "unstructured": "Evangelou E, Maraganore DM, Annesi G, Brighina L, Brice A, Elbaz A, Ferrarese C, Hadjigeorgiou GM, Krueger R, Lambert JC, Lesage S, Markopoulou K, Mellick GD, Meeus B, Pedersen NL, Quattrone A, Van Broeckhoven C, Sharma M, Silburn PA, Tan EK, Wirdefeldt K, Ioannidis JP (2010) Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson\u2019s disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet 153B:220\u2013228", "journal-title": "Am J Med Genet B Neuropsychiatr Genet"}, {"key": "16_CR133", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1097/00002826-200109000-00007", "volume": "24", "author": "SA Factor", "year": "2001", "unstructured": "Factor SA, Molho ES, Feustel PJ, Brown DL, Evans SM (2001) Long-term comparative experience with tolcapone and entacapone in advanced Parkinson\u2019s disease. Clin Neuropharmacol 24:295\u2013299", "journal-title": "Clin Neuropharmacol"}, {"key": "16_CR134", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1002/ana.1132", "volume": "50", "author": "M Farrer", "year": "2001", "unstructured": "Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn-Hardy K, Petrucelli L, Hussey J, Singleton A, Tanner C, Hardy J, Langston JW (2001) Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 50:293\u2013300", "journal-title": "Ann Neurol"}, {"key": "16_CR135", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.2165/11533740-000000000-00000", "volume": "24", "author": "LR Feng", "year": "2010", "unstructured": "Feng LR, Maguire-Zeiss KA (2010) Gene therapy in Parkinson\u2019s disease: rationale and current status. CNS Drugs 24:177\u2013192", "journal-title": "CNS Drugs"}, {"key": "16_CR136", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1007/s12640-011-9255-x", "volume": "20", "author": "LR Feng", "year": "2011", "unstructured": "Feng LR, Maguire-Zeiss KA (2011) Dopamine and paraquat enhance alpha-synuclein-induced alterations in membrane conductance. Neurotox Res 20:387\u2013401", "journal-title": "Neurotox Res"}, {"key": "16_CR137", "first-page": "288", "volume": "22", "author": "Y Feng", "year": "2006", "unstructured": "Feng Y, Liang ZH, Wang T, Qiao X, Liu HJ, Sun SG (2006) Alpha-Synuclein redistributed and aggregated in rotenone-induced Parkinson\u2019s disease rats. Neurosci Bull 22:288\u2013293", "journal-title": "Neurosci Bull"}, {"key": "16_CR138", "doi-asserted-by": "publisher", "first-page": "991", "DOI": "10.1002/syn.20456", "volume": "61", "author": "PO Fernagut", "year": "2007", "unstructured": "Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, Chesselet MF (2007) Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse 61:991\u20131001", "journal-title": "Synapse"}, {"key": "16_CR139", "doi-asserted-by": "publisher", "first-page": "2077", "DOI": "10.1056/NEJMoa0907083", "volume": "362", "author": "KA Follett", "year": "2010", "unstructured": "Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ (2010) Pallidal versus subthalamic deep-brain stimulation for Parkinson\u2019s disease. New Engl J Med 362:2077\u20132091", "journal-title": "New Engl J Med"}, {"key": "16_CR140", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1002/nau.20371", "volume": "26", "author": "CJ Fowler", "year": "2007", "unstructured": "Fowler CJ (2007) Update on the neurology of Parkinson\u2019s disease. Neurourol Urodyn 26:103\u2013109", "journal-title": "Neurourol Urodyn"}, {"key": "16_CR141", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1016/S0079-6123(10)84007-5", "volume": "184", "author": "SH Fox", "year": "2010", "unstructured": "Fox SH, Brotchie JM (2010) The MPTP-lesioned non-human primate models of Parkinson\u2019s disease. Past, present, and future. Prog Brain Res 184:133\u2013157", "journal-title": "Prog Brain Res"}, {"key": "16_CR142", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1038/ncb841", "volume": "4", "author": "H Fujiwara", "year": "2002", "unstructured": "Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164", "journal-title": "Nat Cell Biol"}, {"issue": "Suppl 2", "key": "16_CR143", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.3233/JAD-2011-110182", "volume": "24", "author": "BS Gadad", "year": "2011", "unstructured": "Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from alpha-synuclein, tau, and amyloid-beta peptide. J Alzheimers Dis 24(Suppl 2):223\u2013232", "journal-title": "J Alzheimers Dis"}, {"key": "16_CR144", "doi-asserted-by": "publisher", "first-page": "626", "DOI": "10.1136/jnnp.2006.107904", "volume": "78", "author": "C Gaig", "year": "2007", "unstructured": "Gaig C, Marti MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E (2007) G2019S LRRK2 mutation causing Parkinson\u2019s disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626\u2013628", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "16_CR145", "doi-asserted-by": "publisher", "first-page": "2493", "DOI": "10.1002/mds.23394", "volume": "25", "author": "DA Gallagher", "year": "2010", "unstructured": "Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? Mov Disord 25:2493\u20132500", "journal-title": "Mov Disord"}, {"key": "16_CR146", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1001/archneur.58.2.186", "volume": "58", "author": "JE Galvin", "year": "2001", "unstructured": "Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58:186\u2013190", "journal-title": "Arch Neurol"}, {"key": "16_CR147", "doi-asserted-by": "publisher", "first-page": "1712", "DOI": "10.1212/WNL.56.12.1712", "volume": "56", "author": "N Giladi", "year": "2001", "unstructured": "Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C (2001) Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56:1712\u20131721", "journal-title": "Neurology"}, {"key": "16_CR148", "first-page": "415", "volume": "365", "author": "WP Gilks", "year": "2005", "unstructured": "Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet 365:415\u2013416", "journal-title": "Lancet"}, {"key": "16_CR149", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/j.tins.2010.04.003", "volume": "33", "author": "M Goedert", "year": "2010", "unstructured": "Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317\u2013325", "journal-title": "Trends Neurosci"}, {"key": "16_CR150", "doi-asserted-by": "publisher", "first-page": "937", "DOI": "10.1136/jmg.2004.024455", "volume": "41", "author": "O Goker-Alpan", "year": "2004", "unstructured": "Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937\u2013940", "journal-title": "J Med Genet"}, {"key": "16_CR151", "doi-asserted-by": "publisher", "first-page": "43628", "DOI": "10.1074/jbc.M308947200", "volume": "278", "author": "MS Goldberg", "year": "2003", "unstructured": "Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628\u201343635", "journal-title": "J Biol Chem"}, {"key": "16_CR152", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1016/j.neuron.2005.01.041", "volume": "45", "author": "MS Goldberg", "year": "2005", "unstructured": "Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bernardi G, Roth BL, Pothos EN, Calabresi P, Shen J (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45:489\u2013496", "journal-title": "Neuron"}, {"key": "16_CR153", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1007/s10286-006-0317-8", "volume": "16", "author": "DS Goldstein", "year": "2006", "unstructured": "Goldstein DS (2006) Orthostatic hypotension as an early finding in Parkinson\u2019s disease. Clin Auton Res 16:46\u201354", "journal-title": "Clin Auton Res"}, {"key": "16_CR154", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.7326/0003-4819-133-5-200009050-00009", "volume": "133", "author": "DS Goldstein", "year": "2000", "unstructured": "Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO 3rd (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338\u2013347", "journal-title": "Ann Intern Med"}, {"key": "16_CR155", "doi-asserted-by": "publisher", "first-page": "1247", "DOI": "10.1212/WNL.58.8.1247", "volume": "58", "author": "DS Goldstein", "year": "2002", "unstructured": "Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58:1247\u20131255", "journal-title": "Neurology"}, {"key": "16_CR156", "doi-asserted-by": "crossref", "first-page": "e65", "DOI": "10.1136/jmg.2005.035568", "volume": "42", "author": "S Goldwurm", "year": "2005", "unstructured": "Goldwurm S, Di Fonzo A, Simons EJ, Rohe CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V (2005) The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson\u2019s disease and originates from a common ancestor. J Med Genet 42:e65", "journal-title": "J Med Genet"}, {"key": "16_CR157", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.3389/fnana.2010.00140", "volume": "4", "author": "T Gonzalez-Hernandez", "year": "2010", "unstructured": "Gonzalez-Hernandez T, Cruz-Muros I, Afonso-Oramas D, Salas-Hernandez J, Castro-Hernandez J (2010) Vulnerability of mesostriatal dopaminergic neurons in Parkinson\u2019s disease. Front Neuroanat 4:140", "journal-title": "Front Neuroanat"}, {"key": "16_CR158", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1016/S1353-8020(03)00016-6", "volume": "9", "author": "N Gouider-Khouja", "year": "2003", "unstructured": "Gouider-Khouja N, Larnaout A, Amouri R, Sfar S, Belal S, Ben Hamida C, Ben Hamida M, Hattori N, Mizuno Y, Hentati F (2003) Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. Parkinsonism Relat Disord 9:247\u2013251", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR159", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1007/s00401-009-0622-0", "volume": "119", "author": "MB Graeber", "year": "2010", "unstructured": "Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119:89\u2013105", "journal-title": "Acta Neuropathol"}, {"key": "16_CR160", "doi-asserted-by": "publisher", "first-page": "4078", "DOI": "10.1073/pnas.0737556100", "volume": "100", "author": "JC Greene", "year": "2003", "unstructured": "Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA 100:4078\u20134083", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR161", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.1186/1750-1326-6-6", "volume": "6", "author": "E Greggio", "year": "2011", "unstructured": "Greggio E, Bisaglia M, Civiero L, Bubacco L (2011) Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson\u2019s disease? Mol Neurodegener 6:6", "journal-title": "Mol Neurodegener"}, {"key": "16_CR162", "doi-asserted-by": "crossref", "first-page": "470S", "DOI": "10.1093/ajcn/83.2.470S", "volume": "83", "author": "WS Griffin", "year": "2006", "unstructured": "Griffin WS (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83:470S\u2013474S", "journal-title": "Am J Clin Nutr"}, {"key": "16_CR163", "first-page": "82", "volume": "13", "author": "D Grosset", "year": "2010", "unstructured": "Grosset D (2010) Parkinson\u2019s disease and related disorders\u2014XVIII WFN World Congress. IDrugs 13:82\u201384", "journal-title": "IDrugs"}, {"key": "16_CR164", "doi-asserted-by": "publisher", "first-page": "962", "DOI": "10.1016/j.nbd.2011.12.015", "volume": "45", "author": "AM Gusdon", "year": "2011", "unstructured": "Gusdon AM, Zhu J, Van Houten B, Chu CT (2011) ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis 45:962\u2013972", "journal-title": "Neurobiol Dis"}, {"key": "16_CR165", "doi-asserted-by": "publisher", "first-page": "763", "DOI": "10.1073/pnas.65.3.763", "volume": "65", "author": "M Gutman", "year": "1970", "unstructured": "Gutman M, Singer TP, Beinert H, Casida JE (1970) Reaction sites of rotenone, piericidin A, and amytal in relation to the nonheme iron components of NADH dehydrogenase. Proc Natl Acad Sci USA 65:763\u2013770", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "Suppl 1", "key": "16_CR166", "doi-asserted-by": "publisher", "first-page": "S85", "DOI": "10.1016/S1353-8020(11)70027-X", "volume": "18", "author": "M Hallett", "year": "2012", "unstructured": "Hallett M (2012) Parkinson\u2019s disease tremor: pathophysiology. Parkinsonism Relat Disord 18(Suppl 1):S85\u2013S86", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR167", "doi-asserted-by": "publisher", "first-page": "1519", "DOI": "10.1002/mds.22481", "volume": "24", "author": "G Halliday", "year": "2009", "unstructured": "Halliday G, Herrero MT, Murphy K, McCann H, Ros-Bernal F, Barcia C, Mori H, Blesa FJ, Obeso JA (2009) No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism. Mov Disord 24:1519\u20131523", "journal-title": "Mov Disord"}, {"key": "16_CR168", "doi-asserted-by": "publisher", "first-page": "1015", "DOI": "10.1002/mds.23669", "volume": "26", "author": "G Halliday", "year": "2011", "unstructured": "Halliday G, Lees A, Stern M (2011) Milestones in Parkinson\u2019s disease\u2014clinical and pathologic features. Mov Disord 26:1015\u20131021", "journal-title": "Mov Disord"}, {"key": "16_CR169", "doi-asserted-by": "crossref", "first-page": "918", "DOI": "10.1002/dneu.20978", "volume": "72", "author": "RW Hamill", "year": "2012", "unstructured": "Hamill RW, Tompkins JD, Girard BM, Kershen RT, Parsons RL, Vizzard MA (2012) Autonomic dysfunction and plasticity in micturition reflexes in human alpha-synuclein mice. Dev Neurobiol 72:918\u2013936", "journal-title": "Dev Neurobiol"}, {"key": "16_CR170", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1038/jhg.2010.13", "volume": "55", "author": "TH Hamza", "year": "2010", "unstructured": "Hamza TH, Payami H (2010) The heritability of risk and age at onset of Parkinson\u2019s disease after accounting for known genetic risk factors. J Hum Genet 55:241\u2013243", "journal-title": "J Hum Genet"}, {"key": "16_CR171", "doi-asserted-by": "publisher", "first-page": "781", "DOI": "10.1038/ng.642", "volume": "42", "author": "TH Hamza", "year": "2010", "unstructured": "Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, Payami H (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet 42:781\u2013785", "journal-title": "Nat Genet"}, {"key": "16_CR172", "doi-asserted-by": "publisher", "first-page": "9747", "DOI": "10.1073/pnas.0911175107", "volume": "107", "author": "LY Hao", "year": "2010", "unstructured": "Hao LY, Giasson BI, Bonini NM (2010) DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci USA 107:9747\u20139752", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR173", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1016/j.neuron.2010.10.014", "volume": "68", "author": "J Hardy", "year": "2010", "unstructured": "Hardy J (2010) Genetic analysis of pathways to Parkinson disease. Neuron 68:201\u2013206", "journal-title": "Neuron"}, {"key": "16_CR174", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1002/ana.21022", "volume": "60", "author": "J Hardy", "year": "2006", "unstructured": "Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson\u2019s disease and parkinsonism. Ann Neurol 60:389\u2013398", "journal-title": "Ann Neurol"}, {"key": "16_CR175", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1016/j.gde.2009.03.008", "volume": "19", "author": "J Hardy", "year": "2009", "unstructured": "Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson\u2019s syndromes: a critical review. Curr Opin Genet Dev 19:254\u2013265", "journal-title": "Curr Opin Genet Dev"}, {"key": "16_CR176", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1038/nature10317", "volume": "475", "author": "FU Hartl", "year": "2011", "unstructured": "Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475:324\u2013332", "journal-title": "Nature"}, {"key": "16_CR177", "doi-asserted-by": "publisher", "first-page": "300", "DOI": "10.1016/j.parkreldis.2008.07.010", "volume": "15", "author": "K Hasegawa", "year": "2009", "unstructured": "Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S (2009) Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord 15:300\u2013306", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR178", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/S0006-8993(98)00514-9", "volume": "799", "author": "M Hashimoto", "year": "1998", "unstructured": "Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E (1998) Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799:301\u2013306", "journal-title": "Brain Res"}, {"key": "16_CR179", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1093/brain/83.2.337", "volume": "83", "author": "R Hassler", "year": "1960", "unstructured": "Hassler R, Riechert T, Mundinger F, Umbach W, Ganglberger JA (1960) Physiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain 83:337\u2013350", "journal-title": "Brain"}, {"key": "16_CR180", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1016/j.parkreldis.2009.08.007", "volume": "16", "author": "CH Hawkes", "year": "2010", "unstructured": "Hawkes CH, Del Tredici K, Braak H (2010) A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord 16:79\u201384", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR181", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1016/S1474-4422(08)70117-0", "volume": "7", "author": "DG Healy", "year": "2008", "unstructured": "Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590", "journal-title": "Lancet Neurol"}, {"key": "16_CR182", "doi-asserted-by": "publisher", "first-page": "811", "DOI": "10.1586/14737175.5.6.811", "volume": "5", "author": "C Henchcliffe", "year": "2005", "unstructured": "Henchcliffe C, Schumacher HC, Burgut FT (2005) Recent advances in Parkinson\u2019s disease therapy: use of monoamine oxidase inhibitors. Expert Rev Neurother 5:811\u2013821", "journal-title": "Expert Rev Neurother"}, {"key": "16_CR183", "doi-asserted-by": "publisher", "first-page": "208", "DOI": "10.1016/j.brainres.2007.04.034", "volume": "1155", "author": "S Higashi", "year": "2007", "unstructured": "Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, Faull RL, Waldvogel HJ, Arai H, Dawson TM, Moore DJ, Emson PC (2007) Localization of Parkinson\u2019s disease-associated LRRK2 in normal and pathological human brain. Brain Res 1155:208\u2013219", "journal-title": "Brain Res"}, {"key": "16_CR184", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1159/000324514", "volume": "8", "author": "MP Hinault", "year": "2011", "unstructured": "Hinault MP, Farina-Henriquez-Cuendet A, Goloubinoff P (2011) Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson\u2019s disease. Neurodegener Dis 8:397\u2013412", "journal-title": "Neurodegener Dis"}, {"key": "16_CR185", "doi-asserted-by": "publisher", "first-page": "5976", "DOI": "10.1073/pnas.84.16.5976", "volume": "84", "author": "EC Hirsch", "year": "1987", "unstructured": "Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84:5976\u20135980", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR186", "doi-asserted-by": "publisher", "first-page": "326", "DOI": "10.1212/01.wnl.0000252807.38124.a3", "volume": "68", "author": "D Hirtz", "year": "2007", "unstructured": "Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the \u201ccommon\u201d neurologic disorders? Neurology 68:326\u2013337", "journal-title": "Neurology"}, {"key": "16_CR187", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1212/WNL.17.5.427", "volume": "17", "author": "MM Hoehn", "year": "1967", "unstructured": "Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442", "journal-title": "Neurology"}, {"key": "16_CR188", "doi-asserted-by": "publisher", "first-page": "677", "DOI": "10.1007/s00415-006-0130-2", "volume": "253", "author": "B Holdorff", "year": "2006", "unstructured": "Holdorff B (2006) Fritz heinrich lewy (1885\u20131950). J Neurol 253:677\u2013678", "journal-title": "J Neurol"}, {"key": "16_CR189", "doi-asserted-by": "publisher", "first-page": "1044", "DOI": "10.1001/archneur.61.7.1044", "volume": "61", "author": "RG Holloway", "year": "2004", "unstructured": "Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O\u2019Connell C, Ross T, Richard K, Watts A (2004) Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 61:1044\u20131053", "journal-title": "Arch Neurol"}, {"key": "16_CR190", "doi-asserted-by": "publisher", "first-page": "32592", "DOI": "10.1074/jbc.M404950200", "volume": "279", "author": "JM Hsu", "year": "2004", "unstructured": "Hsu JM, Lee YC, Yu CT, Huang CY (2004) Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region. J Biol Chem 279:32592\u201332602", "journal-title": "J Biol Chem"}, {"key": "16_CR191", "doi-asserted-by": "publisher", "first-page": "1449", "DOI": "10.1002/mds.20609", "volume": "20", "author": "DM Huse", "year": "2005", "unstructured": "Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G (2005) Burden of illness in Parkinson\u2019s disease. Mov Disord 20:1449\u20131454", "journal-title": "Mov Disord"}, {"key": "16_CR192", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1007/s00401-003-0766-2", "volume": "106", "author": "K Imamura", "year": "2003", "unstructured": "Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106:518\u2013526", "journal-title": "Acta Neuropathol"}, {"key": "16_CR193", "doi-asserted-by": "publisher", "first-page": "797", "DOI": "10.1016/S1474-4422(11)70152-1", "volume": "10", "author": "A Iranzo", "year": "2011", "unstructured": "Iranzo A, Valldeoriola F, Lomena F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pavia J, Santamaria J, Tolosa E (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10:797\u2013805", "journal-title": "Lancet Neurol"}, {"issue": "Suppl 3", "key": "16_CR194", "doi-asserted-by": "publisher", "first-page": "P4", "DOI": "10.1007/PL00007745", "volume": "245", "author": "A Ishikawa", "year": "1998", "unstructured": "Ishikawa A, Takahashi H (1998) Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 245(Suppl 3):P4\u2013P9", "journal-title": "J Neurol"}, {"key": "16_CR195", "doi-asserted-by": "publisher", "first-page": "2277", "DOI": "10.1093/hmg/ddg239", "volume": "12", "author": "JM Itier", "year": "2003", "unstructured": "Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, Laville M, Pratt J, Corti O, Pradier L, Ret G, Joubert C, Periquet M, Araujo F, Negroni J, Casarejos MJ, Canals S, Solano R, Serrano A, Gallego E, Sanchez M, Denefle P, Benavides J, Tremp G, Rooney TA, Brice A, Garcia de Yebenes J (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12:2277\u20132291", "journal-title": "Hum Mol Genet"}, {"key": "16_CR196", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/j.parkreldis.2010.08.022", "volume": "17", "author": "S Jain", "year": "2011", "unstructured": "Jain S (2011) Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat Disord 17:77\u201383", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR197", "unstructured": "Jarrya B, Boulet S, Ralph GS, Jan C, Bonvento G, Azzouz M, Miskin JE, Shin M, Delzescaux T, Drouot X, Herard AS, Day DM, Brouillet E, Kingsman SM, Hantraye P, Mitrophanous KA, Mazarakis ND, Palfi S (2009) Dopamine gene therapy for Parkinson\u2019s disease in a nonhuman primate without associated dyskinesia. Sci Transl Med 1(2ra4)", "DOI": "10.1126/scitranslmed.3000130", "doi-asserted-by": "crossref"}, {"key": "16_CR198", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1002/ana.21638", "volume": "67", "author": "KA Jellinger", "year": "2010", "unstructured": "Jellinger KA (2010) Critical evaluation of the braak staging scheme for Parkinson\u2019s disease. Ann Neurol 67:550", "journal-title": "Ann Neurol"}, {"key": "16_CR199", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1002/mds.22189", "volume": "24", "author": "N Jenkinson", "year": "2009", "unstructured": "Jenkinson N, Nandi D, Muthusamy K, Ray NJ, Gregory R, Stein JF, Aziz TZ (2009) Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov Disord 24:319\u2013328", "journal-title": "Mov Disord"}, {"key": "16_CR200", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1111/j.1365-2990.2007.00923.x", "volume": "34", "author": "ME Kalaitzakis", "year": "2008", "unstructured": "Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 34:284\u2013295", "journal-title": "Neuropathol Appl Neurobiol"}, {"key": "16_CR201", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/j.jns.2006.05.003", "volume": "248", "author": "A Kalda", "year": "2006", "unstructured": "Kalda A, Yu L, Oztas E, Chen JF (2006) Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson\u2019s disease. J Neurol Sci 248:9\u201315", "journal-title": "J Neurol Sci"}, {"key": "16_CR202", "doi-asserted-by": "publisher", "first-page": "2745", "DOI": "10.1172/JCI42642", "volume": "120", "author": "C Karachi", "year": "2010", "unstructured": "Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, Bardinet E, Prigent A, Nothacker HP, Hunot S, Hartmann A, Lehericy S, Hirsch EC, Francois C (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120:2745\u20132754", "journal-title": "J Clin Invest"}, {"key": "16_CR203", "doi-asserted-by": "publisher", "first-page": "1073", "DOI": "10.1016/j.febslet.2010.02.016", "volume": "584", "author": "S Kawajiri", "year": "2010", "unstructured": "Kawajiri S, Saiki S, Sato S, Sato F, Hatano T, Eguchi H, Hattori N (2010) PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett 584:1073\u20131079", "journal-title": "FEBS Lett"}, {"key": "16_CR204", "doi-asserted-by": "publisher", "first-page": "482", "DOI": "10.1212/01.wnl.0000266639.50620.d1", "volume": "69", "author": "PA Kempster", "year": "2007", "unstructured": "Kempster PA, Hurwitz B, Lees AJ (2007) A new look at James Parkinson\u2019s essay on the shaking palsy. Neurology 69:482\u2013485", "journal-title": "Neurology"}, {"issue": "Pt 12", "key": "16_CR205", "doi-asserted-by": "publisher", "first-page": "2786", "DOI": "10.1093/brain/awh667", "volume": "128", "author": "NL Khan", "year": "2005", "unstructured": "Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, Healy DG, Gilks WP, Sweeney MG, Ganguly M, Gibbons V, Gandhi S, Vaughan J, Eunson LH, Katzenschlager R, Gayton J, Lennox G, Revesz T, Nicholl D, Bhatia KP, Quinn N, Brooks D, Lees AJ, Davis MB, Piccini P, Singleton AB, Wood NW (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson\u2019s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128(Pt 12):2786\u20132796", "journal-title": "Brain"}, {"issue": "Pt 6", "key": "16_CR206", "doi-asserted-by": "publisher", "first-page": "1772", "DOI": "10.1093/brain/awq091", "volume": "133", "author": "A Kikuchi", "year": "2010", "unstructured": "Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S, Kobayashi M, Sugeno N, Baba T, Miki Y, Mori F, Wakabayashi K, Funaki Y, Iwata R, Takahashi S, Fukuda H, Arai H, Kudo Y, Yanai K, Itoyama Y (2010) In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain 133(Pt 6):1772\u20131778", "journal-title": "Brain"}, {"key": "16_CR207", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1038/emm.2006.40", "volume": "38", "author": "YS Kim", "year": "2006", "unstructured": "Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347", "journal-title": "Exp Mol Med"}, {"key": "16_CR208", "doi-asserted-by": "publisher", "first-page": "605", "DOI": "10.1038/33416", "volume": "392", "author": "T Kitada", "year": "1998", "unstructured": "Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608", "journal-title": "Nature"}, {"key": "16_CR209", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1111/j.1471-4159.2009.06152.x", "volume": "110", "author": "T Kitada", "year": "2009", "unstructured": "Kitada T, Pisani A, Karouani M, Haburcak M, Martella G, Tscherter A, Platania P, Wu B, Pothos EN, Shen J (2009) Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice. J Neurochem 110:613\u2013621", "journal-title": "J Neurochem"}, {"key": "16_CR210", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1097/WCO.0b013e3280adc943", "volume": "20", "author": "A Klegeris", "year": "2007", "unstructured": "Klegeris A, McGeer EG, McGeer PL (2007) Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol 20:351\u2013357", "journal-title": "Curr Opin Neurol"}, {"key": "16_CR211", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1016/j.neurobiolaging.2006.11.013", "volume": "29", "author": "A Klegeris", "year": "2008", "unstructured": "Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, McGeer PL (2008) Alpha-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging 29:739\u2013752", "journal-title": "Neurobiol Aging"}, {"key": "16_CR212", "doi-asserted-by": "publisher", "first-page": "504", "DOI": "10.1038/nm1747", "volume": "14", "author": "JH Kordower", "year": "2008a", "unstructured": "Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008a) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14:504\u2013506", "journal-title": "Nat Med"}, {"key": "16_CR213", "doi-asserted-by": "publisher", "first-page": "2303", "DOI": "10.1002/mds.22369", "volume": "23", "author": "JH Kordower", "year": "2008b", "unstructured": "Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008b) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23:2303\u20132306", "journal-title": "Mov Disord"}, {"key": "16_CR214", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1016/j.nbd.2011.05.001", "volume": "43", "author": "JH Kordower", "year": "2011", "unstructured": "Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, Madhavan L, Sortwell C, Steece-Collier K, Collier TJ (2011) Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis 43:552\u2013557", "journal-title": "Neurobiol Dis"}, {"key": "16_CR215", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1097/00001756-200001170-00041", "volume": "11", "author": "NW Kowall", "year": "2000", "unstructured": "Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11:211\u2013213", "journal-title": "Neuroreport"}, {"key": "16_CR216", "doi-asserted-by": "publisher", "first-page": "106", "DOI": "10.1038/ng0298-106", "volume": "18", "author": "R Kruger", "year": "1998", "unstructured": "Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108", "journal-title": "Nat Genet"}, {"key": "16_CR217", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1007/s007020050002", "volume": "107", "author": "R Kruger", "year": "2000", "unstructured": "Kruger R, Muller T, Riess O (2000) Involvement of alpha-synuclein in Parkinson\u2019s disease and other neurodegenerative disorders. J Neural Transm 107:31\u201340", "journal-title": "J Neural Transm"}, {"key": "16_CR218", "unstructured": "Kuiken HJ, Egan DA, Laman H, Bernards R, Beijersbergen RL, Dirac AM (2012) Identification of F-box only protein 7 as a negative regulator of NF-kappaB signaling. J Cell Mol Med doi:10.1111/j.1582\u20134934.2012.01524"}, {"key": "16_CR219", "doi-asserted-by": "crossref", "first-page": "e20", "DOI": "10.1017/S146239941100192X", "volume": "13", "author": "A Kumar", "year": "2011", "unstructured": "Kumar A, Cookson MR (2011) Role of LRRK2 kinase dysfunction in Parkinson disease. Expert Rev Mol Med 13:e20", "journal-title": "Expert Rev Mol Med"}, {"key": "16_CR220", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1016/j.nbd.2009.08.011", "volume": "36", "author": "R Kumaran", "year": "2009", "unstructured": "Kumaran R, Vandrovcova J, Luk C, Sharma S, Renton A, Wood NW, Hardy JA, Lees AJ, Bandopadhyay R (2009) Differential DJ-1 gene expression in Parkinson\u2019s disease. Neurobiol Dis 36:393\u2013400", "journal-title": "Neurobiol Dis"}, {"key": "16_CR221", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1093/hmg/ddr530", "volume": "21", "author": "Y Kuroda", "year": "2012", "unstructured": "Kuroda Y, Sako W, Goto S, Sawada T, Uchida D, Izumi Y, Takahashi T, Kagawa N, Matsumoto M, Takahashi R, Kaji R, Mitsui T (2012) Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. Hum Mol Genet 21:991\u20131003", "journal-title": "Hum Mol Genet"}, {"key": "16_CR222", "first-page": "310", "volume": "309", "author": "JW Langston", "year": "1983", "unstructured": "Langston JW, Ballard PA Jr (1983) Parkinson\u2019s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. New Engl J Med 309:310", "journal-title": "New Engl J Med"}, {"key": "16_CR223", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1126/science.6823561", "volume": "219", "author": "JW Langston", "year": "1983", "unstructured": "Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980", "journal-title": "Science"}, {"key": "16_CR224", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1016/j.neuroscience.2011.08.016", "volume": "196", "author": "NJ Larsen", "year": "2011", "unstructured": "Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA (2011) DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 196:251\u2013264", "journal-title": "Neuroscience"}, {"key": "16_CR225", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1016/j.gene.2007.06.013", "volume": "400", "author": "E Lavara-Culebras", "year": "2007", "unstructured": "Lavara-Culebras E, Paricio N (2007) Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits. Gene 400:158\u2013165", "journal-title": "Gene"}, {"key": "16_CR226", "doi-asserted-by": "publisher", "first-page": "1741", "DOI": "10.1136/gut.2008.162503", "volume": "57", "author": "T Lebouvier", "year": "2008", "unstructured": "Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, Naveilhan P, Galmiche JP, Bruley des Varannes S, Derkinderen P, Neunlist M (2008) Pathological lesions in colonic biopsies during Parkinson\u2019s disease. Gut 57:1741\u20131743", "journal-title": "Gut"}, {"key": "16_CR227", "first-page": "e11", "volume": "22", "author": "T Lebouvier", "year": "2010a", "unstructured": "Lebouvier T, Coron E, Chaumette T, Paillusson S, Bruley des Varannes S, Neunlist M, Derkinderen P (2010a) Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil 22:e11\u2013e14", "journal-title": "Neurogastroenterol Motil"}, {"key": "16_CR228", "unstructured": "Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N\u2019Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P (2010b) Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS ONE 5:e12728", "DOI": "10.1371/journal.pone.0012728", "doi-asserted-by": "crossref"}, {"key": "16_CR229", "doi-asserted-by": "publisher", "first-page": "2766", "DOI": "10.1091/mbc.E07-11-1115", "volume": "19", "author": "DW Lee", "year": "2008", "unstructured": "Lee DW, Zhao X, Yim YI, Eisenberg E, Greene LE (2008) Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. Mol Biol Cell 19:2766\u20132776", "journal-title": "Mol Biol Cell"}, {"key": "16_CR230", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1007/s11481-009-9176-0", "volume": "4", "author": "JK Lee", "year": "2009", "unstructured": "Lee JK, Tran T, Tansey MG (2009) Neuroinflammation in Parkinson\u2019s disease. J Neuroimmune Pharmacol 4:419\u2013429", "journal-title": "J Neuroimmune Pharmacol"}, {"key": "16_CR231", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.4049/jimmunol.0903480", "volume": "185", "author": "EJ Lee", "year": "2010", "unstructured": "Lee EJ, Woo MS, Moon PG, Baek MC, Choi IY, Kim WK, Junn E, Kim HS (2010) Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185:615\u2013623", "journal-title": "J Immunol"}, {"key": "16_CR232", "doi-asserted-by": "publisher", "first-page": "2364", "DOI": "10.1002/mds.23871", "volume": "26", "author": "HW Lee", "year": "2011", "unstructured": "Lee HW, Choi J, Suk K (2011) Increases of pentraxin 3 plasma levels in patients with Parkinson\u2019s disease. Mov Disord 26:2364\u20132370", "journal-title": "Mov Disord"}, {"key": "16_CR233", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1002/mds.21855", "volume": "23", "author": "AJ Lees", "year": "2008", "unstructured": "Lees AJ, Selikhova M, Andrade LA, Duyckaerts C (2008) The black stuff and Konstantin Nikolaevich Tretiakoff. Mov Disord 23:777\u2013783", "journal-title": "Mov Disord"}, {"key": "16_CR234", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/S1474-4422(11)70039-4", "volume": "10", "author": "PA LeWitt", "year": "2011", "unstructured": "LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A (2011) AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10:309\u2013319", "journal-title": "Lancet Neurol"}, {"issue": "Suppl 1", "key": "16_CR235", "doi-asserted-by": "publisher", "first-page": "S123", "DOI": "10.1002/mds.22786", "volume": "25", "author": "SY Lim", "year": "2010", "unstructured": "Lim SY, Lang AE (2010) The nonmotor symptoms of Parkinson\u2019s disease\u2014an overview. Mov Disord 25(Suppl 1):S123\u2013S130", "journal-title": "Mov Disord"}, {"key": "16_CR236", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1038/nature05292", "volume": "443", "author": "MT Lin", "year": "2006", "unstructured": "Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795", "journal-title": "Nature"}, {"key": "16_CR237", "doi-asserted-by": "publisher", "first-page": "807", "DOI": "10.1016/j.neuron.2009.11.006", "volume": "64", "author": "X Lin", "year": "2009", "unstructured": "Lin X, Parisiadou L, Gu XL, Wang L, Shim H, Sun L, Xie C, Long CX, Yang WJ, Ding J, Chen ZZ, Gallant PE, Tao-Cheng JH, Rudow G, Troncoso JC, Liu Z, Li Z, Cai H (2009) Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein. Neuron 64:807\u2013827", "journal-title": "Neuron"}, {"key": "16_CR238", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1097/nen.0b013e318053716a", "volume": "66", "author": "I Litvan", "year": "2007a", "unstructured": "Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D Jr, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E (2007a) The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol 66:329\u2013336", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "16_CR239", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1097/nen.0b013e3180415e42", "volume": "66", "author": "I Litvan", "year": "2007b", "unstructured": "Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D Jr, Price DL (2007b) The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol 66:251\u2013257", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "16_CR240", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1124/jpet.102.035048", "volume": "304", "author": "B Liu", "year": "2003", "unstructured": "Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1\u20137", "journal-title": "J Pharmacol Exp Ther"}, {"key": "16_CR241", "doi-asserted-by": "publisher", "first-page": "590", "DOI": "10.1007/s11427-010-0104-6", "volume": "53", "author": "L Lu", "year": "2010", "unstructured": "Lu L, Gu L, Liang Y, Sun X, Duan C, Yang H (2010) Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells. Sci China Life Sci 53:590\u2013597", "journal-title": "Sci China Life Sci"}, {"key": "16_CR242", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1016/j.jmb.2007.11.096", "volume": "377", "author": "SM Lynch", "year": "2008", "unstructured": "Lynch SM, Zhou C, Messer A (2008) An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J Mol Biol 377:136\u2013147", "journal-title": "J Mol Biol"}, {"key": "16_CR243", "doi-asserted-by": "publisher", "first-page": "148", "DOI": "10.1016/j.neulet.2011.01.026", "volume": "491", "author": "KL Ma", "year": "2011", "unstructured": "Ma KL, Yuan YH, Song LK, Han N, Chen NH (2011) Over-expression of alpha-synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone. Neurosci Lett 491:148\u2013152", "journal-title": "Neurosci Lett"}, {"key": "16_CR244", "doi-asserted-by": "publisher", "first-page": "271", "DOI": "10.1016/j.phrs.2008.09.006", "volume": "58", "author": "KA Maguire-Zeiss", "year": "2008", "unstructured": "Maguire-Zeiss KA (2008) Alpha-Synuclein: a therapeutic target for Parkinson\u2019s disease? Pharmacol Res 58:271\u2013280", "journal-title": "Pharmacol Res"}, {"key": "16_CR245", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1007/s11481-008-9133-3", "volume": "4", "author": "KA Maguire-Zeiss", "year": "2009", "unstructured": "Maguire-Zeiss KA, Federoff HJ (2009) Immune-directed gene therapeutic development for Alzheimer\u2019s, prion, and Parkinson\u2019s diseases. Neuroimmune Pharmacol 4:298\u2013308", "journal-title": "Neuroimmune Pharmacol"}, {"key": "16_CR246", "doi-asserted-by": "publisher", "first-page": "1019", "DOI": "10.1007/s00702-010-0431-6", "volume": "117", "author": "KA Maguire-Zeiss", "year": "2010", "unstructured": "Maguire-Zeiss KA, Federoff HJ (2010) Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson\u2019s disease. J Neural Transm 117:1019\u20131025", "journal-title": "J Neural Transm"}, {"key": "16_CR247", "doi-asserted-by": "publisher", "first-page": "1198", "DOI": "10.1016/j.bbrc.2006.08.127", "volume": "349", "author": "KA Maguire-Zeiss", "year": "2006", "unstructured": "Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ (2006) Identification of human alpha-synuclein specific single chain antibodies. Biochem Biophys Res Commun 349:1198\u20131205", "journal-title": "Biochem Biophys Res Commun"}, {"key": "16_CR248", "author": "KA Maguire-Zeiss", "year": "2008", "unstructured": "Maguire-Zeiss KA, Su X, Federoff HJ (2008) Microglial activation in a mouse model of alpha-synuclein overexpression. Elsevier Inc, San Diego", "volume-title": "Microglial activation in a mouse model of alpha-synuclein overexpression"}, {"key": "16_CR249", "first-page": "13", "volume": "13", "author": "AB Manning-Bog", "year": "2001", "unstructured": "Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2001) The herbicide paraquat causes upregulation and aggregation of alpha- synuclein in mice. J Biol Chem 13:13", "journal-title": "J Biol Chem"}, {"key": "16_CR250", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1074/jbc.C100560200", "volume": "277", "author": "AB Manning-Bog", "year": "2002", "unstructured": "Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002) The herbicide paraquat causes up-regulation and aggregation of alpha- synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277:1641\u20131644", "journal-title": "J Biol Chem"}, {"key": "16_CR251", "doi-asserted-by": "publisher", "first-page": "148", "DOI": "10.1002/mds.20723", "volume": "21", "author": "L Marsh", "year": "2006", "unstructured": "Marsh L, McDonald WM, Cummings J, Ravina B (2006) Provisional diagnostic criteria for depression in Parkinson\u2019s disease: report of an NINDS/NIMH Work Group. Mov Disord 21:148\u2013158", "journal-title": "Mov Disord"}, {"key": "16_CR252", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1146/annurev-genom-082410-101440", "volume": "12", "author": "I Martin", "year": "2011", "unstructured": "Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson\u2019s disease. Ann Rev Genomics Hum Genet 12:301\u2013325", "journal-title": "Ann Rev Genomics Hum Genet"}, {"key": "16_CR253", "doi-asserted-by": "publisher", "first-page": "12245", "DOI": "10.1073/pnas.211412398", "volume": "98", "author": "E Masliah", "year": "2001", "unstructured": "Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:12245\u201312250", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR254", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1111/j.1468-1331.2006.01256.x", "volume": "13", "author": "IF Mata", "year": "2006", "unstructured": "Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, Blazquez M, Guisasola LM, Salvador C, Martinez C, Farrer M, Alvarez V (2006) LRRK2 mutations are a common cause of Parkinson\u2019s disease in Spain. Eur J Neurol 13:391\u2013394", "journal-title": "Eur J Neurol"}, {"key": "16_CR255", "doi-asserted-by": "publisher", "first-page": "819", "DOI": "10.1002/mds.23642", "volume": "26", "author": "IF Mata", "year": "2011", "unstructured": "Mata IF, Yearout D, Alvarez V, Coto E, de Mena L, Ribacoba R, Lorenzo-Betancor O, Samaranch L, Pastor P, Cervantes S, Infante J, Garcia-Gorostiaga I, Sierra M, Combarros O, Snapinn KW, Edwards KL, Zabetian CP (2011) Replication of MAPT and SNCA, but not PARK16\u201318, as susceptibility genes for Parkinson\u2019s disease. Mov Disord 26:819\u2013823", "journal-title": "Mov Disord"}, {"key": "16_CR256", "doi-asserted-by": "publisher", "first-page": "142", "DOI": "10.1006/exnr.1999.7049", "volume": "157", "author": "RT Matthews", "year": "1999", "unstructured": "Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157:142\u2013149", "journal-title": "Exp Neurol"}, {"key": "16_CR257", "doi-asserted-by": "publisher", "first-page": "645", "DOI": "10.1212/WNL.31.6.645", "volume": "31", "author": "R Mayeux", "year": "1981", "unstructured": "Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment, and Parkinson disease. Neurology 31:645\u2013650", "journal-title": "Neurology"}, {"key": "16_CR258", "doi-asserted-by": "crossref", "first-page": "820", "DOI": "10.1093/oxfordjournals.aje.a117721", "volume": "142", "author": "R Mayeux", "year": "1995", "unstructured": "Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B et al (1995) The frequency of idiopathic Parkinson\u2019s disease by age, ethnic group, and sex in northern Manhattan, 1988\u20131993. Am J Epidemiol 142:820\u2013827", "journal-title": "Am J Epidemiol"}, {"key": "16_CR259", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1111/j.1525-1403.2009.00214.x", "volume": "12", "author": "P Mazzone", "year": "2009", "unstructured": "Mazzone P, Insola A, Sposato S, Scarnati E (2009) The deep brain stimulation of the pedunculopontine tegmental nucleus. Neuromodulation 12:191\u2013204", "journal-title": "Neuromodulation"}, {"key": "16_CR260", "doi-asserted-by": "publisher", "first-page": "793", "DOI": "10.1097/NEN.0b013e318180f0bd", "volume": "67", "author": "AL McCormack", "year": "2008", "unstructured": "McCormack AL, Mak SK, Shenasa M, Langston WJ, Forno LS, Di Monte DA (2008) Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys. J Neuropathol Exp Neurol 67:793\u2013802", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "16_CR261", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1016/S0006-3223(03)00530-4", "volume": "54", "author": "WM McDonald", "year": "2003", "unstructured": "McDonald WM, Richard IH, DeLong MR (2003) Prevalence, etiology, and treatment of depression in Parkinson\u2019s disease. Biol Psychiatry 54:363\u2013375", "journal-title": "Biol Psychiatry"}, {"key": "16_CR262", "doi-asserted-by": "publisher", "first-page": "104", "DOI": "10.1196/annals.1332.007", "volume": "1035", "author": "PL McGeer", "year": "2004", "unstructured": "McGeer PL, McGeer EG (2004) Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 1035:104\u2013116", "journal-title": "Ann NY Acad Sci"}, {"issue": "4", "key": "16_CR263", "doi-asserted-by": "publisher", "first-page": "474", "DOI": "10.1002/mds.21751", "volume": "23", "author": "PL McGeer", "year": "2008", "unstructured": "McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23(4):474\u2013483", "journal-title": "Mov Disord"}, {"key": "16_CR264", "doi-asserted-by": "publisher", "first-page": "1285", "DOI": "10.1212/WNL.38.8.1285", "volume": "38", "author": "PL McGeer", "year": "1988", "unstructured": "McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291", "journal-title": "Neurology"}, {"issue": "Suppl 1", "key": "16_CR265", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1016/j.neurobiolaging.2005.08.008", "volume": "26", "author": "EG McGeer", "year": "2005", "unstructured": "McGeer EG, Klegeris A, McGeer PL (2005) Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26(Suppl 1):94\u201397", "journal-title": "Neurobiol Aging"}, {"key": "16_CR266", "doi-asserted-by": "publisher", "first-page": "1863", "DOI": "10.1212/01.wnl.0000187889.17253.b1", "volume": "65", "author": "IG McKeith", "year": "2005", "unstructured": "McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872", "journal-title": "Neurology"}, {"key": "16_CR267", "doi-asserted-by": "publisher", "first-page": "886", "DOI": "10.1212/01.wnl.0000336340.89821.b3", "volume": "72", "author": "M Menza", "year": "2009", "unstructured": "Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Buyske S, Bienfait K, Dicke A (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72:886\u2013892", "journal-title": "Neurology"}, {"key": "16_CR268", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.1517/14712590903176387", "volume": "9", "author": "A Messer", "year": "2009", "unstructured": "Messer A, Lynch SM, Butler DC (2009) Developing intrabodies for the therapeutic suppression of neurodegenerative pathology. Expert Opin Biol Ther 9:1189\u20131197", "journal-title": "Expert Opin Biol Ther"}, {"key": "16_CR269", "doi-asserted-by": "publisher", "first-page": "1693", "DOI": "10.1093/brain/awh198", "volume": "127", "author": "AW Michell", "year": "2004", "unstructured": "Michell AW, Lewis SJ, Foltynie T, Barker RA (2004) Biomarkers and Parkinson\u2019s disease. Brain 127:1693\u20131705", "journal-title": "Brain"}, {"key": "16_CR270", "doi-asserted-by": "publisher", "first-page": "2012", "DOI": "10.1212/01.wnl.0000264429.59379.d9", "volume": "68", "author": "A Minguez-Castellanos", "year": "2007", "unstructured": "Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007) Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study. Neurology 68:2012\u20132018", "journal-title": "Neurology"}, {"key": "16_CR271", "doi-asserted-by": "publisher", "first-page": "2422", "DOI": "10.1021/ac051978n", "volume": "78", "author": "H Mirzaei", "year": "2006", "unstructured": "Mirzaei H, Schieler JL, Rochet JC, Regnier F (2006) Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. Anal Chem 78:2422\u20132431", "journal-title": "Anal Chem"}, {"key": "16_CR272", "doi-asserted-by": "publisher", "first-page": "230", "DOI": "10.1016/S1474-4422(11)70014-X", "volume": "10", "author": "B Mollenhauer", "year": "2011", "unstructured": "Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) Alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230\u2013240", "journal-title": "Lancet Neurol"}, {"key": "16_CR273", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0079-6123(10)83010-9", "volume": "183", "author": "M Morelli", "year": "2010", "unstructured": "Morelli M, Carta AR, Kachroo A, Schwarzschild MA (2010) Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res 183:183\u2013208", "journal-title": "Prog Brain Res"}, {"key": "16_CR274", "doi-asserted-by": "publisher", "first-page": "768", "DOI": "10.1002/ana.410430612", "volume": "43", "author": "MD Muenter", "year": "1998", "unstructured": "Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM Jr, Snow BJ, Calne DB (1998) Hereditary form of parkinsonism\u2014dementia. Ann Neurol 43:768\u2013781", "journal-title": "Ann Neurol"}, {"key": "16_CR275", "doi-asserted-by": "publisher", "first-page": "595", "DOI": "10.1016/j.conb.2008.11.001", "volume": "18", "author": "A Nambu", "year": "2008", "unstructured": "Nambu A (2008) Seven problems on the basal ganglia. Curr Opin Neurobiol 18:595\u2013604", "journal-title": "Curr Opin Neurobiol"}, {"key": "16_CR276", "doi-asserted-by": "crossref", "first-page": "e1000298", "DOI": "10.1371/journal.pbio.1000298", "volume": "8", "author": "DP Narendra", "year": "2010", "unstructured": "Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8:e1000298", "journal-title": "PLoS Biol"}, {"key": "16_CR277", "doi-asserted-by": "publisher", "first-page": "930", "DOI": "10.1038/nrd3453", "volume": "10", "author": "DW Neef", "year": "2011", "unstructured": "Neef DW, Jaeger AM, Thiele DJ (2011) Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat Rev Drug Discov 10:930\u2013944", "journal-title": "Nat Rev Drug Discov"}, {"key": "16_CR278", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1002/mds.22142", "volume": "23", "author": "L Negre-Pages", "year": "2008", "unstructured": "Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O (2008) Chronic pain in Parkinson\u2019s disease: the cross-sectional French DoPaMiP survey. Mov Disord 23:1361\u20131369", "journal-title": "Mov Disord"}, {"key": "16_CR279", "doi-asserted-by": "publisher", "first-page": "1783", "DOI": "10.1093/brain/awp044", "volume": "132", "author": "J Neumann", "year": "2009", "unstructured": "Neumann J, Bras J, Deas E, O\u2019Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794", "journal-title": "Brain"}, {"key": "16_CR280", "doi-asserted-by": "publisher", "first-page": "848", "DOI": "10.1016/j.neurobiolaging.2005.04.010", "volume": "27", "author": "M Nieto", "year": "2006", "unstructured": "Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T, Ribe E, Ferrer I, Ramirez MJ, Gomez-Isla T (2006) Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 27:848\u2013856", "journal-title": "Neurobiol Aging"}, {"key": "16_CR281", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.2353/ajpath.2007.060359", "volume": "170", "author": "EH Norris", "year": "2007", "unstructured": "Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM (2007) Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol 170:658\u2013666", "journal-title": "Am J Pathol"}, {"key": "16_CR282", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.1097/00002826-200305000-00010", "volume": "26", "author": "D Nyholm", "year": "2003", "unstructured": "Nyholm D, Askmark H, Gomes-Trolin C, Knutson T, Lennernas H, Nystrom C, Aquilonius SM (2003) Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 26:156\u2013163", "journal-title": "Clin Neuropharmacol"}, {"key": "16_CR283", "doi-asserted-by": "publisher", "first-page": "771", "DOI": "10.1002/ana.410380512", "volume": "38", "author": "CW Olanow", "year": "1995", "unstructured": "Olanow CW, Hauser RA, Gauger L, Malapira T, Koller W, Hubble J, Bushenbark K, Lilienfeld D, Esterlitz J (1995) The effect of deprenyl and levodopa on the progression of Parkinson\u2019s disease. Ann Neurol 38:771\u2013777", "journal-title": "Ann Neurol"}, {"key": "16_CR284", "doi-asserted-by": "publisher", "first-page": "1268", "DOI": "10.1056/NEJMoa0809335", "volume": "361", "author": "CW Olanow", "year": "2009", "unstructured": "Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E (2009) A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. New Engl J Med 361:1268\u20131278", "journal-title": "New Engl J Med"}, {"key": "16_CR285", "doi-asserted-by": "publisher", "first-page": "271", "DOI": "10.1111/j.1749-6632.2010.05536.x", "volume": "1198", "author": "JK Olson", "year": "2010", "unstructured": "Olson JK (2010) Immune response by microglia in the spinal cord. Ann NY Acad Sci 1198:271\u2013278", "journal-title": "Ann NY Acad Sci"}, {"key": "16_CR286", "doi-asserted-by": "publisher", "first-page": "414", "DOI": "10.1016/j.expneurol.2007.03.002", "volume": "205", "author": "K Ono", "year": "2007", "unstructured": "Ono K, Hirohata M, Yamada M (2007) Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases. Exp Neurol 205:414\u2013424", "journal-title": "Exp Neurol"}, {"key": "16_CR287", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/S0301-0082(02)00127-2", "volume": "68", "author": "CF Orr", "year": "2002", "unstructured": "Orr CF, Rowe DB, Halliday GM (2002) An inflammatory review of Parkinson\u2019s disease. Prog Neurobiol 68:325\u2013340", "journal-title": "Prog Neurobiol"}, {"key": "16_CR288", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1016/S0304-3940(03)00941-8", "volume": "351", "author": "M Orth", "year": "2003", "unstructured": "Orth M, Tabrizi SJ, Schapira AH, Cooper JM (2003) Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone. Neurosci Lett 351:29\u201332", "journal-title": "Neurosci Lett"}, {"key": "16_CR289", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1002/cbf.978", "volume": "20", "author": "E Ortolan", "year": "2002", "unstructured": "Ortolan E, Vacca P, Capobianco A, Armando E, Crivellin F, Horenstein A, Malavasi F (2002) CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 20:309\u2013322", "journal-title": "Cell Biochem Funct"}, {"key": "16_CR290", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1002/ana.20338", "volume": "57", "author": "Y Ouchi", "year": "2005", "unstructured": "Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57:168\u2013175", "journal-title": "Ann Neurol"}, {"issue": "Suppl 3", "key": "16_CR291", "doi-asserted-by": "publisher", "first-page": "S200", "DOI": "10.1016/S1353-8020(09)70814-4", "volume": "15", "author": "Y Ouchi", "year": "2009", "unstructured": "Ouchi Y, Yagi S, Yokokura M, Sakamoto M (2009) Neuroinflammation in the living brain of Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl 3):S200\u2013S204", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR292", "doi-asserted-by": "publisher", "first-page": "595", "DOI": "10.1016/j.neuron.2004.10.023", "volume": "44", "author": "C Paisan-Ruiz", "year": "2004", "unstructured": "Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44:595\u2013600", "journal-title": "Neuron"}, {"key": "16_CR293", "doi-asserted-by": "publisher", "first-page": "814", "DOI": "10.1016/j.neurobiolaging.2010.05.009", "volume": "33", "author": "C Paisan-Ruiz", "year": "2012", "unstructured": "Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, Chataway J, Bhatia KP, Lees AJ, Hardy J, Revesz T, Houlden H (2012) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 33:814\u2013824", "journal-title": "Neurobiol Aging"}, {"key": "16_CR294", "doi-asserted-by": "publisher", "first-page": "1200", "DOI": "10.1212/01.wnl.0000204007.46190.54", "volume": "66", "author": "S Palhagen", "year": "2006", "unstructured": "Palhagen S, Heinonen E, Hagglund J, Kaugesaar T, Maki-Ikola O, Palm R (2006) Selegiline slows the progression of the symptoms of Parkinson disease. Neurology 66:1200\u20131206", "journal-title": "Neurology"}, {"key": "16_CR295", "doi-asserted-by": "publisher", "first-page": "593", "DOI": "10.1007/s00439-008-0582-9", "volume": "124", "author": "N Pankratz", "year": "2009", "unstructured": "Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124:593\u2013605", "journal-title": "Hum Genet"}, {"key": "16_CR296", "author": "J Parkinson", "year": "1817", "unstructured": "Parkinson J (1817) An essay on the shaking palsy. Neely and Jones, London", "volume-title": "An essay on the shaking palsy"}, {"key": "16_CR297", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1176/appi.neuropsych.14.2.223", "volume": "14", "author": "J Parkinson", "year": "2002", "unstructured": "Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14:223\u2013236; discussion 222", "journal-title": "J Neuropsychiatry Clin Neurosci"}, {"key": "16_CR298", "doi-asserted-by": "publisher", "first-page": "1052", "DOI": "10.1001/archneur.1989.00520460028009", "volume": "46", "author": "Parkinson Study Group", "year": "1989", "unstructured": "Parkinson Study Group (1989) DATATOP: a multicenter controlled clinical trial in early Parkinson\u2019s disease. Arch Neurol 46:1052\u20131060", "journal-title": "Arch Neurol"}, {"key": "16_CR299", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1111/j.1471-4159.2010.07036.x", "volume": "115", "author": "J Peng", "year": "2010", "unstructured": "Peng J, Oo ML, Andersen JK (2010) Synergistic effects of environmental risk factors and gene mutations in Parkinson\u2019s disease accelerate age-related neurodegeneration. J Neurochem 115:1363\u20131373", "journal-title": "J Neurochem"}, {"key": "16_CR300", "doi-asserted-by": "publisher", "first-page": "222", "DOI": "10.1159/000113708", "volume": "5", "author": "G Perry", "year": "2008", "unstructured": "Perry G, Zhu X, Babar AK, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Chen SG (2008) Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson\u2019s disease, but not tau-containing deposits in tauopathies. Neurodegener Dis 5:222\u2013224", "journal-title": "Neurodegener Dis"}, {"key": "16_CR301", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/S1474-4422(03)00307-7", "volume": "2", "author": "RF Pfeiffer", "year": "2003", "unstructured": "Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 2:107\u2013116", "journal-title": "Lancet Neurol"}, {"issue": "Suppl 3", "key": "16_CR302", "doi-asserted-by": "publisher", "first-page": "S211", "DOI": "10.1016/S1353-8020(08)70004-X", "volume": "13", "author": "RF Pfeiffer", "year": "2007", "unstructured": "Pfeiffer RF (2007) Non-motor parkinsonism. Parkinsonism Relat Disord 13(Suppl 3):S211\u2013S220", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR303", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1016/j.parkreldis.2010.08.003", "volume": "17", "author": "RF Pfeiffer", "year": "2011", "unstructured": "Pfeiffer RF (2011) Gastrointestinal dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord 17:10\u201315", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR304", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1111/j.1601-183X.2009.00559.x", "volume": "9", "author": "TT Pham", "year": "2010", "unstructured": "Pham TT, Giesert F, Rothig A, Floss T, Kallnik M, Weindl K, Holter SM, Ahting U, Prokisch H, Becker L, Klopstock T, Hrabe de Angelis M, Beyer K, Gorner K, Kahle PJ, Vogt Weisenhorn DM, Wurst W (2010) DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments. Genes Brain Behav 9:305\u2013317", "journal-title": "Genes Brain Behav"}, {"key": "16_CR305", "doi-asserted-by": "publisher", "first-page": "1732", "DOI": "10.1093/brain/awl127", "volume": "129", "author": "P Plaha", "year": "2006", "unstructured": "Plaha P, Ben-Shlomo Y, Patel NK, Gill SS (2006) Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129:1732\u20131747", "journal-title": "Brain"}, {"key": "16_CR306", "first-page": "175", "volume": "149", "author": "P Pollak", "year": "1993", "unstructured": "Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A, Hoffmann D, Gentil M, Perret J (1993) Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol (Paris) 149:175\u2013176", "journal-title": "Rev Neurol ("}, {"key": "16_CR307", "doi-asserted-by": "publisher", "first-page": "2045", "DOI": "10.1126/science.276.5321.2045", "volume": "276", "author": "MH Polymeropoulos", "year": "1997", "unstructured": "Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047", "journal-title": "Science"}, {"key": "16_CR308", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1007/s12031-011-9696-y", "volume": "47", "author": "M Poulopoulos", "year": "2012", "unstructured": "Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN (2012) Clinical and pathological characteristics of LRRK2 G2019S Patients with PD. J Mol Neurosci 47:139\u2019143", "journal-title": "J Mol Neurosci"}, {"key": "16_CR309", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1002/ana.20587", "volume": "58", "author": "PP Pramstaller", "year": "2005", "unstructured": "Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, Kramer PL, Klein C (2005) Lewy body Parkinson\u2019s disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 58:411\u2013422", "journal-title": "Ann Neurol"}, {"key": "16_CR310", "doi-asserted-by": "publisher", "first-page": "637", "DOI": "10.1046/j.1471-4159.2001.00174.x", "volume": "76", "author": "S Przedborski", "year": "2001a", "unstructured": "Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis VV, Lee VM, Ischiropoulos H (2001a) Oxidative post-translational modifications of alpha-synuclein in the 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. J Neurochem 76:637\u2013640", "journal-title": "J Neurochem"}, {"key": "16_CR311", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1046/j.1471-4159.2001.00183.x", "volume": "76", "author": "S Przedborski", "year": "2001b", "unstructured": "Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001b) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265\u20131274", "journal-title": "J Neurochem"}, {"key": "16_CR312", "doi-asserted-by": "publisher", "first-page": "898", "DOI": "10.1016/j.nbd.2005.05.028", "volume": "20", "author": "MG Purisai", "year": "2005", "unstructured": "Purisai MG, McCormack AL, Langston WJ, Johnston LC, Di Monte DA (2005) Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 20:898\u2013906", "journal-title": "Neurobiol Dis"}, {"issue": "Suppl 1", "key": "16_CR313", "doi-asserted-by": "publisher", "first-page": "S24", "DOI": "10.1016/S1353-8020(11)70010-4", "volume": "18", "author": "A Puschmann", "year": "2012", "unstructured": "Puschmann A, Bhidayasiri R, Weiner WJ (2012) Synucleinopathies from bench to bedside. Parkinsonism Relat Disord 18(Suppl 1):S24\u2013S27", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR314", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1016/j.tins.2004.06.008", "volume": "27", "author": "M Quik", "year": "2004", "unstructured": "Quik M (2004) Smoking, nicotine and Parkinson\u2019s disease. Trends Neurosci 27:561\u2013568", "journal-title": "Trends Neurosci"}, {"key": "16_CR315", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1002/mds.21900", "volume": "23", "author": "M Quik", "year": "2008", "unstructured": "Quik M, O\u2019Leary K, Tanner CM (2008) Nicotine and Parkinson\u2019s disease: implications for therapy. Mov Disord 23:1641\u20131652", "journal-title": "Mov Disord"}, {"key": "16_CR316", "doi-asserted-by": "publisher", "first-page": "1184", "DOI": "10.1038/ng1884", "volume": "38", "author": "A Ramirez", "year": "2006", "unstructured": "Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184\u20131191", "journal-title": "Nat Genet"}, {"key": "16_CR317", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1093/hmg/ddr606", "volume": "21", "author": "D Ramonet", "year": "2012", "unstructured": "Ramonet D, Podhajska A, Stafa K, Sonnay S, Trancikova A, Tsika E, Pletnikova O, Troncoso JC, Glauser L, Moore DJ (2012) PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum Mol Genet 21:1725\u20131743", "journal-title": "Hum Mol Genet"}, {"key": "16_CR318", "doi-asserted-by": "publisher", "first-page": "1484", "DOI": "10.1056/NEJM200005183422004", "volume": "342", "author": "O Rascol", "year": "2000", "unstructured": "Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa. 056 Study Group. New Engl J Med 342:1484\u20131491", "journal-title": "New Engl J Med"}, {"key": "16_CR319", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1007/BF01112571", "volume": "1", "author": "SA Raskin", "year": "1990", "unstructured": "Raskin SA, Borod JC, Tweedy J (1990) Neuropsychological aspects of Parkinson\u2019s disease. Neuropsychol Rev 1:185\u2013221", "journal-title": "Neuropsychol Rev"}, {"key": "16_CR320", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1002/mds.21803", "volume": "23", "author": "JS Reijnders", "year": "2008", "unstructured": "Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord 23:183\u2013189; quiz 313", "journal-title": "Mov Disord"}, {"key": "16_CR321", "doi-asserted-by": "publisher", "first-page": "35308", "DOI": "10.1074/jbc.M110.207134", "volume": "286", "author": "H Ren", "year": "2011", "unstructured": "Ren H, Fu K, Wang D, Mu C, Wang G (2011) Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL. J Biol Chem 286:35308\u201335317", "journal-title": "J Biol Chem"}, {"key": "16_CR322", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1007/s11481-008-9100-z", "volume": "3", "author": "AD Reynolds", "year": "2008", "unstructured": "Reynolds AD, Kadiu I, Garg SK, Glanzer JG, Nordgren T, Ciborowski P, Banerjee R, Gendelman HE (2008) Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities. J Neuroimmune Pharmacol 3:59\u201374", "journal-title": "J Neuroimmune Pharmacol"}, {"key": "16_CR323", "first-page": "195", "volume": "75", "author": "SL Rhodes", "year": "2011", "unstructured": "Rhodes SL, Sinsheimer JS, Bordelon Y, Bronstein JM, Ritz B (2011) Replication of GWAS associations for GAK and MAPT in Parkinson\u2019s disease. Ann Hum Genet 75:195\u2013200", "journal-title": "Ann Hum Genet"}, {"key": "16_CR324", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1006/exnr.2002.7882", "volume": "175", "author": "EK Richfield", "year": "2002", "unstructured": "Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ (2002) Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol 175:35\u201348", "journal-title": "Exp Neurol"}, {"key": "16_CR325", "first-page": "600", "volume": "67", "author": "B Ritz", "year": "2010", "unstructured": "Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S (2010) L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol 67:600\u2013606", "journal-title": "Ann Neurol"}, {"key": "16_CR326", "doi-asserted-by": "publisher", "first-page": "1765", "DOI": "10.1002/mds.22956", "volume": "25", "author": "AM Rodrigues e Silva", "year": "2010", "unstructured": "Rodrigues e Silva AM, Geldsetzer F, Holdorff B, Kielhorn FW, Balzer-Geldsetzer M, Oertel WH, Hurtig H, Dodel R (2010) Who was the man who discovered the \u201cLewy bodies\u201d? Mov Disord 25:1765\u20131773", "journal-title": "Mov Disord"}, {"key": "16_CR327", "first-page": "98", "volume": "103", "author": "JA Rodriguez-Navarro", "year": "2007", "unstructured": "Rodriguez-Navarro JA, Casarejos MJ, Menendez J, Solano RM, Rodal I, Gomez A, Yebenes JG, Mena MA (2007) Mortality, oxidative stress and tau accumulation during ageing in parkin null mice. J Neurochem 103:98\u2013114", "journal-title": "J Neurochem"}, {"key": "16_CR328", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1016/S1474-4422(09)70293-5", "volume": "8", "author": "MC Rodriguez-Oroz", "year": "2009", "unstructured": "Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms. Lancet Neurol 8:1128\u20131139", "journal-title": "Lancet Neurol"}, {"key": "16_CR329", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1002/ana.21291", "volume": "63", "author": "GW Ross", "year": "2008", "unstructured": "Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 63:167\u2013173", "journal-title": "Ann Neurol"}, {"key": "16_CR330", "doi-asserted-by": "publisher", "first-page": "701", "DOI": "10.1007/s004010000225", "volume": "100", "author": "AJ Rozemuller", "year": "2000", "unstructured": "Rozemuller AJ, Eikelenboom P, Theeuwes JW, Jansen Steur EN, de Vos RA (2000) Activated microglial cells and complement factors are unrelated to cortical Lewy bodies. Acta Neuropathol 100:701\u2013708", "journal-title": "Acta Neuropathol"}, {"key": "16_CR331", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1093/jnen/63.4.323", "volume": "63", "author": "Y Saito", "year": "2004", "unstructured": "Saito Y, Suzuki K, Hulette CM, Murayama S (2004) Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 63:323\u2013328", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "16_CR332", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1007/s00702-007-0855-9", "volume": "115", "author": "R Sakakibara", "year": "2008", "unstructured": "Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T (2008) Bladder and bowel dysfunction in Parkinson\u2019s disease. J Neural Transm 115:443\u2013460", "journal-title": "J Neural Transm"}, {"key": "16_CR333", "doi-asserted-by": "publisher", "first-page": "1128", "DOI": "10.1093/brain/awq051", "volume": "133", "author": "L Samaranch", "year": "2010", "unstructured": "Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, Pastor MA, Marrero C, Isla C, Herrera-Henriquez J, Pastor P (2010) PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 133:1128\u20131142", "journal-title": "Brain"}, {"key": "16_CR334", "doi-asserted-by": "publisher", "first-page": "1303", "DOI": "10.1038/ng.485", "volume": "41", "author": "W Satake", "year": "2009", "unstructured": "Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, Toda T (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 41:1303\u20131307", "journal-title": "Nat Genet"}, {"key": "16_CR335", "doi-asserted-by": "publisher", "first-page": "1655", "DOI": "10.1016/S0002-9440(10)61113-3", "volume": "160", "author": "MG Schlossmacher", "year": "2002", "unstructured": "Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160:1655\u20131667", "journal-title": "Am J Pathol"}, {"key": "16_CR336", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1016/S0306-4522(03)00036-8", "volume": "118", "author": "OM Schluter", "year": "2003", "unstructured": "Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, Jahn R, Sudhof TC (2003) Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118:985\u20131002", "journal-title": "Neuroscience"}, {"issue": "Suppl 5", "key": "16_CR337", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1007/s00406-008-5012-4", "volume": "258", "author": "F Schneider", "year": "2008", "unstructured": "Schneider F, Althaus A, Backes V, Dodel R (2008) Psychiatric symptoms in Parkinson\u2019s disease. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):55\u201359", "journal-title": "Eur Arch Psychiatry Clin Neurosci"}, {"key": "16_CR338", "unstructured": "Scholz SW, Mhyre TR, Ressom H, Shah S, Federoff HJ (2012) Genomics and bioinformatics of Parkinson\u2019s disease. (accepted MS)", "DOI": "10.1101/cshperspect.a009449", "doi-asserted-by": "crossref"}, {"key": "16_CR339", "doi-asserted-by": "publisher", "first-page": "1077", "DOI": "10.1002/mds.21333", "volume": "22", "author": "A Schrag", "year": "2007", "unstructured": "Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG (2007) Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 22:1077\u20131092", "journal-title": "Mov Disord"}, {"key": "16_CR340", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1007/s00401-010-0711-0", "volume": "120", "author": "WJ Schulz-Schaeffer", "year": "2010", "unstructured": "Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143", "journal-title": "Acta Neuropathol"}, {"key": "16_CR341", "doi-asserted-by": "publisher", "first-page": "1168", "DOI": "10.1001/jama.1969.03160070046011", "volume": "208", "author": "RS Schwab", "year": "1969", "unstructured": "Schwab RS, England AC Jr, Poskanzer DC, Young RR (1969) Amantadine in the treatment of Parkinson\u2019s disease. JAMA 208:1168\u20131170", "journal-title": "JAMA"}, {"key": "16_CR342", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1001/archneur.2008.65.6.nct70003", "volume": "65", "author": "MA Schwarzschild", "year": "2008", "unstructured": "Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J (2008) Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 65:716\u2013723", "journal-title": "Arch Neurol"}, {"key": "16_CR343", "doi-asserted-by": "publisher", "first-page": "522", "DOI": "10.1097/00002826-198712000-00003", "volume": "10", "author": "KM Shannon", "year": "1987", "unstructured": "Shannon KM, Goetz CG, Carroll VS, Tanner CM, Klawans HL (1987) Amantadine and motor fluctuations in chronic Parkinson\u2019s disease. Clin Neuropharmacol 10:522\u2013526", "journal-title": "Clin Neuropharmacol"}, {"key": "16_CR344", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1002/mds.23838", "volume": "27", "author": "KM Shannon", "year": "2012", "unstructured": "Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH (2012) Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease. Mov Disord 27:709\u2013715", "journal-title": "Mov Disord"}, {"key": "16_CR345", "doi-asserted-by": "crossref", "first-page": "e362", "DOI": "10.1371/journal.pbio.0020362", "volume": "2", "author": "S Shendelman", "year": "2004", "unstructured": "Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2:e362", "journal-title": "PLoS Biol"}, {"key": "16_CR346", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1002/ana.22311", "volume": "69", "author": "M Shi", "year": "2011", "unstructured": "Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69:570\u2013580", "journal-title": "Ann Neurol"}, {"key": "16_CR347", "doi-asserted-by": "publisher", "first-page": "302", "DOI": "10.1038/77060", "volume": "25", "author": "H Shimura", "year": "2000", "unstructured": "Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302\u2013305", "journal-title": "Nat Genet"}, {"key": "16_CR348", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1016/j.cell.2011.02.010", "volume": "144", "author": "JH Shin", "year": "2011", "unstructured": "Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144:689\u2013702", "journal-title": "Cell"}, {"key": "16_CR349", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.1136/jnnp.56.5.467", "volume": "56", "author": "H Shinotoh", "year": "1993", "unstructured": "Shinotoh H, Inoue O, Hirayama K, Aotsuka A, Asahina M, Suhara T, Yamazaki T, Tateno Y (1993) Dopamine D1 receptors in Parkinson\u2019s disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 56:467\u2013472", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "16_CR350", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1002/mds.1099", "volume": "16", "author": "LM Shulman", "year": "2001", "unstructured": "Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease. Mov Disord 16:507\u2013510", "journal-title": "Mov Disord"}, {"key": "16_CR351", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/S1353-8020(01)00015-3", "volume": "8", "author": "LM Shulman", "year": "2002", "unstructured": "Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 8:193\u2013197", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR352", "doi-asserted-by": "publisher", "first-page": "1651", "DOI": "10.1056/NEJMoa0901281", "volume": "361", "author": "E Sidransky", "year": "2009", "unstructured": "Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen C-M, Clark LN, Condroyer C, De Marco EV, D\u00fcrr A, Eblan MJ, Fahn S, Farrer MJ, Fung H-C, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen G-J, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan E-K, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu Y-R, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter Analysis of glucocerebrosidase mutations in Parkinson\u2019s Disease. N Engl J Med 361:1651\u20131661", "journal-title": "N Engl J Med"}, {"key": "16_CR353", "doi-asserted-by": "publisher", "first-page": "1126", "DOI": "10.1227/00006123-199412000-00016", "volume": "35", "author": "J Siegfried", "year": "1994", "unstructured": "Siegfried J, Lippitz B (1994) Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35:1126\u20131129; discussion 1129\u20131130", "journal-title": "Neurosurgery"}, {"key": "16_CR354", "doi-asserted-by": "publisher", "first-page": "1308", "DOI": "10.1038/ng.487", "volume": "41", "author": "J Simon-Sanchez", "year": "2009", "unstructured": "Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312", "journal-title": "Nat Genet"}, {"key": "16_CR355", "doi-asserted-by": "publisher", "first-page": "655", "DOI": "10.1038/ejhg.2010.254", "volume": "19", "author": "J Simon-Sanchez", "year": "2011", "unstructured": "Simon-Sanchez J, van Hilten JJ, van de Warrenburg B, Post B, Berendse HW, Arepalli S, Hernandez DG, de Bie RM, Velseboer D, Scheffer H, Bloem B, van Dijk KD, Rivadeneira F, Hofman A, Uitterlinden AG, Rizzu P, Bochdanovits Z, Singleton AB, Heutink P (2011) Genome-wide association study confirms extant PD risk loci among the Dutch. Eur J Hum Genet 19:655\u2013661", "journal-title": "Eur J Hum Genet"}, {"issue": "Suppl 2", "key": "16_CR356", "first-page": "S65", "volume": "64", "author": "T Simuni", "year": "2008", "unstructured": "Simuni T, Sethi K (2008) Nonmotor manifestations of Parkinson\u2019s disease. Ann Neurol 64(Suppl 2):S65\u2013S80", "journal-title": "Ann Neurol"}, {"key": "16_CR357", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1126/science.1090278", "volume": "302", "author": "AB Singleton", "year": "2003", "unstructured": "Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841", "journal-title": "Science"}, {"key": "16_CR358", "doi-asserted-by": "publisher", "first-page": "768", "DOI": "10.1093/brain/awh081", "volume": "127", "author": "A Singleton", "year": "2004", "unstructured": "Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, Hardy J, Crawley A, Goldstein DS (2004) Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127:768\u2013772", "journal-title": "Brain"}, {"key": "16_CR359", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1111/j.1749-6632.2000.tb06900.x", "volume": "920", "author": "MG Spillantini", "year": "2000", "unstructured": "Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann NY Acad Sci 920:16\u201327", "journal-title": "Ann NY Acad Sci"}, {"key": "16_CR360", "doi-asserted-by": "publisher", "first-page": "839", "DOI": "10.1038/42166", "volume": "388", "author": "MG Spillantini", "year": "1997", "unstructured": "Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840", "journal-title": "Nature"}, {"key": "16_CR361", "doi-asserted-by": "publisher", "first-page": "1172", "DOI": "10.1016/S1474-4422(09)70288-1", "volume": "8", "author": "N Stefanova", "year": "2009", "unstructured": "Stefanova N, Bucke P, Duerr S, Wenning GK (2009) Multiple system atrophy: an update. Lancet Neurol 8:1172\u20131178", "journal-title": "Lancet Neurol"}, {"key": "16_CR362", "doi-asserted-by": "publisher", "first-page": "1040", "DOI": "10.1001/archneur.1993.00540100035011", "volume": "50", "author": "Y Stern", "year": "1993", "unstructured": "Stern Y, Richards M, Sano M, Mayeux R (1993) Comparison of cognitive changes in patients with Alzheimer\u2019s and Parkinson\u2019s disease. Arch Neurol 50:1040\u20131045", "journal-title": "Arch Neurol"}, {"key": "16_CR363", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1017/S1355617798001726", "volume": "4", "author": "Y Stern", "year": "1998", "unstructured": "Stern Y, Tang MX, Jacobs DM, Sano M, Marder K, Bell K, Dooneief G, Schofield P, Cote L (1998) Prospective comparative study of the evolution of probable Alzheimer\u2019s disease and Parkinson\u2019s disease dementia. J Int Neuropsychol Soc 4:279\u2013284", "journal-title": "J Int Neuropsychol Soc"}, {"key": "16_CR364", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1038/gt.2009.20", "volume": "16", "author": "HJ Stewart", "year": "2009", "unstructured": "Stewart HJ, Leroux-Carlucci MA, Sion CJ, Mitrophanous KA, Radcliffe PA (2009) Development of inducible EIAV-based lentiviral vector packaging and producer cell lines. Gene Ther 16:805\u2013814", "journal-title": "Gene Ther"}, {"key": "16_CR365", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1089/hum.2010.142", "volume": "22", "author": "HJ Stewart", "year": "2011", "unstructured": "Stewart HJ, Fong-Wong L, Strickland I, Chipchase D, Kelleher M, Stevenson L, Thoree V, McCarthy J, Ralph GS, Mitrophanous KA, Radcliffe PA (2011) A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson\u2019s disease. Hum Gene Ther 22:357\u2013369", "journal-title": "Hum Gene Ther"}, {"key": "16_CR366", "doi-asserted-by": "publisher", "first-page": "2377", "DOI": "10.1093/hmg/ddm083", "volume": "16", "author": "CC Stichel", "year": "2007", "unstructured": "Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, Lubbert H (2007) Mono- and double-mutant mouse models of Parkinson\u2019s disease display severe mitochondrial damage. Hum Mol Genet 16:2377\u20132393", "journal-title": "Hum Mol Genet"}, {"key": "16_CR367", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1002/1531-8257(200001)15:1<71::AID-MDS1012>3.0.CO;2-W", "volume": "15", "author": "F Stocchi", "year": "2000", "unstructured": "Stocchi F, Badiali D, Vacca L, D\u2019Alba L, Bracci F, Ruggieri S, Torti M, Berardelli A, Corazziari E (2000) Anorectal function in multiple system atrophy and Parkinson\u2019s disease. Mov Disord 15:71\u201376", "journal-title": "Mov Disord"}, {"key": "16_CR368", "doi-asserted-by": "publisher", "first-page": "72", "DOI": "10.1007/s13311-010-0007-z", "volume": "8", "author": "AJ Stoessl", "year": "2011", "unstructured": "Stoessl AJ (2011) Neuroimaging in Parkinson\u2019s disease. Neurotherapeutics 8:72\u201381", "journal-title": "Neurotherapeutics"}, {"key": "16_CR369", "doi-asserted-by": "publisher", "first-page": "987", "DOI": "10.1016/S1474-4422(11)70214-9", "volume": "10", "author": "AJ Stoessl", "year": "2011", "unstructured": "Stoessl AJ, Martin WRW, McKeown MJ, Sossi V (2011) Advances in imaging in Parkinson\u2019s disease. Lancet Neurol 10:987\u20131001", "journal-title": "Lancet Neurol"}, {"key": "16_CR370", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1007/s11910-005-0059-3", "volume": "5", "author": "JC Stout", "year": "2005", "unstructured": "Stout JC, Johnson SA (2005) Cognitive impairment and dementia in basal ganglia disorders. Curr Neurol Neurosci Rep 5:355\u2013363", "journal-title": "Curr Neurol Neurosci Rep"}, {"key": "16_CR371", "doi-asserted-by": "publisher", "first-page": "1690", "DOI": "10.1016/j.neurobiolaging.2007.04.006", "volume": "29", "author": "X Su", "year": "2008", "unstructured": "Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson\u2019s disease. Neurobiol Aging 29:1690\u20131701", "journal-title": "Neurobiol Aging"}, {"key": "16_CR372", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1007/s12640-009-9053-x", "volume": "16", "author": "X Su", "year": "2009", "unstructured": "Su X, Federoff HJ, Maguire-Zeiss KA (2009) Mutant alpha-Synuclein overexpression mediates early proinflammatory activity. Neurotox Res 16:238\u2013254", "journal-title": "Neurotox Res"}, {"key": "16_CR373", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1016/j.neuroscience.2011.10.018", "volume": "199", "author": "Z Sultana", "year": "2011", "unstructured": "Sultana Z, Paleologou KE, Al-Mansoori KM, Ardah MT, Singh N, Usmani S, Jiao H, Martin FL, Bharath MM, Vali S, El-Agnaf OM (2011) Dynamic modeling of alpha-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson\u2019s therapy. Neuroscience 199:303\u2013317", "journal-title": "Neuroscience"}, {"key": "16_CR374", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1016/S1937-6448(08)01406-8", "volume": "270", "author": "A Surguchov", "year": "2008", "unstructured": "Surguchov A (2008) Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 270:225\u2013317", "journal-title": "Int Rev Cell Mol Biol"}, {"key": "16_CR375", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1002/bies.10378", "volume": "26", "author": "R Tabakman", "year": "2004", "unstructured": "Tabakman R, Lecht S, Lazarovici P (2004) Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson\u2019s disease? Bioessays 26:80\u201390", "journal-title": "Bioessays"}, {"issue": "Suppl 1", "key": "16_CR376", "doi-asserted-by": "publisher", "first-page": "S74", "DOI": "10.1016/S1353-8020(11)70024-4", "volume": "18", "author": "LC Tan", "year": "2012", "unstructured": "Tan LC (2012) Mood disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S74\u2013S76", "journal-title": "Parkinsonism Relat Disord"}, {"key": "16_CR377", "doi-asserted-by": "publisher", "first-page": "508", "DOI": "10.1212/WNL.0b013e3181eccfcd", "volume": "75", "author": "EK Tan", "year": "2010", "unstructured": "Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, Au WL, Pavanni R, Ng YY, Satake W, Zhao Y, Toda T, Liu JJ (2010) Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 75:508\u2013512", "journal-title": "Neurology"}, {"key": "16_CR378", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1001/archneur.1996.00550020087019", "volume": "53", "author": "E Tandberg", "year": "1996", "unstructured": "Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson\u2019s disease. A community-based study. Arch Neurol 53:175\u2013179", "journal-title": "Arch Neurol"}, {"key": "16_CR379", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1016/S1474-4422(10)70002-8", "volume": "9", "author": "CC Tang", "year": "2010", "unstructured": "Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 9:149\u2013158", "journal-title": "Lancet Neurol"}, {"key": "16_CR380", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1001/jama.281.4.341", "volume": "281", "author": "CM Tanner", "year": "1999", "unstructured": "Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. JAMA 281:341\u2013346", "journal-title": "JAMA"}, {"key": "16_CR381", "doi-asserted-by": "publisher", "first-page": "866", "DOI": "10.1289/ehp.1002839", "volume": "119", "author": "CM Tanner", "year": "2011", "unstructured": "Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119:866\u2013872", "journal-title": "Environ Health Perspect"}, {"key": "16_CR382", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1002/mds.10332", "volume": "18", "author": "P Teismann", "year": "2003", "unstructured": "Teismann P, Tieu K, Cohen O, Choi DK, Wu DC, Marks D, Vila M, Jackson-Lewis V, Przedborski S (2003) Pathogenic role of glial cells in Parkinson\u2019s disease. Mov Disord 18:121\u2013129", "journal-title": "Mov Disord"}, {"key": "16_CR383", "doi-asserted-by": "publisher", "first-page": "1149", "DOI": "10.1097/NEN.0b013e31818e5e99", "volume": "67", "author": "S Theodore", "year": "2008", "unstructured": "Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67:1149\u20131158", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "16_CR384", "doi-asserted-by": "publisher", "first-page": "1248", "DOI": "10.1227/NEU.0b013e31822b6f71", "volume": "69", "author": "W Thevathasan", "year": "2011", "unstructured": "Thevathasan W, Coyne TJ, Hyam JA, Kerr G, Jenkinson N, Aziz TZ, Silburn PA (2011) Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 69:1248\u20131253; discussion 1254", "journal-title": "Neurosurgery"}, {"key": "16_CR385", "doi-asserted-by": "publisher", "first-page": "40", "DOI": "10.1093/hmg/ddq430", "volume": "20", "author": "KJ Thomas", "year": "2011", "unstructured": "Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M, Sandebring A, Miller D, Maric D, Cedazo-Minguez A, Cookson MR (2011) DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20:40\u201350", "journal-title": "Hum Mol Genet"}, {"issue": "7 Suppl", "key": "16_CR386", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1212/WNL.0b013e318198dace", "volume": "72", "author": "E Tolosa", "year": "2009", "unstructured": "Tolosa E, Poewe W (2009) Premotor Parkinson disease. Neurology 72(7 Suppl):S1", "journal-title": "Neurology"}, {"key": "16_CR387", "doi-asserted-by": "publisher", "first-page": "9879", "DOI": "10.1073/pnas.1004676107", "volume": "107", "author": "Y Tong", "year": "2010", "unstructured": "Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ 3rd, Shen J (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci USA 107:9879\u20139884", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR388", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1192/bjp.bp.110.078816", "volume": "198", "author": "C Tsopelas", "year": "2011", "unstructured": "Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE (2011) Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:109\u2013114", "journal-title": "Br J Psychiatry"}, {"key": "16_CR389", "doi-asserted-by": "publisher", "first-page": "1356", "DOI": "10.1038/ejhg.2010.125", "volume": "18", "author": "A Tucci", "year": "2010", "unstructured": "Tucci A, Nalls MA, Houlden H, Revesz T, Singleton AB, Wood NW, Hardy J, Paisan-Ruiz C (2010) Genetic variability at the PARK16 locus. Eur J Hum Genet 18:1356\u20131359", "journal-title": "Eur J Hum Genet"}, {"key": "16_CR390", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1002/mds.10305", "volume": "18", "author": "D Twelves", "year": "2003", "unstructured": "Twelves D, Perkins KS, Counsell C (2003) Systematic review of incidence studies of Parkinson\u2019s disease. Mov Disord 18:19\u201331", "journal-title": "Mov Disord"}, {"key": "16_CR391", "doi-asserted-by": "publisher", "first-page": "11282", "DOI": "10.1073/pnas.90.23.11282", "volume": "90", "author": "K Ueda", "year": "1993", "unstructured": "Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282\u201311286", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR392", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1016/j.ceb.2007.05.003", "volume": "19", "author": "EJ Ungewickell", "year": "2007", "unstructured": "Ungewickell EJ, Hinrichsen L (2007) Endocytosis: clathrin-mediated membrane budding. Curr Opin Cell Biol 19:417\u2013425", "journal-title": "Curr Opin Cell Biol"}, {"key": "16_CR393", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1016/S0014-5793(01)02597-2", "volume": "500", "author": "VN Uversky", "year": "2001", "unstructured": "Uversky VN, Li J, Fink AL (2001) Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson\u2019s disease. FEBS Lett 500:105\u2013108", "journal-title": "FEBS Lett"}, {"key": "16_CR394", "doi-asserted-by": "publisher", "first-page": "1158", "DOI": "10.1126/science.1096284", "volume": "304", "author": "EM Valente", "year": "2004", "unstructured": "Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160", "journal-title": "Science"}, {"key": "16_CR395", "doi-asserted-by": "publisher", "first-page": "1015", "DOI": "10.1093/aje/kwg068", "volume": "157", "author": "SK Van Den Eeden", "year": "2003", "unstructured": "Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson\u2019s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015\u20131022", "journal-title": "Am J Epidemiol"}, {"key": "16_CR396", "doi-asserted-by": "publisher", "first-page": "10244", "DOI": "10.1073/pnas.0708518105", "volume": "105", "author": "MP van der Brug", "year": "2008", "unstructured": "van der Brug MP, Blackinton J, Chandran J, Hao LY, Lal A, Mazan-Mamczarz K, Martindale J, Xie C, Ahmad R, Thomas KJ, Beilina A, Gibbs JR, Ding J, Myers AJ, Zhan M, Cai H, Bonini NM, Gorospe M, Cookson MR (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci USA 105:10244\u201310249", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR397", "doi-asserted-by": "publisher", "first-page": "1121", "DOI": "10.1086/421052", "volume": "74", "author": "JM van der Walt", "year": "2004", "unstructured": "van der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL, Pericak-Vance MA, Vance JM, Martin ER (2004) Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 74:1121\u20131127", "journal-title": "Am J Hum Genet"}, {"key": "16_CR398", "doi-asserted-by": "publisher", "first-page": "1791", "DOI": "10.1016/j.bbrc.2005.10.146", "volume": "338", "author": "V Vetrugno", "year": "2005", "unstructured": "Vetrugno V, Cardinale A, Filesi I, Mattei S, Sy MS, Pocchiari M, Biocca S (2005) KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Biochem. Biophys Res Commun 338:1791\u20131797", "journal-title": "Biophys Res Commun"}, {"key": "16_CR399", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1046/j.1471-4159.2000.740721.x", "volume": "74", "author": "M Vila", "year": "2000", "unstructured": "Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74:721\u2013729", "journal-title": "J Neurochem"}, {"key": "16_CR400", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1002/ana.410360513", "volume": "36", "author": "FJ Vingerhoets", "year": "1994", "unstructured": "Vingerhoets FJ, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB (1994) Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36:765\u2013770", "journal-title": "Ann Neurol"}, {"key": "16_CR401", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1007/s00401-010-0706-x", "volume": "120", "author": "K Wakabayashi", "year": "2010", "unstructured": "Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1\u201312", "journal-title": "Acta Neuropathol"}, {"key": "16_CR402", "doi-asserted-by": "publisher", "first-page": "1081", "DOI": "10.1126/science.1209038", "volume": "334", "author": "P Walter", "year": "2011", "unstructured": "Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081\u20131086", "journal-title": "Science"}, {"key": "16_CR403", "doi-asserted-by": "publisher", "first-page": "4257", "DOI": "10.3390/ijms11114257", "volume": "11", "author": "M Waragai", "year": "2010", "unstructured": "Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M (2010) Alpha-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson\u2019s Disease. Int J Mol Sci 11:4257\u20134266", "journal-title": "Int J Mol Sci"}, {"key": "16_CR404", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1002/ana.410350110", "volume": "35", "author": "CH Waters", "year": "1994", "unstructured": "Waters CH, Miller CA (1994) Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 35:59\u201364", "journal-title": "Ann Neurol"}, {"key": "16_CR405", "doi-asserted-by": "publisher", "first-page": "1022", "DOI": "10.1002/mds.23664", "volume": "26", "author": "D Weintraub", "year": "2011", "unstructured": "Weintraub D, Burn DJ (2011) Parkinson\u2019s disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022\u20131031", "journal-title": "Mov Disord"}, {"key": "16_CR406", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1093/aje/kwm127", "volume": "166", "author": "MG Weisskopf", "year": "2007", "unstructured": "Weisskopf MG, O\u2019Reilly E, Chen H, Schwarzschild MA, Ascherio A (2007) Plasma urate and risk of Parkinson\u2019s disease. Am J Epidemiol 166:561\u2013567", "journal-title": "Am J Epidemiol"}, {"key": "16_CR407", "doi-asserted-by": "publisher", "first-page": "963", "DOI": "10.1038/sj.bjp.0707167", "volume": "150", "author": "PS Whitton", "year": "2007", "unstructured": "Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150:963\u2013976", "journal-title": "Br J Pharmacol"}, {"key": "16_CR408", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.1016/j.neuroscience.2011.06.048", "volume": "198", "author": "T Wichmann", "year": "2011", "unstructured": "Wichmann T, Dostrovsky JO (2011) Pathological basal ganglia activity in movement disorders. Neuroscience 198:232\u2013244", "journal-title": "Neuroscience"}, {"key": "16_CR409", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1002/mds.22442", "volume": "24", "author": "C Wider", "year": "2009", "unstructured": "Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA (2009) FGF20 and Parkinson\u2019s disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov Disord 24:455\u2013459", "journal-title": "Mov Disord"}, {"key": "16_CR410", "doi-asserted-by": "publisher", "first-page": "2958", "DOI": "10.1093/brain/awp245", "volume": "132", "author": "CH Williams-Gray", "year": "2009", "unstructured": "Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson\u2019s disease: 5\u00a0year follow-up of the CamPaIGN cohort. Brain 132:2958\u20132969", "journal-title": "Brain"}, {"key": "16_CR411", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1089/ars.2010.3481", "volume": "15", "author": "MA Wilson", "year": "2011", "unstructured": "Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15:111\u2013122", "journal-title": "Antioxid Redox Signal"}, {"key": "16_CR412", "doi-asserted-by": "publisher", "first-page": "218", "DOI": "10.1159/000113707", "volume": "5", "author": "M Windisch", "year": "2008", "unstructured": "Windisch M, Wolf H, Hutter-Paier B, Wronski R (2008) The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies? Neurodegener Dis 5:218\u2013221", "journal-title": "Neurodegener Dis"}, {"key": "16_CR413", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1002/nau.20193", "volume": "25", "author": "K Winge", "year": "2006", "unstructured": "Winge K, Skau AM, Stimpel H, Nielsen KK, Werdelin L (2006) Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 25:116\u2013122", "journal-title": "Neurourol Urodyn"}, {"key": "16_CR414", "doi-asserted-by": "publisher", "first-page": "932", "DOI": "10.1002/mds.23070", "volume": "25", "author": "A Winquist", "year": "2010", "unstructured": "Winquist A, Steenland K, Shankar A (2010) Higher serum uric acid associated with decreased Parkinson\u2019s disease prevalence in a large community-based survey. Mov Disord 25:932\u2013936", "journal-title": "Mov Disord"}, {"key": "16_CR415", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1212/01.WNL.0000129841.30587.9D", "volume": "63", "author": "K Wirdefeldt", "year": "2004", "unstructured": "Wirdefeldt K, Gatz M, Schalling M, Pedersen NL (2004) No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63:305\u2013311", "journal-title": "Neurology"}, {"issue": "Suppl 1", "key": "16_CR416", "doi-asserted-by": "publisher", "first-page": "S1", "DOI": "10.1007/s10654-011-9581-6", "volume": "26", "author": "K Wirdefeldt", "year": "2011a", "unstructured": "Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011a) Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1\u201358", "journal-title": "Eur J Epidemiol"}, {"key": "16_CR417", "doi-asserted-by": "publisher", "first-page": "1923", "DOI": "10.1016/j.neurobiolaging.2011.02.017", "volume": "32", "author": "K Wirdefeldt", "year": "2011b", "unstructured": "Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL (2011b) Heritability of Parkinson disease in Swedish twins: a longitudinal study. Neurobiol Aging 32:1923.e1921\u20131928", "journal-title": "Neurobiol Aging"}, {"key": "16_CR418", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.3389/fpsyt.2010.00150", "volume": "1", "author": "S Wray", "year": "2010", "unstructured": "Wray S, Lewis PA (2010) A tangled web\u2014tau and sporadic Parkinson\u2019s disease. Front Psychiatry 1:150", "journal-title": "Front Psychiatry"}, {"key": "16_CR419", "doi-asserted-by": "publisher", "first-page": "1849", "DOI": "10.1080/15287390701459262", "volume": "70", "author": "W Yang", "year": "2007", "unstructured": "Yang W, Tiffany-Castiglioni E (2007) The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells. J Toxicol Environ Health A 70:1849\u20131857", "journal-title": "J Toxicol Environ Health A"}, {"key": "16_CR420", "doi-asserted-by": "publisher", "first-page": "10793", "DOI": "10.1073/pnas.0602493103", "volume": "103", "author": "Y Yang", "year": "2006", "unstructured": "Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103:10793\u201310798", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR421", "doi-asserted-by": "publisher", "first-page": "4412", "DOI": "10.1073/pnas.1000738107", "volume": "107", "author": "YI Yim", "year": "2010", "unstructured": "Yim YI, Sun T, Wu LG, Raimondi A, De Camilli P, Eisenberg E, Greene LE (2010) Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice. Proc Natl Acad Sci USA 107:4412\u20134417", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR422", "doi-asserted-by": "publisher", "first-page": "164", "DOI": "10.1002/ana.10795", "volume": "55", "author": "JJ Zarranz", "year": "2004", "unstructured": "Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173", "journal-title": "Ann Neurol"}, {"key": "16_CR423", "doi-asserted-by": "publisher", "first-page": "533", "DOI": "10.1096/fj.04-2751com", "volume": "19", "author": "W Zhang", "year": "2005", "unstructured": "Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. Faseb J 19:533\u2013542", "journal-title": "Faseb J"}, {"issue": "2", "key": "16_CR424", "doi-asserted-by": "crossref", "first-page": "e16983", "DOI": "10.1371/journal.pone.0016983", "volume": "6", "author": "T Zhao", "year": "2011", "unstructured": "Zhao T, De Graaff E, Breedveld GJ, Loda A, Severijnen LA, Wouters CH, Verheijen FW, Dekker MC, Montagna P, Willemsen R, Oostra BA, Bonifati V (2011) Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). PLoS ONE 6(2):e16983", "journal-title": "PLoS ONE"}, {"key": "16_CR425", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.1016/j.bbadis.2008.09.001", "volume": "1792", "author": "C Zhou", "year": "2009", "unstructured": "Zhou C, Przedborski S (2009) Intrabody and Parkinson\u2019s disease. Biochim. Biophys Acta 1792:634\u2013642", "journal-title": "Biophys Acta"}, {"key": "16_CR426", "doi-asserted-by": "publisher", "first-page": "1023", "DOI": "10.1016/j.ymthe.2004.08.019", "volume": "10", "author": "C Zhou", "year": "2004", "unstructured": "Zhou C, Emadi S, Sierks MR, Messer A (2004) A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Mol Ther 10:1023\u20131031", "journal-title": "Mol Ther"}, {"key": "16_CR427", "doi-asserted-by": "publisher", "first-page": "1036", "DOI": "10.1016/j.jmb.2005.12.030", "volume": "356", "author": "W Zhou", "year": "2006", "unstructured": "Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356:1036\u20131048", "journal-title": "J Mol Biol"}, {"key": "16_CR428", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1002/ana.20928", "volume": "60", "author": "X Zhu", "year": "2006", "unstructured": "Zhu X, Siedlak SL, Smith MA, Perry G, Chen SG (2006) LRRK2 protein is a component of Lewy bodies. Ann Neurol 60:617\u2013618; author reply 618\u2013619", "journal-title": "Ann Neurol"}, {"key": "16_CR429", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1016/j.neuron.2004.11.005", "volume": "44", "author": "A Zimprich", "year": "2004", "unstructured": "Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607", "journal-title": "Neuron"}, {"key": "16_CR430", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1002/ana.410260106", "volume": "26", "author": "RM Zweig", "year": "1989", "unstructured": "Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL (1989) The pedunculopontine nucleus in Parkinson\u2019s disease. Ann Neurol 26:41\u201346", "journal-title": "Ann Neurol"}], "container-title": ["Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease", "Subcellular Biochemistry"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-94-007-5416-4_16", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T07:47:34Z", "timestamp": 1572940054000}, "score": 25.273779, "issued": {"date-parts": [[2012]]}, "ISBN": ["9789400754157", "9789400754164"], "references-count": 430, "URL": "http://dx.doi.org/10.1007/978-94-007-5416-4_16", "relation": {"cites": []}, "ISSN": ["0306-0225"], "issn-type": [{"value": "0306-0225", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:09:09Z", "timestamp": 1574104149259}, "reference-count": 21, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 5, 1]], "date-time": "2001-05-01T00:00:00Z", "timestamp": 988675200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Letters"], "published-print": {"date-parts": [[2001, 5]]}, "DOI": "10.1016/s0304-3940(01)01785-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T21:55:50Z", "timestamp": 1027634150000}, "page": "161-164", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Amyloid \u03b2 protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype"], "prefix": "10.1016", "volume": "304", "author": [{"given": "D.M.A", "family": "Mann", "sequence": "first", "affiliation": []}, {"given": "A.M", "family": "McDonagh", "sequence": "additional", "affiliation": []}, {"given": "S.M", "family": "Pickering-Brown", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Kowa", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Iwatsubo", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0304394001017852?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0304394001017852?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T19:53:17Z", "timestamp": 1555703597000}, "score": 24.98366, "issued": {"date-parts": [[2001, 5]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2001, 5]]}, "issue": "3"}, "alternative-id": ["S0304394001017852"], "URL": "http://dx.doi.org/10.1016/s0304-3940(01)01785-2", "ISSN": ["0304-3940"], "issn-type": [{"value": "0304-3940", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T07:45:27Z", "timestamp": 1575099927154}, "reference-count": 69, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1016/j.neuroscience.2003.08.007", "type": "journal-article", "created": {"date-parts": [[2003, 10, 22]], "date-time": "2003-10-22T12:21:15Z", "timestamp": 1066825275000}, "page": "305-315", "source": "Crossref", "is-referenced-by-count": 108, "title": ["Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients"], "prefix": "10.1016", "volume": "122", "author": [{"given": "Y", "family": "Ji", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Gong", "sequence": "additional", "affiliation": []}, {"given": "W", "family": "Gan", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Beach", "sequence": "additional", "affiliation": []}, {"given": "D.M", "family": "Holtzman", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0306452203006365?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0306452203006365?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 19]], "date-time": "2019-02-19T09:50:16Z", "timestamp": 1550569816000}, "score": 24.766825, "issued": {"date-parts": [[2003, 1]]}, "references-count": 69, "journal-issue": {"published-print": {"date-parts": [[2003, 1]]}, "issue": "2"}, "alternative-id": ["S0306452203006365"], "URL": "http://dx.doi.org/10.1016/j.neuroscience.2003.08.007", "ISSN": ["0306-4522"], "issn-type": [{"value": "0306-4522", "type": "print"}], "subject": ["General Neuroscience"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:18:40Z", "timestamp": 1574104720630}, "reference-count": 28, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 9, 1]], "date-time": "1996-09-01T00:00:00Z", "timestamp": 841536000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the Neurological Sciences"], "published-print": {"date-parts": [[1996, 9]]}, "DOI": "10.1016/0022-510x(96)00123-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:33:30Z", "timestamp": 1027636410000}, "page": "54-58", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Effect of cerebrospinal fluid from normal and Alzheimer's patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein"], "prefix": "10.1016", "volume": "141", "author": [{"given": "Abha", "family": "Chauhan", "sequence": "first", "affiliation": []}, {"given": "Tuula", "family": "Pirttil\u00e4", "sequence": "additional", "affiliation": []}, {"given": "Pankaj", "family": "Mehta", "sequence": "additional", "affiliation": []}, {"given": "Ved P.S.", "family": "Chauhan", "sequence": "additional", "affiliation": []}, {"given": "Henryk M.", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of the Neurological Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0022510X96001232?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0022510X96001232?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T03:27:49Z", "timestamp": 1555644469000}, "score": 24.654732, "issued": {"date-parts": [[1996, 9]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[1996, 9]]}, "issue": "1-2"}, "alternative-id": ["0022510X96001232"], "URL": "http://dx.doi.org/10.1016/0022-510x(96)00123-2", "ISSN": ["0022-510X"], "issn-type": [{"value": "0022-510X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T03:54:40Z", "timestamp": 1575172480995}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 7, 1]], "date-time": "2005-07-01T00:00:00Z", "timestamp": 1120176000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Alzheimer's & Dementia"], "published-print": {"date-parts": [[2005, 7]]}, "DOI": "10.1016/j.jalz.2005.06.243", "type": "journal-article", "created": {"date-parts": [[2005, 8, 25]], "date-time": "2005-08-25T11:30:58Z", "timestamp": 1124969458000}, "page": "S66-S67", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Blocking the apolipoprotein E/amyloid-B interaction reduces amyloid-B load in AD transgenic mice"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Marcin", "family": "Sadowski", "sequence": "first", "affiliation": []}, {"given": "Joanna", "family": "Pankiewicz", "sequence": "additional", "affiliation": []}, {"given": "Henrieta", "family": "Scholtzova", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Wen", "sequence": "additional", "affiliation": []}, {"given": "Pankaj", "family": "Mehta", "sequence": "additional", "affiliation": []}, {"given": "Thomas", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Alzheimer's & Dementia"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S155252600500244X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S155252600500244X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T19:59:26Z", "timestamp": 1548187166000}, "score": 24.310417, "issued": {"date-parts": [[2005, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 7]]}, "issue": "1"}, "alternative-id": ["S155252600500244X"], "URL": "http://dx.doi.org/10.1016/j.jalz.2005.06.243", "ISSN": ["1552-5260"], "issn-type": [{"value": "1552-5260", "type": "print"}], "subject": ["Health Policy", "Developmental Neuroscience", "Epidemiology", "Cellular and Molecular Neuroscience", "Geriatrics and Gerontology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:58:07Z", "timestamp": 1574135887569}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 10, 1]], "date-time": "2002-10-01T00:00:00Z", "timestamp": 1033430400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuroscience Letters"], "published-print": {"date-parts": [[2002, 10]]}, "DOI": "10.1016/s0304-3940(02)00888-1", "type": "journal-article", "created": {"date-parts": [[2002, 10, 7]], "date-time": "2002-10-07T20:21:37Z", "timestamp": 1034022097000}, "page": "171-174", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Pathological relationships between microglial cell activity and tau and amyloid \u03b2 protein in patients with Alzheimer's disease"], "prefix": "10.1016", "volume": "331", "author": [{"given": "A.", "family": "Hayes", "sequence": "first", "affiliation": []}, {"given": "U.", "family": "Thaker", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Iwatsubo", "sequence": "additional", "affiliation": []}, {"given": "S.M.", "family": "Pickering-Brown", "sequence": "additional", "affiliation": []}, {"given": "D.M.A.", "family": "Mann", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Neuroscience Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0304394002008881?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0304394002008881?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T01:23:19Z", "timestamp": 1554772999000}, "score": 24.138063, "issued": {"date-parts": [[2002, 10]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2002, 10]]}, "issue": "3"}, "alternative-id": ["S0304394002008881"], "URL": "http://dx.doi.org/10.1016/s0304-3940(02)00888-1", "ISSN": ["0304-3940"], "issn-type": [{"value": "0304-3940", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:08:20Z", "timestamp": 1574431700510}, "publisher-location": "Dordrecht", "reference-count": 6, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401054508", "type": "print"}, {"value": "9789401132848", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1991]]}, "DOI": "10.1007/978-94-011-3284-8_55", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 8]], "date-time": "2011-12-08T19:48:52Z", "timestamp": 1323373732000}, "page": "219-222", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Clinical Indications of Systemic Amyloidosis in Myeloma Patients"], "prefix": "10.1007", "author": [{"given": "T.", "family": "Isobe", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Matozaki", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Fujita", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Shinoda", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "55_CR1", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1056/NEJM197402282900902", "volume": "290", "author": "T Isobe", "year": "1974", "unstructured": "Isobe, T. and Osserman, EF. (1974) Patterns of amyloidosis and their association with plasma cell dyscrasia, monoclonal immunoglobulins and Bence Jones proteins. N Engl J Med 290, 473\u2013477.", "journal-title": "N Engl J Med"}, {"key": "55_CR2", "first-page": "425", "volume": "74", "author": "T Isobe", "year": "1989", "unstructured": "Isobe, T. (1989) AL amyloidosis: A metabolic disease. Haematologica 74, 425\u2013429.", "journal-title": "Haematologica"}, {"key": "55_CR3", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1097/00005792-197507000-00001", "volume": "54", "author": "RA Kyle", "year": "1975", "unstructured": "Kyle RA, Bayrd ED: Amyloidosis: review of 236 cases. Medicine (Baltimore) 54: 271\u2013299, 1975.", "journal-title": "Medicine (Baltimore)"}, {"key": "55_CR4", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/0037-198X(86)90027-1", "volume": "21", "author": "PP Scott", "year": "1986", "unstructured": "Scott PP, Scott WW, Siegelman SS (1986), Amyloidosis: an overview: Seminars in Roentgenol 21, 103\u2013112.", "journal-title": "Amyloidosis: an overview: Seminars in Roentgenol"}, {"key": "55_CR5", "author": "T Isobe", "first-page": "477", "year": "1986", "unstructured": "Isobe, T, Tonoike H, Kametani F, Shinoda T. (1986) Amyloidogenicity and subgroups of human lambda Bence Jones proteins. In Amyloidosis ed by Glenner GG et al New York, Plenum pp. 477\u2013481.", "volume-title": "Amyloidosis", "DOI": "10.1007/978-1-4613-2199-6_60", "doi-asserted-by": "publisher"}, {"key": "55_CR6", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/path.1711510102", "volume": "151", "author": "A Cohen", "year": "1987", "unstructured": "Cohen, A. and Connors, LH. (1987) The pathogenesis and biochemistry of amyloidosis. J Pathol 151, 1\u201310.", "journal-title": "J Pathol"}], "container-title": ["Amyloid and Amyloidosis 1990"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-94-011-3284-8_55", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 21]], "date-time": "2019-04-21T07:50:36Z", "timestamp": 1555833036000}, "score": 24.074894, "issued": {"date-parts": [[1991]]}, "ISBN": ["9789401054508", "9789401132848"], "references-count": 6, "URL": "http://dx.doi.org/10.1007/978-94-011-3284-8_55", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:44:02Z", "timestamp": 1574095442086}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 6, 1]], "date-time": "1996-06-01T00:00:00Z", "timestamp": 833587200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of the Neurological Sciences"], "published-print": {"date-parts": [[1996, 6]]}, "DOI": "10.1016/0022-510x(96)00007-x", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:51:28Z", "timestamp": 1027601488000}, "page": "168", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reply to M. Yamada's letter to the editor: An amyloid protein in familial cerebral amyloid angiopathy (British type)"], "prefix": "10.1016", "volume": "138", "author": [{"given": "Gordon T.", "family": "Plant", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of the Neurological Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0022510X9600007X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0022510X9600007X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T05:28:57Z", "timestamp": 1556602137000}, "score": 23.96873, "issued": {"date-parts": [[1996, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 6]]}, "issue": "1-2"}, "alternative-id": ["0022510X9600007X"], "URL": "http://dx.doi.org/10.1016/0022-510x(96)00007-x", "ISSN": ["0022-510X"], "issn-type": [{"value": "0022-510X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:20:28Z", "timestamp": 1574162428136}, "reference-count": 16, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6666, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Neurol."], "published-print": {"date-parts": [[1997, 6]]}, "DOI": "10.1002/ana.410410604", "type": "journal-article", "created": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T15:01:22Z", "timestamp": 1104591682000}, "page": "701-702", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Cerebral amyloid angiopathy and apolipoprotein E: Bad news for the good allele?"], "prefix": "10.1002", "volume": "41", "author": [{"given": "Steven M.", "family": "Greenberg", "sequence": "first", "affiliation": []}, {"given": "Bradley T.", "family": "Hyman", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/ana.410410604-BIB1", "author": "Nicoll", "volume": "41", "first-page": "716", "year": "1997", "journal-title": "Ann Neurol"}, {"key": "10.1002/ana.410410604-BIB2", "author": "Davis", "volume": "93", "first-page": "2996", "year": "1996", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/ana.410410604-BIB3", "author": "Mandybur", "volume": "45", "first-page": "79", "year": "1986", "journal-title": "J Neuropathol Exp Neurol"}, {"key": "10.1002/ana.410410604-BIB4", "author": "Vonsattel", "volume": "30", "first-page": "637", "year": "1991", "journal-title": "Ann Neurol"}, {"key": "10.1002/ana.410410604-BIB5", "author": "Maeda", "volume": "24", "first-page": "1857", "year": "1993", "journal-title": "Stroke", "DOI": "10.1161/01.STR.24.12.1857", "doi-asserted-by": "crossref"}, {"key": "10.1002/ana.410410604-BIB6", "author": "Vinters", "volume": "18", "first-page": "311", "year": "1987", "journal-title": "Stroke", "DOI": "10.1161/01.STR.18.2.311", "doi-asserted-by": "crossref"}, {"key": "10.1002/ana.410410604-BIB7", "author": "Schmechel", "volume": "90", "first-page": "9649", "year": "1993", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/ana.410410604-BIB8", "author": "Polvikoski", "volume": "333", "first-page": "1242", "year": "1995", "journal-title": "N Engl J Med"}, {"key": "10.1002/ana.410410604-BIB9", "author": "G\u00f3mez-Isla", "volume": "39", "first-page": "62", "year": "1996", "journal-title": "Ann Neurol"}, {"key": "10.1002/ana.410410604-BIB10", "author": "Corder", "volume": "7", "first-page": "180", "year": "1994", "journal-title": "Nat Genet"}, {"key": "10.1002/ana.410410604-BIB11", "author": "Greenberg", "volume": "38", "first-page": "254", "year": "1995", "journal-title": "Ann Neurol"}, {"key": "10.1002/ana.410410604-BIB12", "author": "Premkumar", "volume": "148", "first-page": "2083", "year": "1996", "journal-title": "Am J Pathol"}, {"key": "10.1002/ana.410410604-BIB13", "author": "Itoh", "volume": "27", "first-page": "216", "year": "1996", "journal-title": "Stroke", "DOI": "10.1161/01.STR.27.2.216", "doi-asserted-by": "crossref"}, {"key": "10.1002/ana.410410604-BIB14", "author": "Greenberg", "volume": "27", "first-page": "1333", "year": "1996", "journal-title": "Stroke", "DOI": "10.1161/01.STR.27.8.1333", "doi-asserted-by": "crossref"}, {"key": "10.1002/ana.410410604-BIB15", "author": "Ma", "volume": "372", "first-page": "92", "year": "1994", "journal-title": "Nature"}, {"key": "10.1002/ana.410410604-BIB16", "author": "Yamada", "volume": "27", "first-page": "1155", "year": "1996", "journal-title": "Stroke", "DOI": "10.1161/01.STR.27.7.1155", "doi-asserted-by": "crossref"}], "container-title": ["Annals of Neurology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410410604", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410410604", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T20:15:12Z", "timestamp": 1533068112000}, "score": 23.779516, "issued": {"date-parts": [[1997, 6]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[1997, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/ana.410410604", "relation": {"cites": []}, "ISSN": ["0364-5134", "1531-8249"], "issn-type": [{"value": "0364-5134", "type": "print"}, {"value": "1531-8249", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T08:31:58Z", "timestamp": 1575189118884}, "reference-count": 5, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 12, 1]], "date-time": "2005-12-01T00:00:00Z", "timestamp": 1133395200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Neurol"], "published-print": {"date-parts": [[2005, 12]]}, "DOI": "10.1038/ncpneuro0019", "type": "journal-article", "created": {"date-parts": [[2005, 11, 23]], "date-time": "2005-11-23T13:40:14Z", "timestamp": 1132753214000}, "page": "84-85", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Is amyloid-\u03b2-peptide immunization clinically effective in patients with Alzheimer's disease?"], "prefix": "10.1038", "volume": "1", "author": [{"given": "Thomas", "family": "Wisniewski", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "BFncpneuro0019_CR1", "doi-asserted-by": "publisher", "first-page": "72", "DOI": "10.1111/j.1750-3639.2005.tb00102.x", "volume": "15", "author": "T Wisniewski", "year": "2005", "unstructured": "Wisniewski T and Frangione B (2005) Immunological and anti-chaperone therapeutic approaches for Alzheimer's disease. Brain Pathol 15: 72\u201377", "journal-title": "Brain Pathol"}, {"key": "BFncpneuro0019_CR2", "doi-asserted-by": "publisher", "first-page": "448", "DOI": "10.1038/nm840", "volume": "9", "author": "JA Nicoll", "year": "2005", "unstructured": "Nicoll JA et al. (2005) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9: 448\u2013452", "journal-title": "Nat Med"}, {"key": "BFncpneuro0019_CR3", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1111/j.1750-3639.2004.tb00493.x", "volume": "14", "author": "I Ferrer", "year": "2004", "unstructured": "Ferrer I et al. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14: 11\u201320", "journal-title": "Brain Pathol"}, {"key": "BFncpneuro0019_CR4", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1212/01.WNL.0000148590.39911.DF", "volume": "64", "author": "E Masliah", "year": "2005", "unstructured": "Masliah E et al. (2005) A\u03b2 vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64: 129\u2013131", "journal-title": "Neurology"}, {"key": "BFncpneuro0019_CR5", "doi-asserted-by": "publisher", "first-page": "1563", "DOI": "10.1212/01.WNL.0000159743.08996.99", "volume": "64", "author": "NC Fox", "year": "2005", "unstructured": "Fox NC et al. (2005) Effects of A\u03b2 immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurol 64: 1563\u20131572", "journal-title": "Neurol"}], "container-title": ["Nature Clinical Practice Neurology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/ncpneuro0019.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/ncpneuro0019", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/doifinder/10.1038/ncpneuro0019", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}, {"URL": "http://www.nature.com/articles/ncpneuro0019.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T22:58:28Z", "timestamp": 1552777108000}, "score": 23.695847, "issued": {"date-parts": [[2005, 12]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2005, 12]]}, "issue": "2"}, "alternative-id": ["BFncpneuro0019"], "URL": "http://dx.doi.org/10.1038/ncpneuro0019", "relation": {"cites": []}, "ISSN": ["1745-834X", "1745-8358"], "issn-type": [{"value": "1745-834X", "type": "print"}, {"value": "1745-8358", "type": "electronic"}], "subject": ["Cellular and Molecular Neuroscience", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:10:53Z", "timestamp": 1574493053356}, "publisher-location": "Berlin, Heidelberg", "reference-count": 32, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642801112", "type": "print"}, {"value": "9783642801099", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996]]}, "DOI": "10.1007/978-3-642-80109-9_13", "type": "book-chapter", "created": {"date-parts": [[2012, 7, 28]], "date-time": "2012-07-28T23:40:23Z", "timestamp": 1343518823000}, "page": "151-160", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Chaperoning Amyloid in Alzheimer\u2019s Disease: The Art of Avoiding Sticky Situations?"], "prefix": "10.1007", "author": [{"given": "B.", "family": "Frangione", "sequence": "first", "affiliation": []}, {"given": "E. M.", "family": "Casta\u00f1o", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Prelli", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Soto", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Ghiso", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Wisniewski", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "13_CR1", "doi-asserted-by": "publisher", "first-page": "2092", "DOI": "10.1073/pnas.90.5.2092", "volume": "90", "author": "J Busciglio", "year": "1993", "unstructured": "Busciglio J, Gabuzda D, Matsudaira P, Yanker B (1993) Generation of \u00df-amyloid in the secretory pathway in neuronal and non neuronal cells. Proc Natl Acad Sci USA 90: 2092\u20132096", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR2", "doi-asserted-by": "publisher", "first-page": "782", "DOI": "10.1016/S0006-291X(86)80241-8", "volume": "141", "author": "E Casta\u00f1o", "year": "1986", "unstructured": "Casta\u00f1o E, Ghiso J, Prelli F, Gorevic P, Migheli A, Frangione B (1986) In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer\u2019s disease \u00df-protein. Biochem Biophys Res Commun 141: 782\u2013789", "journal-title": "Biochem Biophys Res Commun"}, {"key": "13_CR3", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1042/bj3060599", "volume": "306", "author": "EM Casta\u00f1o", "year": "1995", "unstructured": "Casta\u00f1o EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B (1995) Fibrillogenesis in Alzheimer\u2019s disease of amyloid \u00df peptides and apolipoprotein E. Biochem J 306: 599\u2013604", "journal-title": "Biochem J"}, {"key": "13_CR4", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1042/bj2930027", "volume": "293", "author": "J Ghiso", "year": "1993", "unstructured": "Ghiso J, Matsubara E, Koudinov A, Choi-Miura N, Tomita M, Wisniewski T, Frangione B (1993) The cerebrospinal fluid soluble form of Alzheimer\u2019s amyloid beta is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane attack complex. Biochem J 293: 27\u201330", "journal-title": "Biochem J"}, {"key": "13_CR5", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1007/BF02778007", "volume": "8", "author": "J Ghiso", "year": "1994", "unstructured": "Ghiso J, Wisniewski T, Frangione B (1994) Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 8: 49\u201364", "journal-title": "Mol Neurobiol"}, {"key": "13_CR6", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1016/0304-3940(95)11565-7", "volume": "191", "author": "A Golabek", "year": "1995", "unstructured": "Golabek A, Marques MA, Lalowski M, Wisniewski T (1995) Alzheimer\u2019s disease amyloid binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett 191: 79\u201382", "journal-title": "Neurosci Lett"}, {"key": "13_CR7", "doi-asserted-by": "publisher", "first-page": "322", "DOI": "10.1038/359322a0", "volume": "359", "author": "C Haass", "year": "1992", "unstructured": "Haass C, Schlossmacher M, Hung A, Vigo-Pelfrey C, Mellon A, Ostaszewski B, Lieberburg I, Koo E, Schenk D, Teplow D, Selkoe D (1992) Amyloid \u00df-peptide is produced by cultured cells during normal metabolism. Nature 359: 322\u2013325", "journal-title": "Nature"}, {"key": "13_CR8", "doi-asserted-by": "publisher", "first-page": "6953", "DOI": "10.1073/pnas.84.19.6953", "volume": "84", "author": "D Kirschner", "year": "1987", "unstructured": "Kirschner D, Inouye H, Duffy L, Sinclair A, Linda M, Selkoe D (1987) Synthetic peptides homologous to \u00df-protein from Alzheimer\u2019s disease form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 84: 6953\u20136957", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR9", "doi-asserted-by": "publisher", "first-page": "1164", "DOI": "10.1006/bbrc.1994.2788", "volume": "205", "author": "A Koudinov", "year": "1994", "unstructured": "Koudinov A, Matsubara E, Frangione B, Ghiso J (1994) The soluble form of Alzheimer\u2019s amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun 205: 1164\u20131170", "journal-title": "Biochem Biophys Res Commun"}, {"key": "13_CR10", "doi-asserted-by": "publisher", "first-page": "1124", "DOI": "10.1126/science.2111584", "volume": "248", "author": "E Levy", "year": "1990", "unstructured": "Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, VanDuinen SG, Bots GTAM, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124\u20131126", "journal-title": "Science"}, {"key": "13_CR11", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1038/372092a0", "volume": "372", "author": "J Ma", "year": "1994", "unstructured": "Ma J, Yee A, Brewer HB, Das S, Potter H (1994) The amyloid associated proteins a1 antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer\u2019s \u00df-protein into filaments. Nature 372: 92\u201394", "journal-title": "Nature"}, {"key": "13_CR12", "doi-asserted-by": "publisher", "first-page": "7563", "DOI": "10.1074/jbc.270.13.7563", "volume": "270", "author": "E Matsubara", "year": "1995", "unstructured": "Matsubara E, Frangione B, Ghiso J (1995) Characterization of apolipoprotein J-Alzheimer\u2019s A\u00df interaction. J Biol Chem 270: 7563\u20137567", "journal-title": "J Biol Chem"}, {"key": "13_CR13", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1006/abbi.1993.1112", "volume": "301", "author": "DL Miller", "year": "1993", "unstructured": "Miller DL, Papayannopoulos LA, Styles J, Bobin SA, Lin YY, Bieman K, Iqbal K (1993) Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2019s disease. Arch Bioch Biophys 301: 41\u201352", "journal-title": "Arch Bioch Biophys"}, {"key": "13_CR14", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/0896-6273(95)90079-9", "volume": "15", "author": "J Naslund", "year": "1995", "unstructured": "Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N, Gandy SA, Lanndelt L, Terenius L, Nordstedt C (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid \u00df peptide in Alzheimer\u2019s disease brain. Neuron 15: 219\u2013228", "journal-title": "Neuron"}, {"key": "13_CR15", "doi-asserted-by": "publisher", "first-page": "1515", "DOI": "10.1126/science.1675487", "volume": "252", "author": "S Prusiner", "year": "1991", "unstructured": "Prusiner S (1991) Molecular biology of prion diseases. Science 252: 1515\u20131522", "journal-title": "Science"}, {"key": "13_CR16", "doi-asserted-by": "crossref", "first-page": "1467", "DOI": "10.1212/WNL.43.8.1467", "volume": "43", "author": "AM Saunders", "year": "1993", "unstructured": "Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Grapper-Maclachan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43: 1467\u20131472", "journal-title": "Neurology"}, {"key": "13_CR17", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1038/359325a0", "volume": "359", "author": "P Seubert", "year": "1992", "unstructured": "Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer\u2019s -peptide from biological fluids. Nature 359: 325\u2013327", "journal-title": "Nature"}, {"key": "13_CR18", "doi-asserted-by": "publisher", "first-page": "126", "DOI": "10.1126/science.1439760", "volume": "258", "author": "M Shoji", "year": "1992", "unstructured": "Shoji M, Golde T, Ghiso J, Cheung T, Estus S, Shaffer L, Cai X-D, McKay D, Tintner R, Frangione B, Younkin S (1992) Production of the Alzheimer\u2019s amyloid \u00df protein by normal proteolytic processing. Science 258: 126\u2013129", "journal-title": "Science"}, {"key": "13_CR19", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/0304-3940(95)11299-C", "volume": "186", "author": "C Soto", "year": "1995", "unstructured": "Soto C, Frangione B (1995) Two conformational states of amyloid \u00df-peptide: implications for the pathogenesis of Alzheimer\u2019s disease. Neurosci Lett 186: 115\u2013118", "journal-title": "Neurosci Lett"}, {"key": "13_CR20", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1073/pnas.90.5.1977", "volume": "90", "author": "WJ Strittmatter", "year": "1993", "unstructured": "Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD (1993a) Apolipoprotein E: high-avidity binding to \u00df-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer\u2019s disease. Proc Natl Acad Sci USA 90: 1977\u2013 1981", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR21", "doi-asserted-by": "publisher", "first-page": "8098", "DOI": "10.1073/pnas.90.17.8098", "volume": "90", "author": "WJ Strittmatter", "year": "1993", "unstructured": "Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993b) Binding of human apolipoprotein E to synthetic amyloid \u00df: isoform specific effects and implications for lateonset Alzheimer\u2019s disease. Proc Natl Acad Sci USA 90: 8098\u20138102", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "13_CR22", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1038/ng0594-74", "volume": "7", "author": "CM Dujin van", "year": "1994", "unstructured": "van Dujin CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer\u2019s disease. Nature Genet 7: 74\u201378", "journal-title": "Nature Genet"}, {"key": "13_CR23", "doi-asserted-by": "publisher", "first-page": "1965", "DOI": "10.1111/j.1471-4159.1993.tb09841.x", "volume": "61", "author": "C Vigo-Pelfrey", "year": "1993", "unstructured": "Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk D (1993) Characterization of \u00df-amyloid peptide from human cerebrospinal fluid. J Neurochem 61: 1965\u20131968", "journal-title": "J Neurochem"}, {"key": "13_CR24", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0304-3940(92)90444-C", "volume": "135", "author": "T Wisniewski", "year": "1992", "unstructured": "Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathologic chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235\u2013238", "journal-title": "Neurosci Lett"}, {"key": "13_CR25", "doi-asserted-by": "publisher", "first-page": "1247", "DOI": "10.1016/0006-291X(91)91706-I", "volume": "179", "author": "T Wisniewski", "year": "1991", "unstructured": "Wisniewski T, Ghiso J, Frangione B (1991) Peptides homologous to the amyloid protein of Alzheimer\u2019s disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 179: 1247\u20131254", "journal-title": "Biochem Biophys Res Commun"}, {"key": "13_CR26", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1002/ana.410340422", "volume": "34", "author": "T Wisniewski", "year": "1993", "unstructured": "Wisniewski T, Casta\u00f1o E, Ghiso J, Frangione B (1993) Cerebrospinal fluid inhibits Alzheimer \u00df- amyloid fibril formation in vitro. Ann Neurol 34: 631\u2013633", "journal-title": "Ann Neurol"}, {"key": "13_CR27", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/0197-4580(94)90105-8", "volume": "15", "author": "T Wisniewski", "year": "1994", "unstructured": "Wisniewski T, Ghiso J, Frangione B (1994a) Alzheimer\u2019s disease and soluble A\u00df. Neurobiol Aging 15: 143\u2013152", "journal-title": "Neurobiol Aging"}, {"key": "13_CR28", "first-page": "1030", "volume": "145", "author": "T Wisniewski", "year": "1994", "unstructured": "Wisniewski T, Casta\u00f1o EM, Golabek A, Vogel T, Frangione B (1994b) Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030\u20131035", "journal-title": "Am J Pathol"}, {"key": "13_CR29", "doi-asserted-by": "publisher", "first-page": "956", "DOI": "10.1016/S0140-6736(95)90701-7", "volume": "345", "author": "T Wisniewski", "year": "1995", "unstructured": "Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B (1995a) Is Alzheimer\u2019s disease an apolipoprotein E amyloidosis? The Lancet 345: 956\u2013958", "journal-title": "The Lancet"}, {"key": "13_CR30", "first-page": "238", "volume": "147", "author": "T Wisniewski", "year": "1995", "unstructured": "Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B (1995b) Conformational mimicry in Alzheimer\u2019s disease. Am J Pathol 147: 238\u2013244", "journal-title": "Am J Pathol"}, {"key": "13_CR31", "doi-asserted-by": "publisher", "first-page": "1431", "DOI": "10.1006/bbrc.1994.2825", "volume": "205", "author": "BV Zlokovic", "year": "1994", "unstructured": "Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J (1994) Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer\u2019s amyloid \u00df. Biochem Biophys Res Commun 205: 1431\u20131437", "journal-title": "Biochem Biophys Res Commun"}, {"key": "13_CR32", "author": "BV Zlokovic", "year": "1996", "unstructured": "Zlokovic BV, Martel CL, Matsubara E, McComb JG, Zneng G, McCluskey RT, Frangione B, Ghiso J (1996) Gp 330/megalin: probable role in receptor-mediated transport of Apolipoprotein J alone and in complex with Alzheimer\u2019s amyloid \u00df at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci USA (in press)", "volume-title": "Gp 330/megalin: probable role in receptor-mediated transport of Apolipoprotein J alone and in complex with Alzheimer\u2019s amyloid \u00df at the blood-brain and blood-cerebrospinal fluid barriers"}], "container-title": ["Apolipoprotein E and Alzheimer\u2019s Disease"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-80109-9_13", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T17:20:11Z", "timestamp": 1572888011000}, "score": 23.635757, "issued": {"date-parts": [[1996]]}, "ISBN": ["9783642801112", "9783642801099"], "references-count": 32, "URL": "http://dx.doi.org/10.1007/978-3-642-80109-9_13", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}